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Abstract
Dermal wound repair involves complex interactions between cells, cytokines and
mechanics to close injuries to the skin. In particular, we investigate the contribu-
tion of fibroblasts, myofibroblasts, TGFβ, collagen and local tissue mechanics to
wound repair in the human dermis. We develop a morphoelastic model where a
realistic representation of tissue mechanics is key, and a fibrocontractive model that
involves a reasonable approximation to the true kinetics of the important bioactive
species. We use each of these descriptions to elucidate the mechanisms that gener-
ate pathologies such as hypertrophic scars, contractures and keloids.
We find that for hypertrophic scar and contracture development, factors regulating
the myofibroblast phenotype are critical, with heightened myofibroblast activation,
reduced myofibroblast apoptosis or prolonged inflammation all predicted as medi-
ators for scar hypertrophy and contractures. Prevention of these pathologies is pre-
dicted when myofibroblast apoptosis is induced, myofibroblast activation is blocked
or TGFβ is neutralised.
To investigate keloid invasion, we develop a caricature representation of the fibro-
contractive model and find that TGFβ spread is the driving factor behind keloid
growth. Blocking activation of TGFβ is found to cause keloid regression. Thus, we
v
recommend myofibroblasts and TGFβ as targets for clinicians when developing in-
tervention strategies for prevention and cure of fibrotic scars.
Keywords: Apoptosis, biomechanics, continuum mechanics, contracture, dermal
wound healing, fibroblast, hypertrophic scar, inflammation, keloid, mathematical bi-
ology, mathematical modelling, morphoelasticity, myofibroblast, therapy, transform-
ing growth factor β, viscoelasticity, zero stress state
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CHAPTER 1
Introduction
The repair of dermal wounds represents a significant economic burden worldwide.
In the United States alone, chronic wounds affect 6.5 million people, with an esti-
mated US$25 billion spent on treatment regimes annually. Indeed, annual wound
care products for chronic wounds are projected to reach $15.3 billion this year (Sen
et al., 2009). The need for postsurgical wound care is also increasing rapidly. In the
United States it is expected to reach US$38 million annually by 2012 (Sen et al., 2009).
Surgical and burn injuries in particular present unique issues, with 40 − 94% of sur-
gical wounds and 30− 91% of burn injuries healing with pathological scarring (Bloe-
men et al., 2009). Notably, 5 − 15% of acute wounds heal with fibroproliferative dis-
orders, and a significant cost is incurred in the treatment of such pathological scars.
Analysts at Nomura Code conservatively estimate the anti-scarring drug market at
US$12 billion in skin applications alone (Sen et al., 2009). Without effective preven-
tative and curative procedures, each of these costs are expected to rapidly increase.
There is not only the economic pressure to develop effective treatment strategies for
wounds, there is also a social imperative. Skin disorders account for US$39 billion of
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lost wages annually. Indeed, apart from lost of income, these patients endure disabil-
ity, fear, social isolation, anger, depression and negative self-image (Bock et al., 2006;
Herber et al., 2007; Brown et al., 2008, 2010). Indeed, mobile amputees possess a
better psychological outlook than patients with diabetic foot ulcers (Sen et al., 2009).
This psychological aspect is particularly important, as there appears to be a corre-
lation between poor outlook and delayed repair of chronic wounds (Cole-King and
Harding, 2001). Patients also frequently experience pain (both physical and psycho-
logical) and disfigurement from hypertrophic scars and keloids (Brown et al., 2008,
2010). Indeed, the persistent nature of these scars coupled with unempathic man-
agement by medical practitioners compounds the frustration and isolation experi-
enced by these patients (Brown et al., 2008). Additionally, both keloids and hyper-
trophic scars may give rise to contractures, which can result in deformation of the
surrounding tissue and loss of functionality if the contracture occurs near a joint.
Together, these facts highlight the need for research into dermal repair and, in par-
ticular, the urgency for the development of intervention strategies which ameliorate
or prevent scar appearance and thereby decreasing expenditure on wounds while
simultaneously improving patient quality of life.
Under normal circumstances, the repair of severed skin simply results in a scar that
is biologically and mechanically inferior to the surrounding unwounded tissue. In
the case of burns, pathological scarring is common, resulting in hypertrophic scars
and contractures. When healing is hindered by underlying conditions, such as di-
abetes, an impaired response can occur resulting in a chronic wound or ulcer. In
these cases medical intervention is often required to achieve wound closure. As
mentioned above, hypertrophic scars commonly occur following surgery or burns
(Bloemen et al., 2009), while keloids can occur spontaneously. Keloids behave in
a manner similar to benign dermal tumours, invading the surrounded tissue and
causing raised, unsightly and irritable scars. In abnormal healing, it is the complex
interactions between the cellular, chemical and mechanical aspects that contribute
to poor repair. We discuss keloid and hypertrophic scar development in detail in
Chapter 2. In 1996, Clark, a world-leading researcher in wound healing, gave a clear
statement of the state of the field at that time and this statement still holds today:
3Clinical investigators had hoped that the great strides in basic knowl-
edge would quickly lead to advancements in wound care that would cul-
minate in accelerated rates of ulcer and normal wound repair, scars of
greater strength, prevention of keloids and fibrosis, and ultimately sub-
stitute tissue regeneration for scar formation. These lofty ideals still have
not been achieved, new scientific information continues to accumulate
at an accelerating pace. It has never been more clear that today’s scien-
tific breakthroughs will lead to tomorrow’s therapeutic successes. (Clark,
1996)
Skin itself is composed of two layers; the outer superficial layer, known as the epi-
dermis, which functions as a protective barrier to bacteria, viruses, UV radiation and
foreign material (MacNeal, 2006). The inner layer, under the epidermis, is known as
the dermis, providing structural integrity and tethering the skin to the subcutaneous
tissue. Figure 1.1 provides a representation of normal cutaneous architecture. The
dermis also contains nerves, hair follicles, sweat glands, vasculature and other com-
mon skin organs (MacNeil, 2007). In this dissertation we are solely concerned with
dermal repair, choosing to neglect any affects that epidermal healing has on dermal
repair. Consequently, we ignore the signalling between keratinocytes and fibrob-
lasts (the primary cell types in epidermal and dermal repair, respectively), which is
thought to contribute to the closure of dermal wounds and whose interactions are
thought to be key in the generation of keloids. Keratinocytes are thought to regu-
late the fibroblastic response, and by neglecting keratinocytes in our model, we limit
ourselves to cases where the quality of repair is due solely to the dermal response.
Wounds are commonly classified into one of three categories: healing by first, sec-
ond or third intention. Healing by first intention occurs when the wound edges are
abutted, there is minimal infection and there is little necrotic tissue. This injury is
typical of that made following surgery, and usually heals without complications in
healthy individuals. Healing by second intention typically occurs when there is a
delay in the healing response such as if the wound margins are separated, infection
occurs or the wound is devitalized, i.e. involving bruising (comprising disruption of
the blood vessel network) or necrotic tissue (Majno and Joris, 2004). Repair of this
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Figure 1.1: The structure of human skin. This diagram of human skin shows the two
main layers of skin - the upper epidermal barrier layer and the lower, much thicker,
dermis. The epidermal barrier layer is relatively thin (0.1− 0.2mm in depth) and se-
curely attached to the underlying dermis by a specialized basement membrane zone.
This consists of several different types of collagen fibre, which attach cells securely
to the underlying dermis, and is visible at the electron-microscope level. The der-
mis varies in thickness depending on its site in the body and is composed primar-
ily of collagen I, with dermal inclusions of hair shafts and sweat glands, which are
lined with epidermal keratinocytes. The dermis is well vascularised and also con-
tains receptors for touch, temperature and pain. Keratinocytes in the epidermis rely
solely on diffusion from the adjacent dermal capillary network. These cells progres-
sively differentiate from cells in the basal layer, which is located on the basement
membrane and gives rise to daughter keratinocytes, which are are pushed upwards.
These stratify, lose their nuclei and eventually become an integrated sheet of keratin,
which is later shed. The upper keratinized epidermal layers provide the barrier layer,
which resists bacterial entry and prevents fluid and electrolyte loss. Reprinted with
permission from MacNeil (2007) from Elsevier.
5type is far more complicated, involving a more intense inflammatory response than
healing by first intention as infection or foreign materials must be removed from the
wound before closure can proceed successfully. Second intention wounds are typi-
cally left open and allowed to close spontaneously via contraction and reepithelial-
ization. Tertiary wound closure however involves initial debridement of the injury,
followed by an observational period where the wound remains open. Medical inter-
vention is then applied to effect wound closure (Gabriel et al., 2009). More details of
the stages of wound healing are given in Chapter 2.
Wound severity is typically evaluated via depth, as either superficial (involving only
the epidermal layer), partial thickness wounds (extending through the epidermis
partway into the dermal layer) or as full thickness injuries (where the wound reaches
the underlying tissue). Partial and full thickness lesions are more likely to exhibit
fibrotic repair than superficial injuries (Cuttle et al., 2006). This is particularly true
of burn injuries where deep dermal wounds typically have poor aesthetic and func-
tional outcomes.
Building mathematical simulations of biological phenomena is a cost- and time-eff-
ective method to gain insight into complicated biological situations. Additionally,
there continues to be an explosion of experimental results that challenges the abil-
ities of biologists to synthesize the data and draw conclusions from them (Fried-
man, 2010). Representing a biological system as a mathematical model allows the re-
searcher to extract and consider a component of the wider system, develop strategies
and inform clinical research. This is necessarily a coordinated approach between
biologists and mathematicians. The biologist poses the question or a set of exper-
iments and the mathematician develops a model to describe the scenario. Indeed,
there are now many examples that typify the interface of mathematical-biological
research, including DNA transcription, cellular motility and aggregation, tissue me-
chanics, population dynamics, enzyme kinetics, pattern formation, embryogenesis
and tissue development, just to name a few (Murray, 2003a,b). Of particular interest,
is the application of mathematics to biological issues such as infectious diseases,
tumour growth and tissue repair and regeneration, where mathematics can inves-
tigate, elucidate and describe not only the genesis of these ailments but can offer
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insight into potential remedies. Indeed, “the coming decade will demonstrate very
clearly that mathematics is the future frontier of biology and biology is the future
frontier of mathematics” (Friedman, 2010).
One notable example is the realm of acute dermal wound repair where bio-mathe-
maticians have investigated the overall repair process (Tranquillo and Murray, 1992;
Cook, 1995; Olsen et al., 1995; Hall, 2009; Javierre et al., 2009; Murphy et al., 2011b,a),
as well as the pathogenesis of fibrotic healing responses and possible intervention
strategies (see for instance Olsen et al., 1997, and Cobbold and Sherratt, 2000, as well
as Chapters 5 and 6 of this thesis).
In this thesis we consider a mathematical investigation of the interaction between
the inflammatory response and mechanical aspects of dermal wound repair. The
purpose of this investigation is to develop a more realistic representation of dermal
wound healing which can be used to predict possible treatment regimes for hyper-
trophic scars, contractures and keloids.
The thesis is structured as follows:
The need for an appropriate mechanical framework in mathematical models for der-
mal wounds is well established. Thus, in Chapter 3 we consider a morphoelastic
representation for dermal wound repair that utilizes a new representation for tissue
mechanics based on the work of Cook (1995) and Hall (2009). We compare the pre-
dictions from this model against experimental results for rat dermal repair obtained
by McGrath and Simon (1983), and find that this representation simulates each con-
tractile stage of repair. Investigation into the predictions of this model indicates that
the inflammatory response and myofibroblasts are key to the formation of hyper-
trophic scars and contractures.
Currently, mechanochemical models for dermal repair do not include a realistic rep-
resentation of the chemical kinetics. In Chapter 4 we discuss the fibrocontractive
model, which represents an extension of the Tranquillo and Murray (1992), Olsen
et al. (1995) and Dale et al. (1997) models. The fibrocontractive model considers the
interactions between fibroblasts and myofibroblasts, transforming growth factor-β,
collagenase, collagen and tissue mechanics in normal human dermal repair. Using
7this model, we sought to predict the wound contraction results of Catty (1965) for
human dermal repair, and illustrate that human wounds behave in a manner funda-
mentally distinct from those in animal models such as mice, rats and rabbits.
The issue of hypertrophic scars and contractures is fundamental in the repair of der-
mal tissue. In Chapter 5 we examine clinical predictions from the morphoelastic
model described in Chapter 3. In particular, we investigate possible therapeutic op-
tions for wounds healing with excessive contraction or developing into hypertrophic
scars. In Chapter 3 it was surmised that transforming growth factor-β and the pres-
ence of myofibroblasts are key to the development of pathological scars. Here we
seek to investigate targeting of transforming growth factor-β and myofibroblasts as
a therapeutic strategy for hypertrophic scars.
Keloids are particularly distressing for those afflicted. In Chapter 6 we consider
keloid development and treatment by reducing the fibrocontractive model devel-
oped in Chapter 4. We focus on the role of transforming growth factor-β and tis-
sue tension in the formation of keloids, and investigate if targeting of transforming
growth factor-β is an effective method for keloid prevention and regression.
Finally, in Chapter 7 we discuss the conclusions of the work thus far described, pos-
sible extensions and future work.

CHAPTER 2
Literature Review
2.1 Overview of the Wound Healing Process
Despite the underlying processes in wound repair being well-delineated, the over-
arching stages into which these processes are characterised remains disputed. Kir-
itsy and Lynch (1993), Grinnell (1994) and Majno and Joris (2004) all agree on a di-
vision of healing into three stages, but each describes different processes as key to
dermal repair. Enoch et al. (2006) and Enoch and Leaper (2007) suggest four tempo-
rally overlapping yet distinct phases, whilst Shultz et al. (2005) proposes seven stages
of cutaneous repair. In this thesis, we consider the division to be that proposed by
Enoch et al. (2006) and Enoch and Leaper (2007) involving: 1) haemostasis, 2) in-
flammation, 3) proliferation, and 4) remodelling and scar formation (for a graphical
representation see Figure 2.1). We now review each stage in detail.
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Figure 2.1: Overview of Wound Healing Phases. This description of wound healing
assumes four phases. A detailed discussion of the phases is given in the following
text. Reprinted with permission from Enoch et al. (2006) from Elsevier.
2.1.1 Normal Dermal Repair in Humans
Haemostasis
Haemostasis is the rapid, initial response to injury involving arresting blood flow
through the establishment of a fibrin clot (Monroe et al., 2010). This is a three-fold
process. First, bleeding is restricted through vasoconstriction, that is, the contrac-
tion of severed arterioles. Secondly, the coagulation cascade introduces platelets
into the wound space through extravasation of blood. These platelets aggregate,
forming a weak plug, known as a thrombus, in the wound space and at the perfora-
tions in the blood vessels (Majno and Joris, 2004). As the platelets degranulate, they
release fibrinogen, which experiences proteolytic cleavage by thrombin, to form fib-
rin. Finally, the clot is stabilised by platelets binding to fibrin and their combined
adherence to the subendothelium (Enoch and Leaper, 2007; Shih et al., 2010). The
clot generated within the lesion provides a provisional matrix over which fibroblasts,
macrophages and endothelial cells migrate into the wound.
Ejection of the granules by dying platelets also releases inflammatory mediators,
such as platelet-derived growth factor (PDGF), insulin-like growth factor-1 (IGF-1),
epidermal growth factor (EGF), platelet factor-IV and transforming growth factor-
β (TGFβ) (Enoch and Leaper, 2007). PDGF and TGFβ act as chemoattractants for
fibroblasts, the main cell type in dermal repair (Majno and Joris, 2004; Enoch and
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Leaper, 2007).
TGFβ is one of the main regulatory growth factors in dermal repair, implicated in
the stimulation of angiogenesis, the formation of granulation tissue, the regulation
of collagen synthesis and the development of fibroplasia1 (Roberts et al., 1992; Mu-
rata et al., 1997; Rhett et al., 2008). Moreover, the initial relative concentration of
the TGFβ isoforms is involved in determining the quality of the resulting scar. Fer-
guson and O’Kane (2004), when manipulating the repair of wounds in rats, mice
and pigs found that topical addition of TGFβ1 within the first 48 hours following in-
jury exacerbated wound repair, leading to a fibrotic scarring response, whereas addi-
tion of TGFβ3 was able to produce healing without visible scarring. Current clinical
trials in human wounds are showing similar results (Occleston et al., 2008). These
results are consistent with embryonic repair where wounds heal without scarring
and TGFβ3 concentrations are high relative to TGFβ1. Finally, neutrophils, respon-
sible for phagocytosis of bacteria and release of inflammatory mediators, are also
attracted to the wound site by the release of TGFβ1 (Border and Noble, 1994; Majno
and Joris, 2004).
Inflammation
Inflammation is triggered irrespective of the presence of infection. Depending upon
the type and severity of the wound, this process can last from several minutes to
several days. Mast cells and platelets continue to release inflammatory mediators
(Majno and Joris, 2004).
Leukocytes, macrophages and neutrophils phagocytise any bacteria, deceased cells
and detritus. Swelling may occur, and neutrophils attack foreign bodies, dying in
the process. The primary function of neutrophils is to minimize wound contamina-
tion due to bacteria. Removal of foreign bodies and necrotic tissue ensues through
discharge as wound exudate (Enoch et al., 2006), with more leukocytes recruited if
infection is detected. Once the exudate clots, it provides another surface over which
leukocytes and other cells move to attack bacteria. The wound bed is hypoxic, and
1The process of forming fibrous tissue, as normally occurs in wound healing.
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an increase in blood supply is required to support the cells recruited to the site. Un-
der hypoxic conditions, the platelets, macrophages and neutrophils release growth
factors such as vascular-endothelial growth factor (VEGF) that stimulate the unin-
jured arterioles to dilate, releasing oxygenated blood into the region (Bao et al., 2009;
Gabriel et al., 2009). The VEGF growth factors are also key chemical mediators of
angiogenesis (Roy et al., 2006).
Macrophages are a key regulatory cell for dermal repair, with a depleted popula-
tion of macrophages associated with poor wound debridement (removal of foreign
matter and dead tissue), inadequate vasculature development and delayed fibropla-
sia2 (Enoch and Leaper, 2007). The leukocytes, macrophages, platelets and neu-
trophils also release growth factors that trigger fibroblast chemotaxis and prolifer-
ation (Shultz et al., 2005). The final events of the inflammatory phase coincide with
the early onset of the proliferative stage (Enoch and Leaper, 2007).
Proliferation
Under normal repair conditions, proliferation is initiated approximately three to four
days post-wounding when fibroblasts are recruited from the surrounding undam-
aged tissue into the wound space (Shultz et al., 2005; Enoch and Leaper, 2007). These
cells proliferate and are activated to become myofibroblasts, which function as the
primary contractile cell in wound repair, while fibroblasts primarily synthesise and
remodel the local collagen network (Wipff and Hinz, 2009). Previously, it was known
that the activation of fibroblasts to myofibroblasts was TGFβ-dependent (Desmouli-
e`re et al., 1993). However, more recent experimental research by Gabbiani (2003) and
others have shown that mechanical tension is also required to initiate and maintain
this phenotypic change (Hinz, 2007; Wells and Discher, 2008; Hinz, 2009; Wipff and
Hinz, 2009; Eckes et al., 2010; Hinz, 2010).
This differentiation is a two-stage process. Firstly, mechanical tension, the result of
the compaction by tractional forces, initiates the activation to proto-myofibroblasts,
the precursors to myofibroblasts (Hinz and Gabbiani, 2003), which are characterised
2The formation of fibrous tissue.
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by mature focal adhesions and immature actin filaments (Gabbiani, 2003). Further
stimulation by mechanical tension and TGFβ induces the transformation of proto-
myofibroblasts to myofibroblasts. Myofibroblasts resemble smooth muscle cells,
and are distinguished from proto-myofibroblasts by the presence of stress fibres in
their cytosol in the form of α-smooth muscle actin (α-SMA) and supermature focal
adhesions (Hinz and Gabbiani, 2003). In Chapter 3 we extend the mechanochemi-
cal model of Cook (1995), and in Chapter 4, we consider an extension of the work of
Olsen et al. (1995) and Dale et al. (1997), both of these new representations incorpo-
rate the mechanical dependence of fibroblast to myofibroblast differentiation.
Together, these cells synthesize proteins such as collagen to replace the fibrin net-
work, and remodel the resulting collagen lattice (Hinz, 2007). This extracellular ma-
trix (ECM) network is vital for supporting the growth of new blood vessels and the
influx of cells. With the deposition of collagen by fibroblasts, endothelial cells mi-
grate into the wound space, revascularising the wound (Enoch and Leaper, 2007).
These blood vessels carry essential nutrients and oxygen for the cells.
The proliferating fibroblasts, loose collagen network and neovascularised tissue con-
stitute the granulation tissue (Enoch and Leaper, 2007), of which, an estimated 60%
are new capillaries (Kleinman and Malinda, 2000). Granulation tissue acts as a con-
tractile organ under the action of myofibroblasts resulting in a wound reduction of
up to 30% in humans (Desmoulie`re et al., 1995; Hinz et al., 2001; Farahani and Kloth,
2008). Finally, the onset of reepithelialisation signals the beginning of the final reep-
ithelialisation and remodelling phase.
Reepithelialisation and Remodelling
Collagen degradation occurs under the action of matrix metalloproteinases (MMPs)
secreted by fibroblasts, neutrophils and macrophages (Enoch and Leaper, 2005).
Tight regulation of MMPs is critical to repair as impaired healing occurs when MMPs
excessively degrade the essential collagen. The primary MMPs involved in colla-
gen degradation are MMP-1 (collagenase-1), MMP-8 (collagenase-2) and MMP-13
(collagenase-3), with each being capable of cleaving the main collagen types in skin,
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that of collagen types I and III (Ravanti et al., 1999).
Further remodelling induces a decrease in MMP activity, a reduction in the fibrob-
last and macrophage density, a halt in the outgrowth of capillaries, reduced blood
flow and wound contraction. Finally, a mature avascular scar develops consisting of
quiescent fibroblasts, and composed of dense collagen bundles (Enoch et al., 2006).
During the last stage of wound repair reepithelialisation is completed, having re-
stored the outer epidermal layer. Additionally, as tension across the wound is re-
leased, myofibroblasts undergo apoptosis, disappearing from the wound (Moulin
et al., 2004; Hinz, 2007; Farahani and Kloth, 2008), although some argue that my-
ofibroblasts transform back to fibroblasts (Olsen et al., 1995). Fibroblasts remain,
and continue to remodel the ECM, increasing the tensile strength of the wound from
approximately 20% to 70% of normal dermal strength after several months of remod-
elling (Cotran et al., 1999; Singer and Clark, 1999). During this remodelling process,
there is a continual turnover of collagen, tending to a steady state about 21 days post
wounding (Enoch and Leaper, 2007).
2.1.2 Abnormal Wound Repair
Chronic Wounds
If there is a breakdown during the wound repair process, then the wound may not
heal successfully. A wound which is characterized by an insufficient repair process
that fails to yield a sustained anatomical and functional result within an appropriate
timeframe is termed a chronic wound (Schreml et al., 2010). These wounds persist in
time and cause pain, disability and severe stress to those afflicted. Figure 2.2 shows
an example of two large chronic wounds extending over the lower portions of the
patient’s legs.
Notably, the synthesis and activity of particular proteases is heightened in chronic
wounds. Both MMP-2 and MMP-9 are found in chronic wound fluid, and yet are ab-
sent in acute wound fluid (Trengrove et al., 1999; Enoch and Leaper, 2005), although
other MMPs such as MMP-1 and MMP-3 are still found in acute wounds (Shultz et al.,
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Figure 2.2: Bilateral chronic ulcers of the leg. These ulcers are due to mixed (arte-
riovenous) aetiology. Note the extensive slough and non-viable tissue covering the
wound beds and the absence of healthy granulation tissue. Reprinted with permis-
sion from Enoch and Leaper (2007) from Elsevier.
2005). Additionally, several growth factors such as tumour necrosis factor-α (TNFα),
interleukin-1 (IL-1), and interleukin-6 (IL-6), that are associated with the inflamma-
tory response are high in chronic wound fluid (Mast and Schultz, 1996; Barrientos
et al., 2008). TNFα and IL-1 stimulate the release of MMPs while simultaneously in-
hibiting the production of TIMPs. MMPs are known to regulate collagen remodelling
and so may impair the construction of a viable scaffold over which the cells may
migrate, thereby preventing fibroblasts, keratinocytes, macrophages and endothe-
lial cells from entering the wound. There are conflicting results concerning whether
or not concentrations of TGF-β1 are increased or decreased in chronic wound fluid
(Robson, 1997; Enoch and Leaper, 2007; Barrientos et al., 2008). The concentrations
of these cytokines and MMPs decrease once healing of a chronic wound is initiated.
Clearly this suggests a strong association between chronic wounds and the inflam-
matory response (Enoch and Leaper, 2007). Indeed, as Fernandez et al. (2008) state
“one of the key characteristics of a chronic wound is that the healing process appears
to be stalled in the inflammatory phase.”
It is also known that local mechanical effects, such as increased skin tension and
excess local mobility (such as when the wound occurs over a joint) are factors in
the formation of chronic wounds (Grey et al., 2006). In particular, pressure ulcers
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result when there is persistent pressure applied between a bony prominence and an
external surface causing a local breakdown in the soft tissue (Lyder, 2003; Grey et al.,
2006). Pressure caused by the presence of the bone obstructs capillary flow, yielding
tissue necrosis (Lyder, 2003). Hence, perhaps it is the interplay between an aberrant
inflammatory response and local tissue mechanics that initiates poor repair.
Hypertrophic Scars: their origin and treatment
In particular cases such as burn injuries, defective healing occurs during the pro-
liferative and remodelling phases, giving rise to pathologies such as hypertrophic
scars and contractures. The third type of fibroproliferative disorder is known as a
keloid, and may arise from the most trivial injuries such as insect bites or ear pierc-
ings (Polson et al., 1951). Figure 2.3 shows a hypertrophic scar and Figure 2.4 shows
a keloid. Both hypertrophic scars and keloids are characterised by overproduction
of fibroblasts and extracellular components such as collagen, elastin and proteogly-
cans (Enoch and Leaper, 2007). These scars are of particular interest as they arise
in humans only, occurring in 5 − 15% of wounds. For this reason a suitable animal
model remains elusive. Currently, the most promising animal model for the study
of hypertrophic scars was developed by Aarabi et al. (2007) who applied a tension
across the wound, and were able to generate hypertrophic-like wounds in rats.
Figure 2.3: Hypertrophic scar. Hypertrophic scar in the neck region of a 15-year old
female as a result of a chemical burn injury. Reprinted with permission from Tuan
and Nichter (1998) from Elsevier.
Hypertrophic scars appear within four weeks following trauma (during the prolifer-
ative stage) and are characterised by a raised appearance, well-organised collagen
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bundles, the sustained presence of myofibroblasts, decreased cellular apoptosis, hy-
pervascularity, and an increased density of both mast cells and fibroblasts (Aarabi
et al., 2007; Kose and Waseem, 2008). The highest incidence of hypertrophic scars
are in
• wounds crossing tension lines;
• areas of increased tension and movement in skin;
• deep dermal burns; and
• wounds left to heal by secondary intention for greater than three weeks (Enoch
et al., 2006).
Interestingly, Cubison et al. (2006) observed a link between the healing time of pae-
diatric burn injuries due to scalding and the likelihood of hypertrophic scar devel-
opment (see Table 2.1). They concluded that wounds which heal after 21 days post
injury are at risk of hypertrophic scar development, while burns that heal prior to
the 21 day mark are far less likely to incur scar hypertrophy. They also observed a
marked increase in hypertrophic scarring in wounds taking 10 − 14 days to heal if
skin grafting was applied. Thus, they recommend that skin surgery should be re-
served for burns taking longer than 21 days to heal. Unfortunately, no comment
regarding depth or initial severity of the burn is recorded. Tuan and Nichter (1998)
state that hypertrophic scars are associated with prolonged inflammation. Thus, it
is possible that burns healing in under three weeks have a short or normal inflam-
matory response, while burns taking longer than three weeks possess a prolonged
inflammatory response. We explore this idea in Chapter 5.
Additionally, factors triggering local inflammation predispose wounds to forming
hypertrophic scars (Enoch and Leaper, 2007). Therefore it is clear that mechani-
cal aspects, wound depth, and inflammation are key inducers of hypertrophic scars.
Linge et al. (2005) found that while over 40% of fibroblasts undergo apoptosis in con-
tractile collagen3, there was no detection of apoptosis in hypertrophic scar fibrob-
lasts. Interestingly, Linge et al. (2005) determined that this mechanically-induced
3A “contractile collagen lattice” is one that may be deformed under the action of contractile cells
such as fibroblasts and myofibroblasts.
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Treatment Method
Days to Heal
< 10 10− 14 15− 21 22− 25 26− 30 > 30
Overall 0% 8% 20% 40% 68% 92%
Conservative 0% 2% 20% 28% 75% 94%
Skin Grafting 0% 33% 19% 54% 64% 88%
Table 2.1: Data obtained from Cubison et al. (2006) on the hypertrophic scar devel-
opment rate categorized by time to heal. These figures represent the percentage of
wounds that developed evidence of scar hypertrophy given the total time to heal fol-
lowing injury and treatment method, for example, 2% of wounds treated conserva-
tively and that closed within 15− 21 days following injury exhibited evidence of scar
hypertrophy. In total, the records of 337 children with scald injuries were examined;
of those, 251 were treated conservatively while 87 were treated with skin grafting.
apoptosis of fibroblasts was related to the synthesis and degradation of the local col-
lagen network, with the excess activity of cell surface tissue transglutaminase imped-
ing fibroblast apoptosis.
Cell surface tissue transglutaminase is thought to be responsible for ECM stabiliza-
tion, with overexpression of this enzyme associated with fibrotic conditions such
as liver fibrosis, Dupuytren’s disease and hypertrophic scarring. Linge et al. (2005)
found that hypertrophic scar fibroblasts overexpressed this compound, resulting in
a collagen matrix that was resistant to breakdown by matrix metalloproteinases and
altered the products of collagenase digestion. Consequently, there was a reduction
in the apoptosis of hypertrophic fibroblasts on contractile collagen.
Clearly, a breakdown in the regulation of fibroblast cell death is a contributing factor
to hypertrophic scars. Hypertrophic scar fibroblasts also express significantly greater
amounts of TGFβ1 than their normal counterparts (Wang et al., 2000).
Hypertrophic scars usually subside with time, although there are therapeutic modal-
ities to accelerate scar reduction (Wolfram et al., 2009). A simple excision of the scar
tissue is the therapy of choice for hypertrophic scars formed following wound infec-
tion or delayed closure. This technique achieves two aims: removal of damaged tis-
sue and scar minimisation. Where mechanical effects are problematic for tissue re-
pair, techniques which minimize local tension such as full thickness skin transplants
or composite fat-skin grafts can be used (Wolfram et al., 2009). Pressure therapy for
hypertrophic scars partly restores the ECM organization and induces myofibroblast
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apoptosis (Wolfram et al., 2009).
Other treatments for hypertrophic scars include injection of corticosteroids, appli-
cation of silicone, laser therapy, cyrotherapy and radiation (Alster and Tanzi, 2003;
Bloemen et al., 2009; Juckett and Hartman-Adams, 2009). However, each of these
methods act on the remodelling phase of wound repair. Therefore, I expect they will
have limited curative potential as these treatments act on a well-established scar.
The orientation and fibre distribution within the collagen network is largely set, and
processes such as inflammation and fibroplasia, that contribute to hypertrophic scar
appearance, have largely terminated. Indeed, as mentioned above, the timeframe
over which injuries heal is important in hypertrophic scar development, with early
healing paramount if scar hypertrophy is to be averted (Cuttle et al., 2006). Thus, a
treatment strategy applied early that aims to rescue normal repair will likely be more
effective than the aforementioned methods. In Chapter 5, predictions that target the
wound during the proliferative phase of repair with the possibility of rescuing nor-
mal repair are discussed.
Keloids: their origin and treatment
The specific cause of keloids on the other hand remains elusive (Enoch and Leaper,
2007). Formation of keloids is spontaneous and, as mentioned above, may occur
even from trivial injuries such as ear piercings (see Figure 2.4). Indeed, in some
cases, patients reported no previous trauma preceding formation of a keloid (Kose
and Waseem, 2008), although in these cases the keloid may have resulted from slight
injuries such as insect bites, scratching, shaving cuts or pressure (Polson et al., 1951).
Keloid scars develop in a manner similar to benign dermal tumours, invading the
surrounding tissue and expanding beyond the original wound margins. Additionally,
the size of the resultant scar cannot be predicted from the magnitude of the original
injury. Keloids do not usually regress over time and exhibit no quiescent phase, that
is, the structure of the scar tissue is continually undergoing remodelling (Wolfram
et al., 2009).
Interestingly, there is a higher predisposition for occurrence of these scars in peoples
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Figure 2.4: Keloid. a) Keloid scar in the posterior aspect of an ear. Reprinted with
permission from Jagadeesan and Bayat (2007) from Elsevier. b) Massive keloid for-
mation after ear piercing. Reprinted with permission from Wolfram et al. (2009) from
Elsevier.
of non-Caucasian background. Moreover, the higher the concentration of melano-
cytes in a part of the body, the greater the likelihood of keloid formation (Wolfram
et al., 2009). This suggests that there may be a genetic component to the appear-
ance of these scars (Enoch et al., 2006; Wolfram et al., 2009). Keloids also appear to
be age-dependent, with the greatest propensity for development being during and
after puberty. It has been suggested that this is because the skin of individuals in
this age group is more likely to be subject to trauma and that younger skin is more
elastic (Wolfram et al., 2009). Finally, menopause prompts keloid regression, while
pregnancy can prompt the onset or enlargement of keloids (Wolfram et al., 2009).
Keloids themselves are characterised by a raised appearance, large, dense regions of
collagen that are haphazardly arranged and the absence of myofibroblasts (Aarabi
et al., 2007; Jagadeesan and Bayat, 2007; Kose and Waseem, 2008; Wolfram et al.,
2009). Collagen synthesis is excessive, being 20 times higher in keloids than in nor-
mal skin (Enoch and Leaper, 2007). There are contradictory results regarding colla-
genase activity. Enoch and Leaper (2007) state that collagenase activity is 14 times
greater in keloid tissue than in normal scar tissue. Wolfram et al. (2009) comment
that there is a reduced synthesis of MMPs, which might explain why keloid scars do
not regress. It is conceivable therefore, that since collagenase is synthesized by fi-
broblasts in the presence of collagen (Ravanti et al., 1999), that the net amount of
collagenase does increase in keloidal tissue. However, the increase may not be suffi-
cient to regulate collagen production. As a consequence, matrix breakdown may be
2.1 Overview of the Wound Healing Process 21
reduced and a build-up of collagen may persist.
Another phenomenon to consider when investigating the aetiology of keloids is the
action of growth factors. Many studies have found that a number of key regulatory
growth factors, notably TGFβ (Chin et al., 2006; Xia et al., 2006), connective tissue
growth factor (CTGF) (Xia et al., 2007) and PDGF (Haisa et al., 1994) have height-
ened expression in keloid-derived fibroblasts (Butler et al., 2008). Indeed, TGFβ1 and
TGFβ2, notable pro-fibrotic agents (see Ferguson and O’Kane, 2004, for a review), are
overproduced by keloid fibroblasts. Moreover, keloid fibroblasts respond more vig-
orously to TGFβ1 and PDGF than normal fibroblasts, by increasing transcription of
receptors for TGFβ, PDGF and CTGF, enhancing cellular recruitment and synthesiz-
ing excess collagen, proteoglycans and other ECM constituents (Butler et al., 2008).
Consequently, an autocrine loop is established that maintains the fibroplastic re-
sponse (Babu et al., 1992; Chin et al., 2004; Wolfram et al., 2009).
Not only do keloid fibroblasts synthesize pro-fibrotic growth factors, but they have
been shown to have a reduced rate of apoptosis when compared with normal fibrob-
lasts (Ladin et al., 1998; De Felice et al., 2004).
Recent clinical observations implicate mechanical strain in the formation of keloids.
Specifically, keloids are more likely to form in wounds in regions of high skin tension
(Wang et al., 2006). However, as Robles and Berg (2007) suggest, exceptions to this
hypothesis imply that this may be an oversimplification. Keloids rarely occur on the
palms or soles, where there is significant skin tension (Robles and Berg, 2007), and
the anatomic site most prone to keloids is the external ear, which is under minimal
tension (Akoz et al., 2002). Hence while mechanical stimulation is certainly a factor,
it is not the driving phenomenon behind keloid formation. This idea is explored in
Chapter 6 where we suggest that while mechanical stimulation may aid the spread of
keloids, it is the growth factors that are primarily responsible for keloid development.
Therapeutic interventions for keloids are particularly problematic as surgical exci-
sion alone is ineffective, with recurrence rates of 55 − 100% (Butler et al., 2008), and
the possibility of yielding an even larger keloid (Wolfram et al., 2009). Numerous tri-
als involving surgical excision in combination with other treatment modalities such
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as pressure therapy, corticosteroids and radiotherapy have been carried out (Wol-
fram et al., 2009). These methods have yielded promising results, with 5-year recur-
rence rates of 8− 50%. Several controversial therapies have been reported with high
success rates in reducing the height of keloids with no observed recurrences. How-
ever side effects such as altered skin pigmentation, skin pruritus and pain have been
noted (Butler et al., 2008).
Keloids remain a prevalent problem in dermal repair, with clinicians continuing to
seek viable alternative therapies that both prevent and cure keloid development
without significant side-effects to the patient. This issue is compounded by the
absence of clear distinct cause/s for keloid development, their notoriously recur-
rent nature following surgical excision, the lack of a universally acknowledged or ac-
cepted treatment, and the common mischaracterization of keloids as hypertrophic
scars and vice versa (Louw, 2007; Butler et al., 2008). In Chapter 6, we investigate the
cause of keloid development, cessation of growth and possible targets for clinicians
to elicit keloid regression as predicted by our model.
Summary
Comparison of the factors that are thought to both initiate and predispose a person
to either non-healing or fibrotic wounds indicates that aberrant inflammation is a
prominent factor. Fetal wounds, where the inflammatory response is all but absent,
heal with no significant scarring (Ferguson and O’Kane, 2004). In this thesis, we seek
to investigate the interactions between the cellular, mechanical and inflammatory
aspects of wound closure in order to elucidate the specific mechanisms generating
abnormal dermal repair.
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2.2 Review of the Role of Transforming Growth Factor-β in
Wound Healing
Of all the inflammatory mediators, perhaps the most important and widely stud-
ied is transforming growth factor-β (TGFβ). Ubiquitous in the wound repair pro-
cess, it is implicated in coagulation, inflammation, proliferation and remodelling.
As the haemostatic plug is established, TGFβ is released by platelets which, along
with platelet-derived growth factor (PDGF) and platelet factor IV, initiate the wound
healing cascade (Beanes et al., 2003). The presence of TGFβ attracts neutrophils into
the wound space at the onset of inflammation (Shultz et al., 2005).
Approximately 48−72 hours after injury, during late inflammation, macrophages are
chemotactically attracted to the wound site by TGFβ and PDGF (Beanes et al., 2003;
Werner and Grose, 2003). Macrophages are perhaps the key inflammatory cells in
wound repair, with one of their primary roles being a source for growth factors, one
of which is TGFβ. The late inflammation and proliferation stages of wound healing
overlap, and the TGFβ released by the platelets, neutrophils and macrophages stim-
ulates fibroblast mitosis (Enoch and Leaper, 2007). TGFβ also directly regulates the
production and organisation of the extracellular matrix by fibroblasts (Roberts et al.,
1992; Murata et al., 1997), and indirectly influences angiogenesis through regulation
of the proliferation of smooth muscle cells and endothelial cells (Beanes et al., 2003;
Enoch and Leaper, 2007).
Different isoforms of TGFβ have markedly different effects on wound repair. TGFβ1
and TGFβ2 are highly pro-fibrotic cytokines, known to exacerbate wound healing
and stimulate heightened collagen expression and the induction of pathological
scarring. However, TGFβ3 is known to ameliorate the wound repair response, ob-
structing the fibrotic effects of TGFβ1 and TGFβ2 (Viera et al., 2010). This effect is
most clearly illustrated when comparing adult and embryonic wound repair (Fergu-
son and O’Kane, 2004) and we discuss this in the next section. The prominent role
of TGFβ in wound repair will be examined further in Chapters 3, 4, 5 and 6.
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2.2.1 The Prevalence of the TGFβ Isoforms in Adult and Embryonic Wound
Repair
It is widely recognised that the scar formed from adult dermal wounds is histolog-
ically and mechanically inferior to the original tissue whereas embryonic wounds
undergo regenerative, i.e. scar-free, repair. It is largely thought that the difference
is attributable to the relative presence of the different TGFβ isoforms. In adult der-
mal tissue, the relative concentrations of TGFβ1 and TGFβ2 are high, while TGFβ3
is almost negligible in comparison. However, it is the reverse in embryonic tissue,
where the relative concentration of TGFβ3 is high and TGFβ1 and TGFβ2 exist in low
concentrations (see Table 2.2).
TGFβ Isoform Embryonic Tissue Adult Tissue
TGFβ1 Low High
TGFβ2 Low High
TGFβ3 High Low
Table 2.2: The relative concentrations of the three main isoforms of transforming
growth factor-β in embryonic and adult dermal tissue.
This has led researchers to consider the effect of increasing TGFβ3 relative to the
other two isoforms, or by neutralizing TGFβ1 or TGFβ2 in adult dermal tissue (Shah
et al., 1995). Ferguson and O’Kane (2004) report that when TGFβ3 is applied to rat
wounds regenerative repair results. Indeed Ferguson and colleagues at Renovo have
so far found promising results in their clinical trials on human dermal wounds (Oc-
cleston et al., 2008; Ferguson et al., 2009).
Interestingly, targeting each of the TGFβ isoforms is not only being considered for
the treatment of dermal wounds. Current clinical investigations are targeting TGFβ2
and TGFβ3 in renal disease, heart disease and radiation injury, all TGFβ isoforms
in cancer therapies, and TGFβ binding proteins for glomerulopathy (Prud’homme,
2007). Targeting of TGFβ may also mediate the over-expression of collagen by fi-
broblasts and myofibroblasts that marks hypertrophic scars and keloids.
Sun et al. (2009) examined the influence of TGFβ1 on epidermal healing from a math-
ematical standpoint. Their representation examined the ability of TGFβ1 to inhibit
keratinocyte proliferation whilst simultaneously stimulating keratinocyte migration.
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Of the mathematical models that compare embryonic and adult epidermal and der-
mal repair, perhaps the most notable are those of Sherratt and co-workers (Sherratt
et al., 1992; Sherratt, 1993; Dale et al., 1996, 1997). Sherratt et al. (1992) and Sher-
ratt (1993) examined the distinct type of closure exhibited by embryonic epidermal
wounds, where cells appear to ingress due to a circumferential tension at the free
edge established through actin aggregation. This method of contraction is unique to
embryonic tissue and exhibits the intrinsic mechanical differences between embry-
onic and adult wound repair.
Dale et al. (1996) and Dale et al. (1997) were able to simulate the relative profiles of
TGFβ1 and TGFβ3 in both adult and foetal tissue and predict that addition of TGFβ3
to embryonic tissue should result in thicker collagen bundles, while in adult tissue
early addition of TGFβ3 improved wound quality, results later confirmed through ex-
periments by Ferguson and O’Kane (2004). In particular, Dale et al. (1996) predicted
that addition of TGFβ3 reduces the collagen I to III ratio, thereby improving the na-
ture of the collagen network and the resulting scar quality.
2.2.2 The Role of TGFβ in the Regulation of Collagen Density
Fibroblasts and myofibroblasts synthesize the components that constitute the ex-
tracellular matrix such as collagen, elastin, fibronectin, hyaluronic acid and proteo-
glycans, of which perhaps the most important for tissue integrity is collagen (Shultz
et al., 2005; Enoch and Leaper, 2007; Shultz and Wysocki, 2009). TGFβ1 stimulates
collagen expression by both fibroblasts and myofibroblasts and, when associated
with mechanical stress, acts to upregulate collagen expression by myofibroblasts
(Hinz, 2010). Indeed, keloid formation may be mediated by this stimulation of fi-
broblastic cells by TGFβ1 to synthesize collagen (Viera et al., 2010), with heightened
collagen expression characterizing both hypertrophic scars and keloids (Kose and
Waseem, 2008).
However, the role of TGFβ in regulating the collagen density is multi-faceted. Not
only does TGFβ stimulate fibroblastic cells to synthesize collagen, TGFβ is also
known to decrease fibroblastic expression of collagenase (Overall et al., 1989, 1991;
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Kilani et al., 2007). Collagenase is involved in matrix turnover and remodelling
through degradation of the local collagen network (Kilani et al., 2007). Interestingly,
Wang et al. (2000) found that hypertrophic scar fibroblasts produced greater quan-
tities of TGFβ than their normal dermal counterparts. This may explain the results
of Ghahary et al. (1996) and Bahar et al. (2004), who found that collagenase expres-
sion is downregulated by hypertrophic scar fibroblasts. Indeed, Wolfram et al. (2009)
suggests that this decreased expression of collagenase may also contribute to keloid
formation.
The nature of TGFβ regulation of collagen expression becomes even more com-
plex when one considers that TGFβ1 can increase fibroblast expression of tissue in-
hibitors of matrix metalloproteinases (TIMPs) (Watterson et al., 2007). TIMPs in-
hibit the activation of MMPs, including collagenase (Birkedal-Hansen et al., 1993).
Hence, TGFβ1 not only enhances collagen synthesis but also inhibits collagen degra-
dation (Diegelmann and Evans, 2004; Watterson et al., 2007). Indeed, it is likely that
this dual action of TGFβ on collagen regulation contributes to the excessive colla-
gen production in hypertrophic and keloid tissue. TGFβ expression is heightened
in each case, consequently, it may directly decrease MMP expression but also do so
indirectly, by increasing TIMP synthesis, which then causes a decrease in MMP ac-
tivation. This combined effect would lead to significantly less collagen degradation,
thereby giving rise to the high density of collagen in hypertrophic scars and keloids.
The effect of TGFβ on collagenase is considered in Chapter 4.
2.2.3 The Role of TGFβ in Tissue Contraction
As mentioned in Section 2.1.1, the activation of fibroblasts to myofibroblasts is a
two-stage process (see Figure 2.5). Fibroblasts are stimulated to differentiate into the
intermediary cell type, proto-myofibroblasts, in response to changes in the compo-
sition, organization and mechanical properties of the extracellular matrix (Hinz and
Gabbiani, 2003), and in response to growth factors such as platelet-derived growth
factor (Werner and Grose, 2003). Proto-myofibroblasts are characterized by cyto-
plasmic actin fibres that generate small traction forces and mature focal adhesions
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(Hinz et al., 2001; Hinz and Gabbiani, 2003).
Figure 2.5: The two-stage model of myofibroblast differentiation. In vivo, fibrob-
lasts might contain actin in their cortex but they neither show stress fibres nor do
they form adhesion complexes with the extracellular matrix. Under mechanical
stress, fibroblasts will differentiate into proto-myofibroblasts, which form cytoplas-
mic actin-containing stress fibres that terminate in fibronexus adhesion complexes.
Proto-myofibroblasts also express and organize cellular fibronectin including the
ED-A splice variant at the cell surface. Functionally, these cells can generate con-
tractile force. Transforming growth factor β1 (TGF-β1) increases the expression of
ED-A fibronectin. Both factors, in the presence of mechanical stress, promote the
modulation of proto-myofibroblasts into differentiated myofibroblasts that are char-
acterized by the de novo expression of α-smooth muscle actin in more extensively
developed stress fibres and by large fibronexus adhesion complexes (in vivo) or su-
permature focal adhesions (in vitro). Functionally, differentiated myofibroblasts
generate greater contractile force than proto-myofibroblasts, which is reflected by
a higher organization of extracellular fibronectin into fibrils. Used with permission
from Tomasek et al. (2002), from Elsevier.
Under the continued and increased presence of mechanical tension, and stimu-
lation by TGFβ1, proto-myofibroblasts modulate into myofibroblasts (Hinz, 2007;
Wipff and Hinz, 2008; Hinz, 2009, 2010). Myofibroblasts are most notably distin-
guished from proto-myofibroblasts by their expression ofα-SMA (Desmoulie`re et al.,
2005; Hinz, 2006), which represents the most common marker for myofibroblasts
(Tomasek et al., 2002). Additionally, myofibroblasts possess supermature focal ad-
hesions, which aid the generation of comparatively large contractile forces by these
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cells. Myofibroblasts are also marked by their active synthesis of granulation tissue
constituents such as collagen and fibronectin (Rhett et al., 2008).
As described in Section 2.1.1, TGFβ is the primary growth factor involved in the ac-
tivation of fibroblasts to myofibroblasts. While other factors may initiate the pro-
cess (such as platelet-derived growth factor), only TGFβ is known to activate proto-
myofibroblasts to myofibroblasts (Tomasek et al., 2002). Myofibroblasts are the key
cellular mediator of fibrosis (Wynn, 2008), and largely responsible for the contrac-
tion observed during dermal repair. Any factor that aids or maintains the appear-
ance of this cell type contributes to the fibrotic scarring response. Consequently, the
coupled action of TGFβ and myofibroblasts appears to be the primary instigator of
tissue fibrosis. In Chapter 3, we explore a model of pathological scar development
when TGFβ and myofibroblasts are poorly regulated, while in Chapters 5 and 6, we
consider treatment modalities that involve blocking TGFβ and decreasing the pres-
ence of myofibroblasts.
2.3 Observations on Wound Contraction
Many experimental papers have investigated acute wound closure and a list of the
most notable studies is given in Table 2.3. Of particular interest has been the tem-
poral variation in wound area, as this illustrates the progress of wound contraction.
Wound contraction itself is a transitory phase of wound repair involving a rapid re-
duction in wound area largely due to cellular traction forces (Watts et al., 1958; Watts,
1960). The process can last anywhere from 10 − 30 days (Grillo et al., 1958; Yannas
et al., 1996; Sewell et al., 2003; Tuncali et al., 2005; Sardari et al., 2006), reducing a
scar to 30 − 80% of its original area (Catty, 1965; McGrath and Simon, 1983). Nu-
merous experiments have shown that the animal species, age of the individual, ge-
ometry of the wound, location, extent of inflammation, fibroplasia and angiogen-
esis, and mechanical considerations all contribute to the extent of wound contrac-
tion (Watts, 1960; Kennedy and Cliff, 1979; McGrath and Simon, 1983; McGrath and
Emery, 1985).
A thorough investigation of recent literature reveals a distinct lack of experimental
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Study No. Reference Species
1 Abercrombie et al. (1954) Rat
2 Billingham and Medawar (1955) Rabbit
3 Abercrombie et al. (1956) Guinea Pig
4 Billingham and Russell (1956) Rabbit
5 Grillo et al. (1958) Guinea Pig
6 Watts et al. (1958) Guinea Pig
7 Watts (1960) Guinea Pig
8 Grillo and Potsaid (1961) Guinea Pig
9 Luccioli et al. (1964) Rabbit
10 Catty (1965) Human
11 Mott et al. (1969) Rat
12 Stephens et al. (1977) Rabbit
13 Kennedy and Cliff (1979) Rat, Rabbit & Guinea Pig
14 Snowden (1981) Rabbit, Mouse, Rat & Human
15 Snowden et al. (1982) Rabbit
16 McGrath and Hundahl (1982) Pig
17 McGrath and Simon (1983) Rat
18 McGrath and Emery (1985) Rat
19 Snowden and Cliff (1985) Rat
20 Doillon et al. (1987) Rat
21 Welch et al. (1990) Pig
22 Robson et al. (1994) Rat
23 Karr et al. (1995) Rat
24 Yannas et al. (1996) Frog
25 Calvin et al. (1998) Rat
26 Davidson et al. (2002) Frog
27 Mott et al. (2003) Human
28 Sewell et al. (2003) Mouse
29 Tuncali et al. (2005) Rat
30 Sardari et al. (2006) Dog
31 Gallant-Behm et al. (2008) Pig
32 Sardari et al. (2009) Horse
33 Slavkovsky et al. (2009) Rat
Table 2.3: Studies relating to wound contraction. For a comprehensive list of papers
investigating wound contraction, see Cook (1995).
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results regarding human wound contraction. Obtaining patients willing to have skin
segments removed and then regular wound tracings taken is difficult. The animal
used in experiments that most closely resembles human wound repair is the porcine
model. However, experiments on pigs incur substantial cost, time and thus are not
readily performed (Middelkoop et al., 2004). Rats and mice are comparatively cheap
and require little effort to house and maintain. Experiments on these small animals
also enable large numbers of animals within a particular study or specific character-
istics (e.g. knockouts or transgenic animals) to be studied (Middelkoop et al., 2004).
Thus experiments usually involve murine repair. However, rats and mice (as well as
dogs and cats) possess an extra skin organ, the panniculus carnosus, which endows
murine dermis with greater elasticity, allowing wounds in murine tissue to heal with
far greater contraction than that observed in human tissue. Moreover, these rodents
are distinct enough from primates so as to hamper direct applicability of the knowl-
edge gained from murine experiments to human therapies (Vodic˘ka et al., 2005).
Consequently, the repair observed in murine wounds is not quantitatively compa-
rable with human dermal healing.
Of the papers that discuss human contraction, Snowden (1981) does not generate
his own data, but instead considers the human wound contraction data obtained by
Carrel and Hartmann (1916) and Du Nouy (1919). In the wound measurements de-
scribed by Carrel and Hartmann (1916) and Du Nouy (1919), no clear distinction is
made between what portion of wound closure is achieved purely by contraction and
what is associated with reepithelialisation. Thus, comparison between our numer-
ical results of wound contraction and the data of Carrel and Hartmann (1916) and
Du Nouy (1919) is unfeasible. Catty (1965) however, tattooed the original wound
edge and thus was able to directly measure the amount of wound contraction unim-
peded by closure due to reepithelialisation. Mott et al. (2003) also examines hu-
man contraction, but they simply examine the mean contraction observed over the
course of repair, and do not track the temporal changes in the wound boundary.
Thus, only comparisons between the final extent of contraction may be made. How-
ever, we wish to compare our simulation predictions against temporal data to verify
if the behaviour produced by our model agrees with observed experimental results.
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Thus, the data obtained by Mott et al. (2003) while interesting, does not possess
enough information to be used for model justification.
Thus, of the papers investigating wound contraction, Catty (1965) appears to be the
most appropriate for investigating the role of contraction in human dermal wounds.
In Chapter 4, we compare our model predictions against the data presented by Catty
(1965). Rats remain the most common animal upon which wound contraction stud-
ies focus. Of these, perhaps the most notable are those by McGrath and Simon
(1983). These experiments were performed to investigate the effect of wound geom-
etry on closure rates. The data presented by McGrath and Simon (1983) for changes
in wound area illustrates each of the phases characteristic of wound contraction. In
this thesis, we compare our simulation results against those of McGrath and Simon
(1983) to verify if the quantitative wound closure predicted by our models is in ac-
cordance with experimental results.
2.3.1 Phases of Wound Contraction: A General Discussion
Here we focus on the four phases of wound closure; 1) retraction, 2) a lag or plateau
phase, 3) contraction and 4) late retraction as illustrated in Figure 2.6. However, not
all of these phases are observed in any given experiment.
Retraction
Immediately following injury the wound boundary retracts, increasing the size of the
wound (Billingham and Medawar, 1955). Early retraction is attributable to the im-
balance in forces across the wounded and unwounded domains. Cells exert tensile
stresses on their surrounding ECM. When an injury results there are no contractile
cells inside the wound, and there is nothing to counter the cell traction forces and
residual stresses in the tissue proximal to the wound (Silver et al., 2003), and the
wound expands. McGrath and Simon (1983) report anywhere from a 30 − 60% re-
traction in rat wounds, while Catty (1965) observes approximately a 30% retraction
in human dermal wounds. This will be discussed further in Chapters 3 and 4.
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Figure 2.6: The phases of contraction as illustrated in the experimental data obtained from
McGrath and Simon (1983) for the contraction of small square wounds on rats. Arrows show
the respective phases of wound contraction with (1) indicating retraction, (2) the lag phase,
(3) contraction and (4) late retraction. Dashed curves help delineate the changes between
retraction and the lag phase, and between the lag phase and contraction.
Plateau Phase
Following wound expansion, there is a lag phase, typically of 5−10 days before rapid
contraction ensues, and the wound decreases in size (Grillo et al., 1958; McGrath and
Simon, 1983).
Experimental results from rats and rabbits seem to indicate that, in some instances,
there is no initial retraction (Abercrombie et al., 1954; Billingham and Medawar,
1955; Welch et al., 1990), or that no lag phase is observed and the wound begins
contracting immediately (Abercrombie et al., 1954; Billingham and Medawar, 1955;
Billingham and Russell, 1956; Doillon et al., 1987). There may be a simple possible
explanation. In the experiments described by Abercrombie et al. (1954), Billingham
and Medawar (1955) and Welch et al. (1990), the first wound contraction measure-
ment occurs 3 − 5 days post wounding. Since the entire expansion and lag phase
can be observed within this period (see for example McGrath and Hundahl (1982);
McGrath and Simon (1983) and McGrath and Emery (1985)), it is not surprising that
they would be absent from these results.
Alternatively, there may be some variation in the amount of initial retraction or the
length of the lag phase across different species. Kennedy and Cliff (1979) observed
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wound contraction in rats, rabbits and guinea pigs. Their rabbit wounds showed
no retraction. Instead, a significant wound size reduction of 40% occurred over the
first day post wounding. Interestingly, a lag phase followed this initial contraction,
lasting approximately two days before contraction continued, although at a much
slower rate. Kennedy and Cliff (1979) report that in their experiments on rat wounds
they observed no early retraction, and only a minor lag phase before contraction
occurred. Guinea pig wounds, on the other hand, showed about a 20% increase in
wound area over the first day post wounding, before a lag phase of approximately
one day which was then followed by contraction. Indeed, guinea pig wounds ap-
peared to contract the slowest of the three species. Clearly there may be different
mechanisms acting across different species to effect closure. Moreover, this illus-
trates the difficulty in comparing wound contraction results across species, and the
need for careful measurements of wound area, particularly early in the repair pro-
cess.
Contraction
This feature of wound healing occurs primarily in wounds healing by second inten-
tion. The exact mechanism by which contraction occurs is unknown, although sev-
eral relevant features have been observed:
1. Fibrin contracts, arresting haemorrhage. Platelets or fibroblasts then contract
the fibrin network further by exerting a force as they squeeze the excess fluid
out of the clot.
2. Myofibroblasts, the activated form of fibroblasts, exert a contraction force on
the local environment.
3. Fibroblasts themselves are able to rearrange the local collagen network, creat-
ing tension and contracting the region.
These observations are consistent with wound contraction experiments by Watts
and colleagues who found that contraction is “essentially a cellular process affect-
ing the edge of the wound” (Watts et al., 1958; Watts, 1960).
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In animals, such as mice and rats, contraction has been observed to produce approx-
imately 80% of wound closure (Levenson et al., 1965; Majno and Joris, 2004). This is
largely due to the flexible nature of the panniculus carnosus, the skin organ that at-
taches the dermis to deep fascia or bone. However, this organ is highly specialised
in human tissue, so that the tethering between the dermis and fascia is stronger, re-
sulting in less flexible tissue, with wound contraction accounting for approximately
a 20−30% reduction in wound area (Rudolph, 1979; Farahani and Kloth, 2008). Con-
sequently, whilst contraction does aid in wound closure, it is not the primary means
by which closure is observed in humans. Nonetheless, severe contraction is a com-
mon problem in burns and around joints where it can result in excessive pulling of
the skin around the wound, deformities and reduced movement (Majno and Joris,
2004).
As mentioned in Section 2.1.1, in both animal and human wounds, fibroblasts con-
tinue to remodel the extracellular matrix, restoring mechanical strength to at best
70% that of normal tissue (Singer and Clark, 1999). This is an ongoing process, with
only 20% of a scar’s final strength acquired during the first three weeks post injury.
The rate at which tensile strength is returned is slow, relying upon continual contrac-
tion and fibroblast activity (Cotran et al., 1999; Singer and Clark, 1999).
Fibroblasts and myofibroblasts together effect wound contraction. Fibroblasts pri-
marily remodel the collagen network, whilst myofibroblasts exert contractile forces
on the collagen fibres themselves. Grinnell and co-workers have studied the rela-
tionship between fibroblasts and mechanics in fibroblast populated collagen gels
extensively (Guidry and Grinnell, 1985; Grinnell, 1994, 2000; Grinnell et al., 2003;
Grinnell, 2003, 2008). In some instances, lattices were shown to contract to a tenth
of their original size in the absence of myofibroblasts (Guidry and Grinnell, 1985;
Tamariz and Grinnell, 2002; Tomasek et al., 2002). The majority of this contraction
was found to persist following inducement of fibroblast apoptosis. Guidry and Grin-
nell (1985) showed that fibroblasts are able to contract the gels through physically
rearranging the existing fibres, and conclude that the ability of fibroblasts to remodel
the collagen architecture is critical to effecting wound closure through contraction.
Indeed, Murphy et al. (2011a) developed a model to investigate wound contraction
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which found that the extent of fibroblast and myofibroblast remodelling was critical
in determining the magnitude of wound reduction (see Chapter 3 for a brief discus-
sion).
Late Retraction
Late retraction is thought to be associated with continued remodelling of the colla-
gen network, inducing a relaxation in the scar tissue. In some of the aforementioned
experimental papers no late retraction was observed (Abercrombie et al., 1954; Watts
et al., 1958; Kennedy and Cliff, 1979). Most experiments were terminated at about
3−4 weeks following injury (Watts et al., 1958). Catty (1965) however tracked wounds
up to six months post wounding in order to observe scar progress and found that
late retraction had occurred. Hence, it is entirely possible that under normal cir-
cumstances, all wounds experience late retraction, but that the experiments are not
conducted for long enough to observe this increase in wound size.
Experimental results on rats reported by McGrath and Simon (1983) and on rabbits
by Luccioli et al. (1964), however, both display late retraction within the first 30 days
following injury. Catty (1965) reported that in humans this occurred sometime after
the first 16 days, at which time daily wound area measurements ceased. Nonethe-
less, records of the same wounds six months post-wounding revealed significant
secondary retraction (this will be discussed in more detail in Chapter 4). Since scars
such as hypertrophic scars may actually undergo further contraction (and therefore
no late retraction), and numerous experimental results report no late expansion, it
is possible that this secondary retraction is not a universal feature of wound repair.
2.4 Mathematical Modelling of Wound Healing
Mathematical literature abounds with investigations into wound repair. For in-
stance, consider the wealth of research into epidermal wound closure summarised
in Table 2.4. Indeed, the same diversity is observed in mathematical investigations of
dermal repair. A selection of the phenomena considered is summarised in Table 2.5.
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Feature Examined Papers
Estimations of the speed of healing
Sherratt and Murray (1992)
Dale et al. (1994)
Wound geometry
Sherratt and Murray (1992)
Vermolen et al. (2006)
Activator mechanisms Myers et al. (2007)
Sherratt and Murray (1990)
Sherratt and Murray (1992)
Changes in cell kinetics Sherratt et al. (1992)
controlled by growth factors Dale et al. (1994)
Sheardown and Cheng (1996)
Gaffney et al. (1999)
Gaffney et al. (2002)
The role of oxygen and angiogenesis Maggelakis (2002)
in epidermal healing Maggelakis (2003)
Vermolen and Adam (2007)
Investigation into the behaviour and
Savill and Sherratt (2003)
generation of stem cells in epidermal tissue
Salva et al. (2004)
Mechanical effects on epithelial healing Dupps Jr and Wilson (2006)
Sadovsky and Wan (2007)
Agent-based modelling of interactions Walker et al. (2004a)
between the cells Walker et al. (2004b)
Investigation into the critical
Adam (1999)
size defect
Dale et al. (1994)
Corneal wound healing
Sheardown and Cheng (1996)
Gaffney et al. (1999)
Dupps Jr and Wilson (2006)
Lavker and Sun (2000)
Embryonic epidermal wounds Matic et al. (2002)
Sadovsky and Wan (2007)
Differences between embryonic
Sherratt et al. (1992)
and adult epidermal wound repair
Interactions between dermal and
Wearing and Sherratt (2000)
epidermal repair
Table 2.4: Summary of mathematical models of epidermal wound healing.
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This thesis concentrates on dermal wound healing, and we now consider a review of
mechanochemical models for dermal repair.
Feature Examined Papers
Angiogenesis
Pettet et al. (1996)
Tranqui and Tracqui (2000)
Dallon and Sherratt (1998)
The interaction between fibroblast
Dallon et al. (1999)
and collagen fibre orientation
Dallon et al. (2001)
McDougall et al. (2006)
Cumming et al. (2010)
Effects due to growth factors
Dale et al. (1997)
Vermolen and Javierre (2010)
Tranquillo and Murray (1992)
Simple mechanical effects on Tracqui et al. (1995)
wound closure Murray et al. (1998)
Murray (2003b)
Myofibroblast-enhanced contraction
Olsen et al. (1995)
Olsen et al. (1996)
The interaction between the collagen
Barocas and Tranquillo (1997)lattice and extracellular fluid during
contraction
The effects of matrix anisotropy Cook (1995)
The effect of hyperbaric oxygen therapy
Thackham et al. (2008)
in the treatment of chronic wounds
Combinations of wound healing phenomena
Javierre et al. (2009)
Hall (2009)
Murphy et al. (2011b)
Murphy et al. (2011a)
Table 2.5: Summary of mathematical models of dermal wound healing.
2.4.1 Mechanochemical Models of Wound Repair
The first mechanochemical models for dermal wound healing were developed by
Murray et al. (1988) and Tranquillo and Murray (1992), and were based on the model
by Oster and co-workers that described developmental pattern formation (Oster
et al., 1983, 1985). The key feature of this model is the mechanical interaction be-
tween the cells and a viscoelastic ECM on which they reside.
The “base” Tranquillo-Murray model comprises three governing equations. Two of
these determine the cell density and ECM density, respectively, while the third de-
scribes the force balance in the system, from which the velocity of the ECM is de-
rived. In the base model and all extensions, Tranquillo and Murray (1992) consider
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a cell population consisting of both fibroblasts and myofibroblasts, moving actively
through the ECM, with this random migration of the cell density described by the
equivalent of Fick’s Law. The cells also undergo logistic growth rate and move pas-
sively through ECM-mediated advection.
In the base model, Tranquillo and Murray (1992) apply several simplifying assump-
tions such as neglecting ECM synthesis and degradation. Consequently, the only
variations in the ECM density are due to advection. With regard to the force balance
equation, Tranquillo and Murray (1992) assume that the cell/ECM composite can be
described by an isotropic, linear viscoelastic stress tensor. This expression is mod-
ified to include contraction of the tissue by the cells, and an elastic restoring force.
The base dimensional model in its full tensorial representation takes the following
form:
Cells :
∂n
∂t
+∇ ·
(
n
∂u
∂t
)
= ∇ ·D0∇n+ r0n(n0 − n); (2.1)
ECM :
∂ρ
∂t
+∇ ·
(
ρ
∂u
∂t
)
= 0; (2.2)
Force
Balance
: sρu = ∇ ·
[
µ1
∂
∂t
+ µ2
∂θ
∂t
I+
E
1 + ν
[
 +
(
ν
1− 2ν
)
θI
]
+
τρn
1 + γn2
I
]
;
(2.3)
where ∂u/∂t represents the velocity of the cell/ECM composite, and
Displacement Vector : u = x− x0; (2.4)
Strain Tensor :  =
1
2
(∇u+∇uT ) ; (2.5)
Dilation : θ = ∇ · u; (2.6)
where x is the distance from the wound centre, n is the cell density, ρ is the ECM den-
sity, u is the ECM displacement, D0 is the cell diffusion coefficient (random motil-
ity), r0 is the growth rate constant, n0 is the maximum cell concentration, s is the
tethering coefficient representing the strength of dermal attachments to the subder-
mal layer, µ1 and µ2 are related to the shear, µ, and bulk, K, viscosities (µ1 = 2µ,
µ2 = K − 2/3µ), E is the Young’s modulus of the tissue, ν is the Poisson’s ratio, I is
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the unit tensor, τ is a measure of the cell traction strength, γ is a parameter quanti-
fying “social loafing” (the amount that a species will reduce work in the presence of
other members of the same species) and x0 denotes the initial position of the mate-
rial point located at position x at time t.
When generating numerical results to (2.1)-(2.6) as well as investigating extensions
of the base system, Tranquillo and Murray (1992) consider a linear wound with long
parallel wound boundaries. Thus, Tranquillo and Murray (1992) reduce (2.1)-(2.6) to
a one-dimensional representation in Cartesian coordinates, which takes the follow-
ing form:
Cells :
∂n
∂t
+
∂
∂x
(
n
∂u
∂t
)
= D0
∂2n
∂x2
+ r0n(n0 − n); (2.7)
ECM :
∂ρ
∂t
+
∂
∂x
(
ρ
∂u
∂t
)
= 0; (2.8)
Force Balance : sρu =
∂
∂x
[
µ
∂2u
∂t∂x
+ E
∂u
∂x
+
τρn
1 + γn2
]
; (2.9)
where µ is the “viscosity” of the dermal layer, E is the elasticity coefficient of the
tissue layer, and all other parameters and variables are as defined above.
One of the most significant assumptions made by Tranquillo and Murray (1992) was
that of linear viscoelasticity and a linear stress-strain relationship. However, each is
only appropriate under the condition that strains are sufficiently small. Moreover,
in wounds that heal with significant contraction strains can be considerable. Con-
sequently, valid comparison between the model predictions and experimental data
can only be made when wounds exhibit minimal contraction. Indeed, the model
predicts wound boundary variations of less than 3%. Frequently small contraction
is not the case in dermal wounds, as detailed in Section 2.3.1, rat wounds may heal
with up to 80% contraction while human wound closure may be as high as 30% in
wounds healing by second intention (Catty, 1965; McGrath and Simon, 1983). Such
measures of contraction do not imply a small strain relationship.
Another key issue associated with contraction in this base model is that permanent
40 Chapter 2. Literature Review
wound contraction is not observed. This is a consequence of assuming linear vis-
coelasticity. Since both the cell and ECM densities tend to uniform values through-
out the domain, this implies that at long times the displacement uniformly tends
to zero. Accordingly, the wound boundary returns to its initial position and no net
contraction is observed. Tranquillo and Murray (1992) do modify their base model
to include chemically-dependent cell traction and growth factor kinetics, chemo-
taxis, and ECM biosynthesis. The first three extensions rely on a static chemical dis-
tribution and it is this dependency that achieves permanent wound contraction in
these cases. However, a temporally-independent yet spatially-dependent chemical
distribution is not physically realistic, and while the model now predicts permanent
wound closure, it still only predicts at most 12% contraction for the parameter values
described by Tranquillo and Murray (1992).
While this seminal model laid the groundwork for the subsequent years of research,
it neglected some of the essential features of wound healing, such as significant
wound boundary contraction, collagen biosynthesis and heightened collagen den-
sity in the wound space. While Tranquillo and Murray (1992) did extend their model
to incorporate some of these features, the limitations of this formulation together
with the wealth of new experimental data have meant that a more detailed represen-
tation has become a necessity.
One of the key simplifying assumptions made by Tranquillo and Murray (1992) was
that alterations to the ECM do not modify the mechanical properties of the tissue.
However, experimental results reveal that this is not the case (Shultz et al., 2005). In
the mechanochemical models developed in Chapters 3 and 4, we assume that tissue
elasticity is dependent upon the collagen density.
Olsen and co-workers extended the work of Tranquillo-Murray in a series of papers
(Olsen et al., 1995, 1996, 1997, 1998, 1999). They incorporate more realistic chemical
and collagen kinetics, and consider two cellular populations. These cellular species
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are the fibroblast and its activated form, the myofibroblast. Inter-conversion be-
tween the two phenotypes is assumed, with fibroblast to myofibroblast differen-
tiation dependent upon the presence of platelet-derived growth factor. The sec-
ond extension concerns the description of the growth factor kinetics. Previously,
when Tranquillo-Murray extended their base model to include dependence on a
bioactive chemical species, the chemical species distribution was assumed to be
static. To make the description more realistic, Olsen et al. (1995) incorporate a time-
dependent growth factor model. In addition, the Olsen et al. model now includes
collagen synthesis and degradation.
The Olsen et al. (1995) model predicts plastic deformation (permanent wound con-
traction) when collagen kinetics are ignored, with little collagen within the wound
space, but unwounded levels outside. Since, in their model, cell traction is inhibited
by high collagen densities, and the small collagen densities persist in the wound, it
follows that large cell traction is maintained within the lesion. This situation is main-
tained at steady state, and gives rise to permanent wound contraction. Moreover,
whilst matrix remodelling occurs on a longer timescale than proliferation (typically
months versus 3 − 4 weeks) matrix turnover is initially rapid, implying collagen ki-
netics should not be neglected. Hence, another modelling approach is required to
generate plastic deformation.
Cook (1995) also extended the work of Tranquillo and Murray (1992) by developing a
more realistic representation of tissue mechanics that accounts for the structure of a
changing, anisotropic ECM. In so doing, Cook was the first to address tissue growth
and remodelling, and their associated effects upon tissue mechanics. These effects
are also considered in Murphy et al. (2011a), who also incorporated direct coupling
between tissue stress and cell behaviour.
As described in Sections 2.1.1 and 2.2.3, when cultured under mechanical strain
and/or on a stiff substrate, fibroblasts develop actin stress fibres (Grinnell, 2000;
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Tomasek et al., 2002; Grinnell et al., 2003; Desmoulie`re et al., 2005; Hall, 2009), trans-
forming into proto-myofibroblasts. Under the action of TGFβ and mechanical ten-
sion, as detailed in Section 2.1.1, proto-myofibroblasts differentiate into myofibrob-
lasts, the primary contractile cell in dermal repair. Javierre et al. (2009) and Mur-
phy et al. (2011a) are the only mathematical models for dermal wound healing in-
corporating the experimentally-observed stress-dependency of the fibroblast to my-
ofibroblast transformation. However, neither representation considers the proto-
myofibroblast stage, instead adopting a combined proto-myofibroblast and myofi-
broblast population.
The model developed by Javierre et al. (2009) represents an extension of the Olsen
et al. (1995) description, and includes the assumption that PDGF is the chemical
involved in activating fibroblasts. While PDGF can induce the formation of proto-
myofibroblasts, it does not induce transformation to myofibroblasts (Tomasek et al.,
2002). Indeed there is now ample experimental evidence to suggest that TGFβ is the
primary growth factor involved in this process (Hinz, 2007; Wells and Discher, 2008;
Wipff and Hinz, 2008, 2009; Hinz, 2010). Furthermore, Javierre et al. (2009) assume
that cell traction stress activates fibroblasts but Hall (2009) showed that, for consis-
tency between the mathematical representation and experimental results, the stress
component involved in fibroblast activation is the elastic and not the cell traction
stress. Following Hall, we assume the fibroblast modulation is dependent upon the
elastic stress. This is discussed further in Chapters 3 and 4.
Incorporating these observations into a model means that it is impossible to decou-
ple the mechanics from the biology because there is two-way feedback between cel-
lular behaviour and mechanical stress. In the Olsen et al. (1995) and Tranquillo and
Murray (1992) descriptions, passive ECM-mediated advection was the only interac-
tion between the cell and ECM behaviour and the wound mechanics. However, since
the velocity was generally small, advection could essentially be neglected without
significantly altering the model predictions (Hall, 2009). The cellular and ECM com-
ponents could evolve essentially independent of the mechanics. In light of recent
experimental results this coupling is important and in this thesis we incorporate the
stress-dependence in the activation of fibroblasts and myofibroblast proliferation.
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Many mechanochemical descriptions of wound repair lack a detailed description of
the bioactive mediators. Dale et al. (1994) developed a representation of wound re-
pair which has a more realistic description of the chemical interactions than any of
those described in the aforementioned mechanochemical models. However, Dale
et al. (1994) include no mechanics. They incorporated the interactions between fi-
broblasts, both latent and active TGFβ, zymogens and collagenases, procollagen and
collagen, and the enzymes which inform activation of each of these species. These
authors assume that TGFβ is critical to collagen deposition and the primary media-
tor in dermal healing.
2.5 The Zero Stress State
One of the most attractive applications of mathematics to biology is in the descrip-
tion of growth and remodelling of soft biological tissues. Living materials present
the peculiar ability to deform under their own action, even without stimulation from
external loads (Ambrosi, 2010). Moreover, in response to environmental cues, liv-
ing organisms can alter their geometry, internal architecture and even their mate-
rial properties (Murray et al., 1998). The primary effector of change within living
materials are the cells, each programmed genetically and epigenically (i.e. via envi-
ronmental factors) to serve different functions within the body. Importantly many
cells, termed mechanocytes, alter their function and internal structure in response
to minor changes in their mechanical environment (Humphrey, 2003). One example
would be the activation of fibroblasts to myofibroblasts under tension as discussed
earlier in Section 2.1.1.
The nature of the ECM is equally important. It confers a material with its strength
and resilience, and serves as a scaffold over which cells migrate, regulates pheno-
typic changes in cells, and acts as a reservoir for cytokines. While the ECM informs
the function of the local cells, these same cells construct and cultivate the ECM net-
work, fashioning new fibres and removing old ones, thereby continually remodelling
the local ECM architecture. The strong interactions between the cells and the ECM
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are vital when considering an appropriate mechanical framework to model biologi-
cal tissues (Humphrey, 2003).
These are not the only issues to consider. Biological tissues do not behave like tra-
ditional engineering materials such as metals, wood and concrete, or ideal elastic
springs, which develop large stresses when stretched (Humphrey, 2003). Instead,
stresses within a growing living tissue are kept small due to internal remodelling by
cells that continually rearrange the local fibre network by remodelling existing fibres
or by laying down prestressed fibres to reduce the local strain in the tissue. Conse-
quently, the cells fundamentally alter the mechanical structure of the tissue. One
may be tempted to treat this phenomenon as plastic behaviour. However, as dis-
cussed at a recent Oberwolfach meeting, growth involves “chemically and physically
distinct species that exchange mass, momentum and energy among themselves and
with external reservoirs”, and as such, growth of a biological tissue presents as an
open, and not a closed system (Ambrosi et al., 2008). Consequently, standard plas-
ticity techniques are not appropriate.
An additional complication is the presence of residual stresses. Biomaterials, like
metals after rolling, typically support residual stresses, which can persist even when
all external stimuli are removed (Murray et al., 1998). When making incisions into a
biological material, shape changes occur that reveal the presence of residual stresses
(Vandiver and Goriely, 2009). Residual stresses have been observed in the trachea
(Han and Fung, 1991), ventricular wall (Taber et al., 1993), arteries (Liu and Fung,
1988; Vaishnav and Vossoughi, 1983, 1987), and in many plant tissues (Burstrom,
1971; Kutschera, 1989; Brown et al., 1995a,b; Hejnowicz and Sievers, 1995, 1996; Hej-
nowicz, 1997; Peters and Tomos, 2000). The presence of residual stresses in the ma-
terial violates the assumption that the reference state is stress free. The dermal layer
involves residual stresses4 and possesses a continually evolving extracellular struc-
ture. Thus, classical continuum mechanical theory may not be appropriate when
4Residual stresses within dermal tissue are generated by the cells. However, stresses created within
the ECM will remain if the residing cells are sacrificed. This phenomenon is most easily observed in
FPCL contraction experiments by Guidry and Grinnell (1985). Gels contracted to one tenth their origi-
nal size due to fibroblast remodelling of the collagen network. However, when apoptosis was induced,
while some relaxation was observed, the gels did not return to their original size but instead remained
contracted.
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attempting to develop a realistic representation of dermal tissue.
Conventional models of dermal repair consider a standard mechanical framework
that represents the extracellular matrix as a viscoelastic material that can be de-
formed when the cells exert tractional forces. This approach is used as dermal tissue,
like other organs, shows both solid and fluid-like behaviour, exhibiting characteris-
tic viscoelastic features. Indeed, this approach is considered in Chapter 4 where we
develop an extension of the models developed by Olsen et al. (1995) and Dale et al.
(1997). While this representation of tissue mechanics is a well-accepted simplifica-
tion of the mechanical stresses in the tissue, it does not capture the reality that the
extracellular matrix is an anisotropic, deformable construct, where the cells continu-
ally remodel the collagen lattice within the matrix. Additionally, the linear viscoelas-
tic framework assumes that displacements of the material are small. However, in
adult human dermal repair, up to 30% of wound closure is achieved by contraction,
and in murine dermal wounds, this may be as high as 90%. Clearly, these defor-
mations are not small, and consequently, the conventional framework may not be
appropriate.
The need to model the extracellular matrix as an evolving material, incorporating
the growth and remodelling intrinsic to living tissue, as well as residual stresses, has
necessarily led to the application of morphoelasticity and the concept of a zero stress
state to the realm of mechanochemical models for dermal repair. This framework
enables the growth and deformation to be discussed in relation to the kinematics
involved.
2.5.1 Formulating a Description of the Zero Stress State
The zero stress state is a local virtual configuration in which every element within a
body is unstressed (Goriely et al., 2008; Hall, 2009). It is necessary to represent the
zero stress state as a local tissue definition, since it may not be possible to determine
a compatible deformation for the entire body where each element of the tissue is
simultaneously at zero stress. Nonetheless, a consistent theory has been developed
by considering a multiplicative decomposition of the deformation gradient (for a
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detailed description see Lee (1969), Rodriguez et al. (1994) and Goriely and Ben Amar
(2007)).
Rodriguez et al. (1994) introduced a theoretical framework for the development of
tissues where the growth is dependent on residual stresses. In it, he considered the
growth of the tissue to inform the nature of the zero stress state. An elastic deforma-
tion ensues that maintains tissue integrity. In this representation, the deformation
gradient, F, is decomposed into a growth tensor, G, representing the plastic defor-
mations generated during growth, and an elastic deformation tensor, E (Lee, 1969;
Rodriguez et al., 1994; Goriely and Ben Amar, 2007), i.e.
F = EG (2.10)
Typically, stresses in this formulation are small, while deformations are large. Struc-
turing the representation for deformations in this manner allows for large deforma-
tions to occur without contradicting the model assumption that the elastic deforma-
tion is small.
The growth phase does not necessarily imply continuity of the tissue. Since growth
occurs in an isolated manner involving individual elements of the body, each of
which grow separately, these elements may not describe a continuous body follow-
ing growth, i.e. overlaps or gaps may result. In this case the growth strain is said to be
“incompatible”. Skalak et al. (1996) suggests that as growth occurs, residual stresses
are necessarily developed within the construct to ensure the tissue remains intact
(Vandiver and Goriely, 2009). Skalak et al. (1996) also remarks that residual stresses
within a body indicate that the growth was incompatible. Thus, following growth
there is an elastic deformation or relaxation, described by the residual stresses, that
maintains tissue integrity and compatibility (Skalak et al., 1996). Following the elas-
tic deformation, the tissue takes its new configuration (for a diagrammatic represen-
tation of this process, see Figure 2.7).
Thus, three states are considered:
1. the Reference Configuration, or initial state of the material;
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Figure 2.7: The decomposition of finite growth. The deformation gradient F maps
the reference configuration into the current configuration. F can be decomposed
into the product of a growth tensor, G, and an elastic deformation tensor, E. The in-
termediate state, following growth is termed the “virtual configuration” as the growth
tensor may not maintain continuity of the material. Adapted from Vandiver and
Goriely (2009).
2. the Virtual Configuration, representing an intermediate step between the
growth and relaxation phases; and
3. the Final Configuration, or the final state of the tissue.
Residual strains govern the local growth deformation between the reference and vir-
tual configurations, while effective strain governs the elastic stress transformation
between the zero stress state and final configuration. Finally, the observed strain,
as represented by F, describes the global growth-deformation gradient (Rodriguez
et al., 1994; Murray et al., 1998). Successive discrete applications of growth and elas-
tic deformation can be considered to result in net tissue growth (Lee, 1969; Goriely
and Ben Amar, 2007). This representation quickly becomes cumbersome, and we
require a representation where the zero stress state is able to evolve over time. Addi-
tionally, it may not be possible to determine an initial state of the tissue since strain
measurements necessarily alter the distribution of stresses within the tissue. Even
given these issues, a mathematical description of the changing zero stress state can
be described.
Rodriguez et al. (1994) considers a growth velocity gradient that describes the shape
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changes of an infinitesimal volume within the tissue. This growth velocity gradi-
ent determines the development of the local growth strain (Murray et al., 1998). If
growth is assumed to be slow, then the tissue exists in a state of elastic equilibrium.
Thus, deformation due to growth occurs as a result of volumetric growth or remod-
elling as determined by tissue forces and boundary conditions. Cook (1995) devel-
oped this representation, considering the effective strain to be represented by the
Cauchy strain minus the residual strain, with the residual strain representing a cor-
rection to the effective strain due to alterations in the zero stress state. His evolution
equation for residual stress incorporated the changes in strain due to ECM turnover
and advection. Finally, Hall (2009) extended Cook’s formulation to include a gen-
eral representation for the evolving effective strain incorporating growth and elastic
relaxation.
The morphoelastic framework is currently being employed in diverse areas. Van-
diver and Goriely (2008, 2009) and Goriely et al. (2010) consider the zero stress state
when modelling the growth of cylindrical elastic structures such as the bronchial
tube, airways or plants, Rachev et al. (1998) and Taber (1998a,b) apply this theory to
the area of vascular mechanics, Liao et al. (2007) considers the zero stress state when
modelling the mucosal folding of the oesophagus and clearly, morphoelasticity for-
mulations have also been described in the area of dermal wound repair (Cook, 1995;
Hall, 2009; Murphy et al., 2011a).
2.5.2 Applying Morphoelasticity in Models of Dermal Repair
The first morphoelastic model applied to human dermal wound repair was de-
scribed by Cook (1995). Cook developed both a partial differential equation system
and an ordinary differential equation system that was able to account for the per-
manent deformations and contraction observed during tissue repair. Cook argued
that the viscous behaviour previously observed by experimentalists was in fact due
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to local remodelling of the tissue. Hence, Cook formulated a morphoelastic repre-
sentation, consistent with this argument. However, instead of considering a multi-
plicative decomposition of the deformation gradient, as this formulation rapidly be-
comes excessively complex, Cook related the tissue’s mechanical development and
contraction through tissue strain.
Cook refers to strain measured relative to the zero stress state as effective strain,
while strain measured relative to the reference state is termed residual strain. Cook
assumes that the zero stress state is close to the final configuration, and therefore,
that the elastic restoration is small. Hence, while growth of the tissue may result in
large deformations, and thus large residual strains, the effective strain within the
system remains small. This allowed Cook to develop a small strain morphoelas-
tic model and significantly reduced the complexity of the mechanical formulation.
Cook’s model then became the first to describe the permanent wound contraction
observed in dermal repair.
Whilst Cook (1995) was able to describe a significant improvement on the mechani-
cal framework, there are several shortcomings, which we now describe.
Despite previous research by Tranquillo and Murray (1992) concluding that an in-
flammatory mediator is essential in wound repair, Cook (1995) neglects all chemical
effects. In order to effect wound contraction, Cook instead assumes that the cell
traction stress is biphasic, given by
τ = τ0n(1− n)θ (2.11)
where τ0 is a parameter characterizing the cell traction stress and θ is a parameter
that modifies the logistic form adopted for the cell traction dependence on fibrob-
last density. In contrast, Tamariz and Grinnell’s (2002) experiments suggest that trac-
tional stress is a monotonically increasing function of cell density, consistent with
previous models of dermal repair such as those of Tranquillo and Murray (1992) and
Olsen et al. (1995). A further problem with Cook’s formulation is that it leads to a
situation where there is no tension in the healthy skin or the healed wound; this is
unrealistic (Reihsner et al., 1995).
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Cook also models the effective strain explicitly. He assumes that it is governed by
the movement of the wound boundary and, inside the wound, the residual strain.
Whilst Cook allows the residual strain to evolve by incorporating the effect of cells
laying down new fibres, he ignores the action of cells actively remodelling the colla-
gen matrix. However, in fibroblast populated collagen lattice experiments by Grin-
nell et al. (2003), it was found that significant permanent contraction occurs as a
result of fibroblasts physically remodelling the lattice. In Chapter 3 we incorporate a
new representation of the evolution of effective strain that includes these effects.
Finally, Cook neglects the synthesis of collagen in the unwounded region. Conse-
quently, the steady state value of the collagen density outside the wound is history-
dependent; the collagen density inside the wound tends to healed levels, but the
collagen density outside the wound does not. In the proposed mechanochemi-
cal wound repair model, we have addressed these issues and also extended Cook’s
model to include the presence of myofibroblasts and the effects of TGFβ.
The next major advance in the development of a morphoelastic framework was by
Hall (2009). Hall considered the representation proposed by Tranquillo and Murray
(1992), and, based on experimental data by Kucharˇova´ et al. (2007), argued that the
viscous component in the viscoelastic framework is negligible on the timescale of
wound repair. Hall then extended the work of Cook (1995), addressing the develop-
ment of the morphoelastic description. Hall considered the effective strain descrip-
tion, developing a time-dependent description of effective strain that incorporated
fibre remodelling and contraction by fibroblasts and myofibroblasts, advection and
elastic relaxation. We consider this representation in Chapter 3 when we extend the
dermal wound repair model developed by Cook (1995).
CHAPTER 3
A Morphoelastic Representation of Dermal Repair
The work presented in this chapter was published in the Journal of Theoretical Bi-
ology in 2011 (Murphy et al., 2011a). As such, it represents a self-contained work.
Consequently, some of the material covered in Chapter 2 will be overviewed again
here.
Author Contribution: KEM, SWM and DLSM developed the mathematical model
and KEM implemented the numerical algorithms. KEM performed the numerical
experiments and analyzed the data. KEM, SWM and DLSM wrote the manuscript
and CLH contributed to the results discussion and editorial work of the manuscript.
The repair of dermal tissue is a complex process of interconnected phenomena,
where cellular, chemical and mechanical aspects all play a role, both in an autocrine
and in a paracrine fashion. Recent experimental results have shown that transform-
ing growth factor−β (TGFβ) and tissue mechanics play roles in regulating cell prolif-
eration, differentiation and the production of extracellular materials. In this chapter
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we develop a 1D mathematical model that considers the interaction between the cel-
lular, chemical and mechanical phenomena, allowing the combination of TGFβ and
tissue stress to inform the activation of fibroblasts to myofibroblasts. Additionally,
our model incorporates the observed feature of residual stress by considering the
changing zero-stress state in the formulation for effective strain. Using this model,
we predict that the continued presence of TGFβ in dermal wounds will produce con-
tractures due to the persistence of myofibroblasts; in contrast, early elimination of
TGFβ significantly reduces the myofibroblast numbers resulting in an increase in
wound size. Similar results were obtained by varying the rate at which fibroblasts
differentiate to myofibroblasts and by changing the myofibroblast apoptotic rate.
Taken together, the implication is that elevated levels of myofibroblasts are the key
factor behind wounds healing with excessive contraction, suggesting that clinical
strategies which aim to reduce the myofibroblast density may reduce the appear-
ance of contractures.
3.1 Introduction
Severance of the dermal layer triggers a repair response that fails to regenerate the
original architecture of the tissue. Consequently the final outcome, scar tissue, is
both biologically and mechanically inferior to the unwounded dermis. The overall
healing process is complex and can be described in terms of four overlapping but
well-defined stages of wound repair: haemostasis, inflammation, proliferation and
lastly, remodelling and scar formation (Moulin et al., 2004; Enoch et al., 2006).
Haemostasis is the initial response to injury, beginning with arresting blood flow by
vasoconstriction. Platelets aggregate at the perforations in the vasculature, forming
a thrombus. This establishes a fibrin clot in the wound space that acts as a tempo-
rary scaffold over which cells migrate. In addition, growth factors such as thrombin
(Majno and Joris, 2004), platelet-derived growth factor (PDGF) (Singer and Clark,
1999) and transforming growth factors β1 and β2 (TGFβ) (Singer and Clark, 1999) are
released, attracting macrophages into the wound space and initiating the inflamma-
tory response.
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Inflammation is triggered irrespective of the presence of infection. Leukocytes such
as macrophages, mast cells and neutrophils migrate into the region, phagocytose
damaged tissue and detritus and remove foreign bodies. These cells release large
quantities of growth factors including TGFβ, which is one of the main regulatory
growth factors in dermal repair. TGFβ is implicated in the stimulation of angiogene-
sis, the formation of granulation tissue, the regulation of fibroblast collagen synthe-
sis (Roberts et al., 1992; Murata et al., 1997; Rhett et al., 2008) and the development
of fibroplasia; later in the wound healing process it also helps to determine the fi-
nal appearance of the scar (Ferguson and O’Kane, 2004). Late in the inflammatory
stage TGFβ initiates the recruitment of fibroblasts, the main cell type in dermal re-
pair, into the lesion. This migration of fibroblasts corresponds to the beginning of
the proliferative phase.
In the proliferative stage, the fibroblasts migrate over the fibrin framework simul-
taneously replacing it with a collagen lattice and thereby restoring the extracellular
matrix (ECM) within the wound. Endothelial cells, responsible for the vascularisa-
tion of scar tissue, use the ECM as a scaffold for the new vessels. Hence, angiogenesis
occurs concurrently with proliferation. Fibroblasts also modulate into their active,
contractile phenotype, the myofibroblast, and together fibroblasts and myofibrob-
lasts effect wound contraction through physically exerting traction on the collagen
fibres and through remodelling the collagen lattice. Experimental results for rat der-
mal repair have shown that for this contractile phase, the wound size can be mod-
elled by an exponential decay function (McGrath and Simon, 1983).
As discussed in Section 2.1.1, it was known previously that the activation of fibrob-
lasts to myofibroblasts was TGFβ-dependent (Desmoulie`re et al., 1993). However,
more recent experimental research by Gabbiani (2003), Hinz (2007, 2009, 2010) and
others have shown that mechanical tension is also required to initiate and main-
tain this phenotypic change (Wells and Discher, 2008; Wipff and Hinz, 2009; Eckes
et al., 2010). This differentiation is a two-stage process. Firstly, mechanical tension,
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the result of the compaction by tractional forces, initiates the activation to proto-
myofibroblasts, the precursors to myofibroblasts (Hinz and Gabbiani, 2003). Proto-
myofibroblasts are characterised by mature focal adhesions and immature actin fil-
aments (Gabbiani, 2003). Further stimulation by mechanical tension and TGFβ in-
duces the transformation of proto-myofibroblasts to myofibroblasts. Myofibroblasts
are distinguished from proto-myofibroblasts by the presence of stress fibres in their
cytosol in the form of α-smooth muscle actin (α-SMA) and supermature focal ad-
hesions (Hinz and Gabbiani, 2003). In addition, myofibroblasts are thought to per-
form the majority of wound contraction, while fibroblasts primarily synthesise and
remodel the local collagen network.
Once wound closure is complete the scar becomes relatively avascular and myofi-
broblasts and leukocytes are no longer present. It is speculated that myofibrob-
lasts undergo apoptosis (Moulin et al., 2004). Fibroblasts remain, performing further
ECM remodelling that increases the tensile strength of the scar tissue. The process of
scar maturation can last for months or even years following injury (Majno and Joris,
2004).
It is our purpose to develop a mathematical model that captures the essential fea-
tures of the proliferative stage of dermal wound repair and, recognising the impor-
tance of both chemical and mechanical signals within the wound healing process,
we consider a mechanochemical representation.
As described in Section 2.4.1, the majority of mechanochemical models for dermal
repair, such as those of Olsen et al. (1995, 1996, 1997, 1998, 1999), Tracqui et al.
(1995), Tranqui and Tracqui (2000), Javierre et al. (2009) and Vermolen and Javierre
(2010), are fundamentally based on the seminal work of Tranquillo and Murray
(1992) who considered a linear viscoelastic tissue framework. However, this is ap-
propriate only for small deformations and in human dermal wounds 20-30% of clo-
sure is associated with mechanical contraction while in murine dermal wounds this
can be up to 80% (Tranquillo and Murray, 1992; Farahani and Kloth, 2008). Clearly,
the deformations that occur in dermal wound healing are not always small, and so
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Tranquillo and Murray’s preliminary mechanical framework is unsuitable. In addi-
tion, this model does not capture the permanent contraction observed experimen-
tally unless a permanent chemical mediator with a static distribution is invoked.
In the present study, we develop an ordinary differential equation (ODE) model that
incorporates the most important features of wound closure and that allows for large
tissue displacements.
In the next section, we discuss the only other two-compartment morphoelastic
model for dermal repair, which was developed by Cook (1995). We then describe
our mathematical representation of dermal wound healing in Section 3.3, and dis-
cuss parameter estimation, a crucial aspect of computational biology. In Section 3.4,
we examine the model predictions and validate the model against experimental re-
sults for wound closure. Finally, in Section 3.5, we discuss the implications of our
results and describe possible extensions of the model.
3.2 The Cook Model
We build upon the work of Cook (1995), who developed an ODE mechanochemical
model for dermal repair that accounts for the permanent deformations and contrac-
tion of the tissue during healing. This approach employed the idea of a zero stress
state, which is defined as a state in which each element of the tissue is unstressed
(Goriely and Ben Amar, 2007; Hall, 2009). The zero stress state is necessarily defined
locally, as it may not be possible to find a compatible deformation of the entire tis-
sue where every point is simultaneously at zero stress. However, it is still possible
to develop a consistent theory with only locally-defined zero stress states by using a
multiplicative decomposition of the deformation gradient. Strain measured relative
to the zero stress state is termed the effective strain, while the classical strain associ-
ated with being at the local zero stress state is referred to as the residual strain (Cook,
1995).
Plastic tissue deformation associated with growth and cellular remodelling leads to
changes in the zero stress state. Since the effective strain is measured relative to the
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zero stress state, these changes can be incorporated into how the effective strain de-
velops. We assume the current state is everywhere a small elastic deformation from
the local zero stress state. This enables us to consider linear elasticity based on the
effective strain. In turn, our formulation for effective strain incorporates many mor-
phological aspects of tissue repair, such as cellular remodelling of collagen fibres and
the growth of new tissue. Thus, we develop a morphoelastic representation of wound
repair as it can capture both the growth and mechanical considerations involved in
tissue repair.
Cook (1995) uses these ideas to develop a preliminary morphoelastic model of
wound closure. He assumes symmetry about the wound centre at x = 0, and consid-
ers two compartments: one on 0 < x < L, which corresponds to the wound space
and a second on L < x < α, which represents the undamaged tissue (see Figure 3.1).
In this chapter, L is the location of the wound boundary and an increase in L indi-
cates an increase in wound size (or retraction) while a decrease inL indicates wound
contraction. We note that x = α represents an undisturbed point far from the wound
and that Cook considers a value of α = 1.
0
Wound
Space
L
Undamaged
Tissue
α
Figure 3.1: Wound compartment diagram.
This formulation allowed Cook to consider each time-varying species in two forms:
one inside the wound and another outside. Cook thus simplified his full model to
one that contained only time derivatives. Since the full model included advection,
this ODE approach required a representation of the spatial derivative of the velocity;
Cook used the approximation
∂v
∂x
=

1
L
dL
dt 0 < x < L,
−1
L−α
dL
dt L < x < α.
(3.1)
Combining these ideas, Cook developed the following 1D non-dimensional model
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of wound closure:
dn
dt
= n(1− n)− n
L
dL
dt
, (3.2)
ds
dt
= κn(1− s)− s
L
dL
dt
, (3.3)
SE = s+ τ(n), (3.4)
dz
dt
=
κq(s)n
s
, (3.5)
dS
dt
=
S
1− L
dL
dt
, (3.6)
τ(n) = τ0n(1− n)θ, (3.7)
 =
L− L0
L
− z, (3.8)
E =
L− L0
L− 1 , (3.9)
q(s) =

1− sβ if s < β,
0 if s > β.
(3.10)
Here n is the fibroblast density, s and S are the collagen densities inside and outside
the wound respectively,  andE are the effective strains inside and outside the lesion,
z is the residual strain, τ is the cell traction, κ is the production rate of collagen,
2L0 is the initial wound size, τ0 is a parameter characterising the cell traction, θ is a
parameter that modifies the logistic form adopted for the cell traction dependence
on fibroblast density, q(s) represents the proportion of fibres laid down in a relaxed
state and β is the threshold value of the residual strain above which alterations to the
residual strain are negligible.
While Cook (1995) was able to describe permanent wound contraction with his
model, a feature not observed in any of the previous models, there are several short-
comings, which we now describe.
Despite previous research by Tranquillo and Murray (1992) concluding that an in-
flammatory mediator is essential in wound repair, Cook (1995) neglects all chemical
effects. In order to effect wound contraction, Cook instead assumes that the cell
traction stress is biphasic. In contrast, Tamariz and Grinnell’s (2002) experiments
suggest that tractional stress is a monotonically increasing function of cell density,
consistent with previous models of dermal repair such as those of Tranquillo and
Murray (1992) and Olsen et al. (1995). A further problem with Cook’s formulation is
that it leads to a situation where there is no tension in the healthy skin or the healed
wound; this is unrealistic (Reihsner et al., 1995).
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Cook also models the effective strain explicitly. He assumes that it is governed by the
movement of the wound boundary and, inside the wound, the residual strain. While
Cook allows the residual strain to evolve by incorporating the effect of cells laying
down new fibres, he ignores the action of cells actively remodelling the collagen ma-
trix. However, in fibroblast populated collagen lattice experiments by Grinnell et al.
(2003), it was found that significant permanent contraction occurs as a result of fi-
broblasts physically remodelling the lattice. We incorporate a new representation of
the evolution of effective strain that includes these effects.
Finally, Cook neglects the synthesis of collagen in the unwounded region. Conse-
quently, the steady state value of the collagen density outside the wound is history-
dependent. Hence, the collagen density inside the wound tends to healed levels but
the collagen density outside the wound may not.
In the proposed mechanochemical wound repair model, we have addressed these
issues and also extended Cook’s model to include the presence of myofibroblasts
and the effects of TGFβ.
3.3 Proposed Mathematical Model
3.3.1 Two-Compartment Model of Wound Repair
Following Cook (1995), we consider a two-compartment model for wound repair. We
assume symmetry about the wound centre atx = 0 and take x = L(t) to represent the
time-dependent wound boundary, with 0 < x < L corresponding to one half of the
wound space. We also assume that there is a fixed point, x = α, that is sufficiently far
from the wound space that the tissue is undisturbed there. In our model, L < x < α
therefore corresponds to the unwounded dermis. We also note that the proliferative
stage occurs over approximately a one month period (Enoch and Leaper, 2007) and
so we measure time, t, in days.
Our model examines the interactions between cells, TGFβ, ECM and wound me-
chanics. We consider eight dependent variables: the fibroblast density inside and
outside the wound (n and N respectively), the myofibroblast density in the wound
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(m), the TGFβ concentration within the wound (β), the ECM density within and
without the wound (s and S, respectively), the effective strain within and without
the wound (e and E, respectively), and the location of the wound boundary (L).
During the course of repair the wound deforms as a result of competing cell trac-
tion forces inside and outside the wound. This yields a corresponding movement in
the wound boundary location indicating compression or release of the lesion. This
movement in turn shifts the cells and extracellular material within the wound, and
we refer to this as passive advection. Each species in the model is assumed to un-
dergo this passive advection.
Fibroblasts are assumed to undergo logistic growth, to transform into myofibroblasts
in response to mechanical stimuli and to advect with the moving ECM. It is known
that fibroblasts migrate into the wound space from the surrounding dermis and we
model this with a simple form: the recruitment of fibroblasts to the wound is taken to
be proportional to the difference between the fibroblast density in the undamaged
tissue and the density in the wound. Hence, the fibroblast equation takes the form
dn
dt
= gn
(
1− n
Nˆ
)
+
R(N − n)
L
− rKβen− n
L
dL
dt
, (3.11)
N(t) = Nˆ , (3.12)
where g is the intrinsic growth rate of fibroblasts, Nˆ represents the unwounded den-
sity of fibroblasts, R represents the rate at which cells migrate into the wound from
the unwounded dermis, r characterises the activation rate of fibroblasts to myofi-
broblasts, and K is the elastic modulus of the dermis. Assuming tissue stiffness to
be proportional to collagen density, we find that K = Y s, where Y is a constant of
proportionality.
The activation term, rKβen, has been chosen since fibroblasts are activated to my-
ofibroblasts by the presence of TGFβ (β) and tensile stress. It should be noted that
elastic stress (Ke) is used, rather than traction stress or total stress. This can be justi-
fied by noting that the traction stress is in fact a body force due to the action of cells.
Moreover, a simple comparison of the elastic stress and traction stress profiles in the
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Tranquillo and Murray (1992) model makes it clear that elastic stress is the most ap-
propriate for governing the activation of fibroblasts. The elastic stress monotonically
decreases with distance away from the wound centre while traction monotonically
increases. If the modulation of fibroblasts to myofibroblasts were dependent on cell
traction, the monotone increase in stress would mean that the highest rate of differ-
entiation of fibroblasts to myofibroblasts would happen outside the wound. How-
ever, using the elastic stress leads to the sensible result where activation is highest in
the wound. This behaviour is consistent with the observation by Hinz et al. (2001)
that myofibroblast differentiation slows, or is even arrested, upon release of tension
from splinted wounds. As the wound contracts, the elastic stress decreases and the
rate of the myofibroblast differentiation also slows. This phenomenon is observed
regardless of the magnitude of the initial cell traction outside the wound space.
As mentioned above, myofibroblasts are assumed to be present only within the
wound space and the only source of myofibroblasts is taken to be the activation of fi-
broblasts. Myofibroblasts are assumed not to transform back to fibroblasts, instead
undergoing natural cell death (apoptosis) (Moulin et al., 2004). In addition, these
cells are advected as the ECM deforms due to retraction or contraction of the wound
space. Hence, the governing equation for the myofibroblast density is
dm
dt
= rKβen− am− m
L
dL
dt
, (3.13)
where a characterises the rate of myofibroblast apoptosis.
Fibroblasts migrate into the wound space 2-4 days post-wounding (Enoch and
Leaper, 2007) and experimental results by Yang et al. (1999) show that there is a
large concentration of TGFβ in the wound space at around this time, which then
decays approximately exponentially. In our model, where t = 0 represents day 2
post-wounding, we therefore assume that TGFβ can be modelled by an exponential
decay function of the form
β(t) = β0exp (−bt) , (3.14)
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where β0 is the initial concentration of TGFβ and b is the natural decay rate. It is
noted that in Section 2.2, the distinct roles of TGFβ1 and TGFβ3 were discussed. In
this model, we consider the effects of TGFβ1, but in subsequent sections, refer to this
growth factor as TGFβ.
The ECM is synthesized by both the fibroblasts and myofibroblasts, with produc-
tion ceasing once unwounded levels are obtained. Both the ECM inside the wound
and the ECM outside the lesion undergo advection as the wound deforms during
the course of repair. Based on these assumptions, the governing equations for ECM
density are
ds
dt
= k1(n+ ηm)− k2(n+ δm)s− s
L
dL
dt
, (3.15)
dS
dt
= k1N − k2NS + S
α− L
dL
dt
, (3.16)
where k1 and k2 are the synthesis and degradation rates of ECM by fibroblasts respec-
tively, and η and δ are the synthesis and degradation rates of ECM by myofibroblasts
relative to fibroblasts.
Strain in the ECM develops as cells rearrange the matrix, generating tension in the
fibres, and is reduced when new fibres are laid down in a relaxed state. Advection
also affects the local strain, with the effect of tissue elasticity represented in the
(1/L)dL/dt term. We consider a form of the effective strain based upon Hall’s (2009)
repair description, obtaining the following governing equations for strain inside and
outside the wound:
de
dt
= kζs(n+ piζm)− kρ(n+ piρm)e
s
+
(1− e)
L
dL
dt
, (3.17)
dE
dt
= kζNS − kρNE
S
− (1− E)
α− L
dL
dt
, (3.18)
where kζ is the rate at which fibroblasts cause permanent contraction of the ECM,
piζ represents the rate of permanent contraction due to myofibroblasts relative to
fibroblasts, kρ is the rate of matrix turnover as a result of replacing stressed fibres
with unstressed fibres and piρ represents the remodelling achieved by myofibroblasts
relative to that of fibroblasts. Here kζ , kρ, piζ , piρ are all constants.
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It is assumed that there are no body forces apart from those due to cell traction.
Consequently, the tissue forces (due to elastic and cell traction stress) inside and
outside the wound must balance, leading to
Y se+ τ(n+ ζm)s = Y SE + τNS, (3.19)
where τ is a constant measuring the fibroblast traction and ζ represents the strength
of myofibroblasts relative to fibroblasts. This formulation also assumes an abrupt
interface between the wound and unwounded dermis. In an acute wound this inter-
face is gradual. However, since the width of this interface is typically much smaller
than the wound width, this represents a reasonable assumption. We note that in
Cook’s model the cell traction term is independent of collagen density; here, we take
it to be directly proportional to s, in line with Tranquillo and Murray (1992). From
(3.19), the governing equation for the wound boundary
dL
dt
=
Y
{
κ [E(1− S)− (n+ ηm)(1− s)e] + kζ
[
S2 − (n+ pim) s2]}
s
L {Y (1− 2e)− 2τ(n+ ζm)}+ Sα−L {Y (1− 2E)− τ}
−Y kρ [E − (n+ ηm) e] + τκ [(1− S)− (n+ ηm)(1− s)(n+ ζm)]
s
L {Y (1− 2e)− 2τ(n+ ζm)}+ Sα−L {Y (1− 2E)− τ}
(3.20)
+τ
{
rY s2enβ(1− ζ) + ζasm− s(1− n) (n+R/L)}
s
L {Y (1− 2e)− 2τ(n+ ζm)}+ Sα−L {Y (1− 2E)− τ}
is obtained by differentiating (3.19) with respect to time, substituting in equations
(3.11)-(3.18), and rearranging for dL/dt.
The system is non-dimensionalized (see Appendix A.1), and from this point on we
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consider the following non-dimensional equations, dropping bars for convenience:
dn
dt
= n (1− n) + R(1− n)
L
− rY βsen− n
L
dL
dt
, (3.21)
dm
dt
= rY βsen− am− m
L
dL
dt
, (3.22)
β(t) = exp (−bt) , (3.23)
ds
dt
= κ(n+ ηm)(1− s)− s
L
dL
dt
, (3.24)
dS
dt
= κ(1− S) + S
1− L
dL
dt
, (3.25)
de
dt
= kζs(n+ pim)− kρ(n+ ηm)e
s
+
(1− e)
L
dL
dt
, (3.26)
dE
dt
= kζS − kρE
S
− (1− E)
1− L
dL
dt
, (3.27)
Y SE + τS = Y se+ τ(n+ ζm)s. (3.28)
Since N(t) ≡ 1, we no longer consider the fibroblast density outside the wound
space. Note, the problem is scaled so that one unit of time represents approximately
one day.
Recall that we are modelling the second stage of wound healing, the proliferative
phase. We assume that, initially, the scaled ECM density and the effective strain out-
side the wound space are given by
S(0) = 1 and E(0) =
kζ
kρ
,
their unwounded values. It is assumed that the wound is small and hence there is a
very small population of fibroblasts in the wound initially. Additionally, we assume
that there is a small amount of collagen already within the wound space. Based on
these assumptions we use the initial conditions
L(0) = 0.1, n(0) = 0.001 and s(0) = 0.25.
The strain inside the wound, e, must satisfy the force balance equation, (3.28), thus
e(0) =
kζ
kρs(0)
+
τ
Y s(0)
− τn(0)
Y
.
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With these initial conditions, the full dimensionless system of (3.21)-(3.28) can be
solved using MATLAB’s inbuilt ordinary differential equation routine, ode45.
3.3.2 Parameter Estimation
One complication common to almost all mathematical representations of biological
systems is that it is usually impossible to determine the values of all the parame-
ters directly from experimental evidence. In some cases, an appropriate value can
be estimated based on experimental results or a plausible range can be determined;
nonetheless, some parameters may need to be estimated from numerical simula-
tions so that the predictions are physically realistic. Clearly, assigning parameters
values is a nontrivial process.
In Table 3.1 we present the parameters we used in our model; this table also includes
a description of whether the value was known, calculated or estimated and, where
appropriate, references are provided. Fortuitously, the sensitivity analysis in Sec-
tion 3.4 shows our model to be quite robust to significant variations in a number
of parameter values. This means that we can have some confidence that the solu-
tions obtained with these parameter values are indicative of the solution trajectory
for physiologically correct parameter values.
In the morphoelastic representation of tissue dynamics that we use, we assume that
the zero stress state is close to the current state. This implies that the effective strain
is small (i.e. e  1) and enables us to assume linear elasticity. Given that the steady
state of the effective strain in healthy skin is kζ/kρ, this indicates that kζ  kρ. With
this in mind, we choose kρ and kζ such that kζ/kρ is O(10−2) (i.e. has order or 10−2).
A wide range of values is reported in the present literature for the magnitude of trac-
tion forces exhibited by human dermal fibroblasts; estimates range from 0.1nN/cell
(Eastwood et al., 1994, 1996, 1998; Campbell, 2002; Wrobel et al., 2002; Shreiber et al.,
2003) to 2.65µN/cell (Delvoye et al., 1991; Fray et al., 1998). There is a number of pos-
sible reasons for this apparent discrepancy. Firstly, there is a lot of variation in the
matrix material upon which the cells are seeded. While fibroblast populated collagen
gels appear to be the most widely used, 3-D bio-artificial hydrogels (Zahalak et al.,
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Non-Dimensional Parameter Range Reference
R, Influx of fibroblasts R ≈ 0.04 Sillman et al. (2003)
r, Fibroblast activation r ≈ 0.22 Desmoulie`re et al. (1993)
to myofibroblasts
a, Myofibroblast apoptosis 0.096 < a < 0.24 Moulin et al. (2004)
b, TGFβ decay b ≈ 0.426 Est. from Yang et al. (1999)
κ, Collagen production 0.1− 1 TW
η, Relative collagen production 2 Moulin et al. (1998),
by myofibroblasts Olsen et al. (1995)
kζ , Contractile strain produced 0.002 < kζ < 0.02 TW
by fibroblasts
kρ, Matrix turnover by fibroblasts 0.2 < kρ < 2 TW
pi, Myofibroblast to fibroblast 15 TW
contractile strain generation
Y , Elastic modulus 10 < Y < 300 Silver et al. (2001),
Genzer and Groenewold (2006)
τ , Fibroblast cell traction 1 < τ < 3 Fray et al. (1998),
Wrobel et al. (2002)
ζ, Myofibroblast to fibroblast ζ ≈ 5 Olsen et al. (1995)
cell traction
n0, Initial fibroblast density 0.001 Cook (1995)
s0, Initial collagen density 0.25 TW
L0, Initial wound boundary 0.1 Cook (1995)
Table 3.1: Table of parameters. Unless otherwise specified, these parameters are
used for all simulations. TW refers to assumed values made during this work. For
determination of the dimensional parameter values see Appendix A.1.
2000), GAG-collagen scaffolds (Freyman et al., 2001), elastomers (Wrobel et al., 2002)
and other 3-D constructs (Harley et al., 2007) have also been employed. Addition-
ally, different experiments involve matrices of different stiffnesses with elastic mod-
uli ranging from 40Pa to 70GPa (Freyman et al., 2001, 2002; Campbell, 2002). None
of these experiments considered a modulus between 0.1− 0.7MPa, the approximate
stiffness of human dermal tissue (Diridollou et al., 2000; Silver et al., 2001; Khatyr
et al., 2004; Genzer and Groenewold, 2006; Ahlfors and Billiar, 2007; Kuchar˘ova´ et al.,
2007), although it is possible to manufacture collagen gels that possess an elastic
modulus in the appropriate range (Chapuis and Agache, 1992; Ahlfors and Billiar,
2007). As cell traction strength is thought to vary significantly with tissue stiffness,
the failure of experimental research to adequately control for tissue stiffness might
account for the large variation in measured cell traction strength. Moreover, the fail-
ure to use lattices of stiffness similar to that of the skin means that what results have
been obtained may not be physiologically relevant.
Moreover, there is no consistency in the method used to determine the cell traction
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force. Current methods include studies of free-floating fibroblast-populated colla-
gen lattices (Li and Wang, 2009), the use of cellular force monitors (Freyman et al.,
2002), micropost force sensor arrays (Li and Wang, 2009), and cell traction force mi-
croscopy (Fray et al., 1998; Li and Wang, 2009). These different techniques seem to
yield inconsistent measurements of the cell traction force and there is a need for
further work to harmonise the various experimental approaches.
Also, it is possible that the variation in cell traction estimates is associated with mixed
populations of fibroblasts and myofibroblasts and with the effects of fibroblasts dif-
ferentiating into myofibroblasts. Myofibroblasts are known to function in a manner
similar to smooth muscle cells, and cell traction values of 1µN/cell are close to those
of smooth muscle cells at 1.5µN/cell (Wakatsuki et al., 2000). Hence, cell traction
values around 1nN/cell may correspond to the force generated by fibroblasts, while
values near 1µN/cell may be associated with myofibroblasts.
We have also reviewed the non-dimensional values of the traction force used by pre-
vious bio-mathematicians who have modelled dermal repair. Even amongst these
papers there are discrepancies. There are two clusters of values used by researchers;
some authors used cell traction parameters in the range 0.02 − 0.05 (Olsen et al.,
1995; Ferrenq et al., 1997; Tranqui and Tracqui, 2000) while others took traction to
be in the range 0.5− 2 (Tranquillo and Murray, 1992; Cook, 1995; Tracqui et al., 1995;
Tranqui and Tracqui, 2000; Ramtani et al., 2002; Ramtani, 2004). It is possible that
this discrepancy is partly due to the different non-dimensionalizations used by the
authors. The cell traction parameter depends on the scaling of cell density, which
varies significantly in different papers from O(103) to O(106) (Olsen et al., 1996; Fer-
renq et al., 1997). This may account for the order of magnitude variation in the non-
dimensionalized cell traction parameter.
The previous model by Cook (1995) (on which this work is based) used a non-dimen-
sional cell traction value of 2. Therefore, it is reasonable to assume that the non-di-
mensional value of cell traction in this work should be of O(1). Consideration of the
scaling then implies that the cell traction force is approximately 2µN/cell, consistent
with Kolodney and Wysolmerski (1992), Fray et al. (1998), Wakatsuki et al. (2000),
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Wrobel et al. (2002) and Wagenseil and Okamoto (2007).
3.4 Results
Following Cook (1995), we consider the effect of varying particular parameter values
on the system. The significant results are summarised in Table 3.2.
3.4.1 Base Results
In the base system (illustrated in Figure 3.2) we see that the fibroblast density, n, in-
creases rapidly over the first week of wound repair, essentially reaching near-healed
densities around day 5. Myofibroblasts undergo the greatest activation early on,
achieving a maximum density on day 3, after which the myofibroblast density, m,
decreases due to a reduction in the number of fibroblasts activated to become my-
ofibroblasts. This decrease is primarily associated with the decay of TGFβ; as β de-
creases, there is a corresponding reduction in the activation of fibroblasts to myofi-
broblasts.
The collagen density inside the wound, s, follows the fibroblast profile with a lag,
attaining close to a healed density by day 12. Changes in the collagen density outside
the wound, S, are entirely mediated by the advection of the wound boundary. Thus,
S increases during the retraction phase, decreases while the wound contracts and
finally tends towards healed levels as the damaged dermis is repaired.
Initially, the wound boundary, L, increases (wound retracts). This expansion in
wound size is due to the unbalanced stresses acting on the wound boundary. As
Watts (1960) comments, “contraction is essentially a cellular process affecting the
edge of the wound.” Early in the healing process, there is greater cell traction stress
outside the wound than within it. As such, the wound boundary is pulled open.
Typically, retraction occurs over the first 2 days of wound repair (Billingham and
Medawar, 1955; McGrath and Emery, 1985), and we predict maximum retraction to
occur just following two days of repair. As the wound space is repopulated with fi-
broblasts and as fibroblasts are transformed into myofibroblasts, cell traction stress
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Figure 3.2: Dermal repair profiles predicted by the model. Parameter values were κ = 0.27,
τ = 2, kζ = 0.0054, kρ = 0.54, Y = 71.3, R = 0.04, r = 0.22, a = 0.2, ζ = 5, pi = 15, η = 2 and
b = 0.426.
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within the wound increases beyond that of the surrounding tissue, and wound con-
traction results.
This ensuing contractile phase is approximately exponential in nature. The contrac-
tile phase is highly dependent on the presence of myofibroblasts. However, fibrob-
last activation decreases as the wound heals; fewer myofibroblasts are generated and
apoptosis dominates, reducing the density of myofibroblasts. This causes contrac-
tion of the wound to decrease also, reaching a plateau stage where further contrac-
tion is negligible. By this stage, it is observed that approximately 10% of wound clo-
sure has been effected by wound contraction, which is consistent with previous pre-
dictions of human dermal wound repair (Murray, 2003b).
3.4.2 Varying the activation rate of fibroblasts, r
As expected, increasing (decreasing) the activation rate of fibroblasts to myofibrob-
lasts significantly increases (decreases) the myofibroblast density (see Figure 3.3),
while having only a limited effect on fibroblast density. If the activation rate is very
small, there are few myofibroblasts. As a result, the total traction stress associated
with the cells is significantly weaker and the wound boundary may retract and stay
retracted (instead of contracting). In contrast, if the activation rate is quite high,
there may be no initial retraction. Thus, the system exhibits contraction only and,
due to the increased myofibroblast density, the contraction of the wound boundary
is significantly increased. Variations in the remainder of the system are essentially
due to advection.
3.4.3 Varying the rate of myofibroblast apoptosis, a
When the apoptotic rate of myofibroblasts is increased so that myofibroblasts die
out rapidly, there is only a marginal difference in the fibroblast profile (see Figure
3.4).
In the case where myofibroblast apoptosis is small, the effective strain inside the
wound is reduced, decreasing the activation rate and causing the fibroblast density
to achieve unwounded levels more quickly. While the activation rate is small in this
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Figure 3.3: The fibroblast activation rate was varied by multiplying or dividing the base
activation rate of 0.22 by 10, so that the activation rates considered were r = 2.2 (- -), r = 0.22
(-) and r = 0.022 (..). The other parameter values were κ = 0.27, τ = 2, kζ = 0.0054, kρ = 0.54,
Y = 71.3, R = 0.04, a = 0.2, ζ = 5, pi = 15, η = 2 and b = 0.426.
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Figure 3.4: The rate of myofibroblast apoptosis was varied by roughly one order of magni-
tude from the base rate of 0.2, so that the death rates considered were a = 2 (- -), a = 0.2 (-)
and a = 0.03 (..). The other parameter values were κ = 0.27, τ = 2, kζ = 0.0054, kρ = 0.54,
Y = 71.3, R = 0.04, r = 0.22, ζ = 5, pi = 15, η = 2 and b = 0.426.
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case, the maximum myofibroblast density significantly increases with decreasing
apoptotic rate since myofibroblasts persist for longer. Indeed, for sufficiently small
apoptosis the myofibroblasts increase collagen density within the wound space and
cause excessive wound contraction, both of which persist for some time following
wound closure.
In summary, increasing (decreasing) the rate at which myofibroblasts undergo apop-
tosis causes the system to behave in a manner similar to when the fibroblast differ-
entiation rate is decreased (increased). For instance, increasing the activation rate
resulted in excess collagen, while decreasing the myofibroblast apoptotic rate pre-
dicted the same outcome.
3.4.4 Varying the decay rate of TGFβ, b
Decreasing the decay rate of TGFβ achieves a similar effect to reducing myofibrob-
last apoptosis (see Figure 3.5). When TGFβ persists, the activation of fibroblasts to
myofibroblasts is prolonged. Consequently, myofibroblasts remain following wound
closure, causing a mild increase in collagen production within the wound space as
well as continued severe wound contraction. If, on the other hand, the decay rate is
increased, fibroblast differentiation ceases quickly and few myofibroblasts are pro-
duced. This causes the wound boundary to retract permanently and in this case, the
wound expands to cover an area approximately 120% that of the original.
3.4.5 Comparison with Experimental Data
Currently, there is no experimental data for human full thickness wounds showing
the three phases of wound boundary movement (retraction, exponential contraction
and permanent contraction). While Catty (1965) did obtain data for wound closure
in the human dermis, the data is sparse and wound measurements ceased at day 16
following injury, which is prior to the end of the proliferative phase. Consequently,
further wound contraction may have occurred than what was reported. Additionally,
a large late retraction of the wounds was observed when wounds were re-examined
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Figure 3.5: The decay rate of TGFβ was varied by multiplying or dividing the base decay rate
of 0.1 by 10, so that the decay rates considered were b = 4.26 (- -), b = 0.426 (-) and b = 0.0426
(..). The other parameter values were κ = 0.27, τ = 2, kζ = 0.0054, kρ = 0.54, Y = 71.3,
R = 0.04, r = 0.22, a = 0.2, ζ = 5, pi = 15 and η = 2.
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six months following injury. However, no data was recorded between the measure-
ments at day 16 and at six months. Moreover, for comparison with this model we
require data that exhibits each phase of wound boundary movement and observes
the wound to at least the end of the proliferative phase (approximately one month
following injury). As such, it was chosen not to compare this model with the data
obtained by Catty (1965).
Multiple studies measuring wound contraction have been conducted (Billingham
and Medawar, 1955; Billingham and Russell, 1956; Grillo et al., 1958; Watts, 1960;
Luccioli et al., 1964; Kennedy and Cliff, 1979; Doillon et al., 1987). However, the
results that most ably illustrate the three stages of wound movement are those ob-
tained by McGrath and Simon (1983). Therefore, the model was tested by comparing
our predictions with McGrath and Simon’s (1983) experimental results of rat wound
contraction. Figure 3.6 shows their experimental results plotted against our simula-
tion curve.
The only alteration made to the parameter values was to the values of kρ, which re-
flects the proportion of collagen fibres that are laid down prestressed, and kζ , the rate
at which fibroblasts cause permanent strain in the lattice. In the early figures, we
have used kζ = 0.0054 and kρ = 0.54, but the McGrath-Simon data can be fitted well
with the values kζ = 0.0235 and kρ = 0.81. Hence, it appears that, in comparison with
human wound healing, rat dermal repair involves greater contraction of collagen fi-
bres relative to collagen production. This is consistent with the observation that rat
wounds heal primarily by contraction while human injuries heal primarily by migra-
tion and proliferation. Indeed, rat skin contains an additional organ, the panniculus
carnosus, which changes the elasticity of the skin and acts to pull the wound closed
mechanically. This affects the mechanical behaviour of the skin and would need to
be reflected within our model. Since the panniculus carnosus moves the substra-
tum of the skin and effectively holds the wound closed while it heals, we expect that
the presence of the panniculus carnosus should principally affect the morphoelastic
properties of the skin. This is consistent with the fact that we obtain a good fit be-
tween our model and the McGrath-Simon data by modifying the parameters kρ and
kζ , which both appear in the strain evolution equation.
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Figure 3.6: Comparison of our predicted curves with McGrath and Simon’s (1983) experi-
mental results for rat dermal repair. All black curves correspond to our simulated results,
the red points on the wound boundary figure correspond to McGrath and Simon’s exper-
imental results, and the blue curve has been fitted to the contractile phase of our sim-
ulation to illustrate that exponential contraction is observed, with its equation given by
A(t) = 0.28 + 1.49exp(−0.141t). Clearly we see that there is a large initial retraction followed
by a slow permanent contraction. The fibroblasts and collagen increase to unwounded val-
ues and the TGFβ concentration tends to zero. Myofibroblasts increase while the TGFβ con-
centration is high, until apoptosis dominates and the myofibroblast density tends to zero.
The parameter values were κ = 0.27, τ = 2, kζ = 0.0235, kρ = 0.81, Y = 71.3, R = 0.04,
r = 0.22, a = 0.2, ζ = 5, pi = 15, η = 2 and b = 0.426. In our model, time was scaled by the
parameter characterizing the fibroblast proliferation rate, g, where g = 0.832/day. In order
to compare dimensional and non-dimensional results, we also scaled time in McGrath and
Simon’s data by this parameter.
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From Figure 3.6, it appears that there is a difference between the estimate of the time
scale of retraction predicted by the model and that observed in McGrath and Simon’s
(1983) experimental data. Rat dermal tissue is highly elastic and typically retracts
fully over the first day of repair. However, wound geometry may affect the time at
which maximum retraction is observed. McGrath and Simon (1983) observed small
square wounds to require approximately one and a half days to retract, while circular
wounds (as seen in Figure 3.6) retract over the first day of repair. The model predicts
wound retraction to terminate on day 3. The difference is likely due to the inability to
approximate values for the strain parameters kρ and kζ and that in lieu of a measure
for the elasticity of rat tissue, the Young’s modulus for human dermis has been used.
To verify that the model predicted exponential contraction of the wound, the follow-
ing exponential decay function was fitted to the contractile stage of the simulation
curve,
A(t) = Af + (A0 −Af )exp(−kt),
where A0 is the wound size when contraction begins and Af is the final area once
contraction is completed. The constants A0 and Af are both scaled with respect to
L0 and k is the contraction rate constant. It was found that values of A0 = 2.05,
Af = 0.279 and k = 0.141 generated the best approximation to the simulation curve
and the approximation is shown as the dashed curve in Figure 3.6. This exponen-
tial function closely modelled the contractile phase of wound repair; as such we are
satisfied that the model predicts an exponential rate of wound contraction.
From Figure 3.6, we see that the model simulation appears to provide a good ap-
proximation to the contraction data from McGrath and Simon (1983). To verify this,
we quantitatively compare the experimental wound boundary data from McGrath
and Simon (1983) with our model predictions and the exponential curve fitted to
our simulation. Table 3.3 gives the scaled values for initial wound size, maximum
retraction, one month following wounding, and after 71 days observed by McGrath
and our simulation curves. The final measurement is given at 71 days post wounding
as this represents the time at which McGrath and Simon ceased recording data for
rat wound contraction.
78 Chapter 3. A Morphoelastic Representation of Dermal Repair
Series Initial Maximum One Month Final
Retraction (71 Days)
McGrath 1.000 1.284 0.2914 0.3048
Model 1.000 1.286 0.2973 0.2817
Exponential - 1.439 0.3041 0.2787
Table 3.3: Data from McGrath and Simon (1983) together with the corresponding
predictions from our model. Wound measurements are typically carried out to one
month, as such we include these measurements together with the initial wound area,
maximum wound area following retraction and final wound area at 71 days.
From Table 3.3, we can see that our model predictions are very similar to the ex-
perimental data obtained by McGrath and Simon (1983). This confirms that good
agreement is seen between the model predictions and the experimental data. The
only noticeable difference occurs when comparing the one month and final mea-
surements. The wounds observed by McGrath and Simon were observed to expe-
rience late retraction. Our model however predicted a mild further contraction to
occur over the same period of time. Nonetheless, the difference between these mea-
surements are so small as to be considered negligible. Regardless, the model com-
pares well with the experimental data. When comparing the model predictions and
exponential curve, good agreement is also seen, apart from the maximum contrac-
tion. However, both from Table 3.3 and Figure 3.6 it can be seen that the exponential
curve ably approximates the simulation curve.
Finally, good agreement is observed between the experimental and simulated results
and so we are satisfied that the model is producing realistic results.
3.5 Discussion
We have developed a mechanochemical model of wound repair that combines a re-
alistic representation of tissue mechanics with known cell and chemical indicatory
dynamics. In particular, we consider a morphoelastic description of tissue mechan-
ics. This gives an improved representation of strain within the system by incorpo-
rating remodelling and growth of the tissue. In addition, the activation of fibroblasts
to myofibroblasts is taken to be dependent on both TGFβ and mechanical strain,
consistent with recent experiments (Hinz, 2007; Wells and Discher, 2008). Finally,
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we incorporated deposition and degradation of collagen into our model and devel-
oped a force balance equation to include the contribution of myofibroblasts to cell
traction.
This representation of dermal repair is capable of reproducing the contractile be-
haviour of acute wounds, simulating the two transient aspects of wound closure (re-
traction and exponential contraction) as well as the permanent reduction in wound
area observed experimentally (McGrath and Simon, 1983; McGrath and Emery,
1985). This repair description is an advance on previous models of wound repair
since it does not require an artificial mechanism to induce permanent wound con-
traction. In addition, the model has been shown to reproduce McGrath and Simon’s
(1983) experimental data for rat dermal repair and, using realistic parameter values,
it accurately models the course of adult human dermal repair.
A parameter investigation was carried out to determine the influence of TGFβ con-
centration and myofibroblast density on the wound healing process. Variation of the
decay rate of TGFβ was used as an indicator of the length of the inflammatory re-
sponse, with small decay rates indicating a long inflammatory response. In the case
of “inflamed” wounds, a myofibroblast population is maintained after wound clo-
sure, ultimately resulting in excess contraction. For a short inflammatory response,
the myofibroblast density decreases rapidly and there is in an increase in wound size.
These results suggest that TGFβ is required for wound contraction; a deficiency in
TGFβ results in very few myofibroblasts and this leads to an increase in wound area.
However, an excessive inflammatory response results in a heightened myofibroblast
density and the possible development of contractures.
In further simulations it was found that certain other parameter changes could lead
to similar results. Indeed, the effect of a long inflammatory response could be repli-
cated by either increasing the fibroblast activation rate or by decreasing myofibrob-
last apoptosis. Hence, there are different mechanisms that can initiate pathological
scarring. Indeed, work by Aarabi et al. (2007) found that application of mechanical
loading of murine wounds during the early proliferative stage resulted in the forma-
tion of hypertrophic scars due to down-regulated myofibroblast apoptosis. Likewise,
80 Chapter 3. A Morphoelastic Representation of Dermal Repair
our results suggest that an elevated myofibroblast density is key to invoking exces-
sive contraction of wounds. Indeed, to verify this idea the system was extended to in-
clude stress dependence for myofibroblast apoptosis. The results, which for brevity
are not included here, found that significantly more myofibroblasts were required
to undergo apoptosis than when myofibroblast apoptosis is not stress dependent in
order to obtain normal repair. Therefore, if a wound appears to be exhibiting se-
vere contraction, it may be beneficial to reduce the myofibroblast density within the
wound to prevent the development of a problematic contracture.
A reasonable fit to McGrath and Simon (1983)’s experimental data was obtained by
adjusting just two parameters: kρ, the proportion of fibres laid down that are pre-
stressed, and kζ , the rate of morphoelastic remodelling of the collagen network by
cells acting on collagen fibres. The parameter kρ was increased from 0.54 to 0.81, rep-
resenting an increased percentage of prestressed fibres in the healing wound. The
parameter kζ was also increased from 0.0054 to 0.0235, representing a four-fold in-
crease in the contractile strain produced by cells. This indicates a difference between
the repair responses of human and murine wounds. The significant increase in the
value of kζ from human to murine repair indicates that murine wounds achieve clo-
sure with significantly more contraction that human dermal wounds (a fact sup-
ported by experimental evidence). Furthermore, the high kρ value compared with
the kζ value in human repair indicates that repair is primarily attributable to synthe-
sis of collagen and cellular proliferation. Thus, our model suggests human wounds
heal mainly by infilling, which is consistent with experimental observations.
Significant difficulties were encountered when obtaining reliable experimental es-
timates of some parameter values, especially parameters pertaining to mechanics.
As noted above, the variability in experimental values for fibroblast traction reflects
the wide range of matrix polymers, matrix elasticities and measurement techniques
used in the experiments. We estimated parameter values by fitting to the qualitative
details of human wound healing. However, the fact that it is possible to synthesise
collagen lattices with similar mechanical properties to the skin suggests that it may
be possible to develop better estimates based on experiments.
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The model could be extended in various ways. For example, the representation of the
matrix present in the wound before the healing process begins could be improved. It
is known that a provisional matrix composed largely of fibrin is present in the wound
at the beginning of the proliferative phase. Fibroblasts degrade this fibrin network,
replacing it with collagen (Shultz et al., 2005; Enoch and Leaper, 2007). Although
the current initial condition of s(0) = 0.25 could be thought of as representing the
fibrin, we would like to model the fibrin and collagen separately, with the fibroblasts
degrading the local fibrin matrix and replacing it with collagen. The contribution of
the fibrin lattice towards tissue stiffness and cell traction would be included. Taken
together, this would enable a smaller initial collagen concentration to be considered,
which would more realistically describe the early stages of wound healing.
Another aspect of the system that could be revised is the representation of the in-
flammatory response and its impact on the proliferative phase of wound repair.
There are a number of key chemokines released during the inflammatory response
and these chemokines affect the progress of proliferation. Indeed, defective inflam-
mation is implicated in poor healing responses such as chronic wounds and patho-
logical scarring. Additionally, greater interaction between the cellular and chemical
components would be a useful way of extending the model. For example, TGFβ is
known to upregulate fibroblast proliferation and act as a chemoattractor for these
cells. However, the inflammatory response itself is very complicated, with macro-
phages, mast cells, neutrophils and platelets all playing significant roles. Each of
these cells are also primary sources of inflammatory mediators in wound repair, such
as TGFβ, PDGF, basic fibroblast growth factor (bFGF), platelet activating factor (PAF)
and many more (Majno and Joris, 2004). A simple extension of the model would be
to include an equation for a generic inflammatory cell, perhaps a leukocyte, where
its behaviour is representative of the net inflammatory response of these cells. In so
doing, we would also be modelling one of the primary sources of TGFβ, and so the
behaviour of TGFβ within the system would also be more realistic.
One inflammatory cell that is known to be directly linked to the fibrotic response
is the mast cell (Majno and Joris, 2004). Mast cells are recruited early in the in-
flammatory process and release vast quantities of growth factors via degranulation.
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Amongst these is PAF, which aids the platelet cascade and the subsequent release
of inflammatory mediators, and bFGF, which stimulates fibroblast proliferation and
recruitment to the wound site. Hence, instead of modelling a generic inflammatory
cell, a possible extension would be to explore a single aspect of inflammation and
investigate its effects on the proliferative response in isolation. Only considering an
extension to the inflammation model presupposes that the interaction between the
inflammatory and proliferative responses in the wound is the most crucial in wound
repair. This may not be true, as proliferation is known to be strongly coupled to an-
giogenesis.
Angiogenesis and proliferation occur at about the same time as fibroblasts lay down
the collagen through which the endothelial cells migrate as they extend and de-
velop the vasculature system. Indeed, supply of blood is crucial to repair as oxy-
gen levels are thought to be critical in wound closure. Furthermore, oxygen affects
the rate of recruitment of fibroblasts through the wound space, the rate at which fi-
broblasts differentiate into myofibroblasts and the apoptotic rate of myofibroblasts.
We have shown that the role of myofibroblasts in wound repair is crucial to wound
contraction. Thus, factors like oxygen concentration that affect these cells are cer-
tainly worth consideration. Therefore, the inclusion of angiogenesis in future models
would be valuable to elucidate the mechanisms that lead to poor wound repair.
Finally, the model developed represents a time-only description. However, there are
numerous aspects of wound repair that cannot be assessed through this representa-
tion. Wound depth is known to influence the likelihood that a wound will develop
with scar hypertrophy (Enoch and Leaper, 2007), and both wound geometry and the
anisotropic distribution of forces across the wound influence wound closure and the
cosmetic appearance of the resulting scar (Watts, 1960; McGrath and Simon, 1983).
Indeed, other possible indicators of scar quality such as collagen fibre alignment can
only be considered within a spatially-dependent framework (Ferguson and O’Kane,
2004). Hence, this model could be extended to include spatial dependence.
CHAPTER 4
A Fibrocontractive Model of Wound Healing
The work presented in this chapter is under review at the Bulletin of Mathematical
Biology (Murphy et al., 2011b). As such, it represents a self-contained work. Conse-
quently, some of the material covered in Chapter 2 will be repeated in this chapter.
Author Contribution: KEM, SWM and DLSM developed the mathematical model
and KEM implemented the numerical algorithms. KEM performed the numerical
experiments and analyzed the data. KEM, SWM and DLSM wrote the manuscript
and PKM contributed to the results discussion and editorial work of the manuscript.
Fibroblasts and their activated phenotype, myofibroblasts, are the primary cell types
involved in the contraction associated with dermal wound healing. Recent experi-
mental evidence indicates that the transformation from fibroblasts to myofibrob-
lasts involves two distinct processes: the cells are stimulated to change phenotype
by both transforming growth factor β (TGFβ) and mechanical tension. This obser-
vation indicates a need for a detailed exploration of the effect of the strong interac-
tions between the mechanical changes and growth factors in dermal wound healing.
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We review the experimental findings in detail and develop a model of dermal wound
healing that incorporates these phenomena. Our model includes the interactions
between TGFβ and collagenase, providing a more biologically realistic form for the
growth factor kinetics than those included in previous mechanochemical descrip-
tions. A comparison is made between the model predictions and experimental data
on human dermal wound healing and all the essential features are well matched.
4.1 Introduction
The process of dermal repair is intricate and the resulting scar is inferior to un-
wounded tissue in several aspects. Aberrant healing may result in pathological scar-
ring that can cause both physical and psychosocial distress to the patient (Herber
et al., 2007; Brown et al., 2008, 2010). Understanding and elucidating the mecha-
nisms that elicit normal and regenerative repair is vital to ameliorating the wound
healing response.
There are various ways of characterizing the stages of acute healing. A recent de-
scription proposed by Enoch et al. (2006), separates wound healing into four over-
lapping, yet distinct, phases: (1) Haemostasis, which involves arresting blood flow
through the establishment of a fibrin clot (Monroe et al., 2010), (2) Inflammation,
where neutrophils, macrophages and other leukocytes debride the wound, remov-
ing necrotic cells and damaged tissue (Enoch and Leaper, 2007). These cells also
release growth factors that attract fibroblasts, the main cell type in dermal repair,
to the wound (Shultz et al., 2005). The other stages are (3) Proliferation and (4) Ep-
ithelialisation and Remodelling. As the model we describe concerns these final two
phases, we now discuss these stages in more detail.
The proliferative phase begins around day 4 post-wounding when fibroblasts are re-
cruited from the surrounding undamaged tissue (Shultz et al., 2005). These cells
proliferate and are activated to become myofibroblasts. Both fibroblasts and myofi-
broblasts function as the primary contractile cells in wound repair, with myofibrob-
lasts exerting stronger cell traction stresses than fibroblasts (Wipff and Hinz, 2009).
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Together, these cells synthesize proteins such as collagen to replace the fibrin net-
work, and they remodel the resulting collagen lattice (Hinz, 2007). Concurrently,
endothelial cells migrate into the wound space, revascularising the wound in a pro-
cess known as angiogenesis (Enoch and Leaper, 2007). The proliferating fibroblasts,
loose collagen network and neovascularised tissue form a temporary contractile or-
gan known as granulation tissue (Enoch and Leaper, 2007). The contraction of gran-
ulation tissue due to the action of fibroblasts and myofibroblasts results in a wound
reduction of up to 30% in humans (Desmoulie`re et al., 1995; Hinz et al., 2001; Fara-
hani and Kloth, 2008) and up to 80% in rats (Farahani and Kloth, 2008). Finally, the
onset of reepithelialisation signals the final phase of proliferation.
In the fourth and final stage of wound healing, the outer epidermal layer is re-
stored. Fibroblasts continue to remodel the extracellular matrix, increasing the ten-
sile strength of the wound from approximately 20% to 70% of normal dermal strength
after several months of remodelling (Cotran et al., 1999; Singer and Clark, 1999). Fi-
nally, a mature scar consisting mainly of collagen develops.
As discussed in Chapter 2.4.1, the first mechanochemical models for dermal wound
healing were developed by Murray et al. (1988) and Tranquillo and Murray (1992).
The key feature of these models was the mechanical interaction between the cells
and their viscoelastic substrate of extracellular matrix (ECM). The “base” Tranquillo-
Murray model comprises three governing equations; two of these stipulate the rate of
change of the fibroblast concentration, n, and the ECM density, ρ, respectively, while
the third describes a force balance, from which the velocity of the ECM is derived. In
one-dimensional Cartesian coordinates, the base non-dimensional model takes the
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following form:
Cells :
∂n
∂t
+
∂
∂x
(
n
∂u
∂t
)
=
∂2n
∂x2
+ rn(1− n); (4.1)
ECM :
∂ρ
∂t
+
∂
∂x
(
ρ
∂u
∂t
)
= 0; (4.2)
Force Balance : sρu =
∂
∂x
(
σ + µ
∂v
∂x
+ ψ
)
; (4.3)
Elastic Force : σ =
∂u
∂x
; (4.4)
Cell-Traction Force : ψ =
τρn
1 + γn2
; (4.5)
Velocity : v =
∂u
∂t
; (4.6)
where x is the distance from the wound centre, u is the ECM displacement, µ is the
viscosity of the tissue, γ is a parameter quantifying “social loafing” (the amount that a
species will stop doing work in the presence of other members of the same species),
s is the tethering coefficient of the dermal layer to the subcutaneous tissue, τ is a
measure of the fibroblast traction on ECM fibres, and r is the intrinsic growth rate of
fibroblasts.
While this seminal model laid the groundwork for much of the subsequent years of
research in this area, it neglected some of the essential features of wound healing,
such as collagen biosynthesis and heightened collagen density in the wound space.
Moreover, this model was unable to describe the significant wound boundary con-
traction common in dermal repair. While Tranquillo and Murray (1992) did extend
their model to incorporate some of these features, the limitations of this formula-
tion, together with the wealth of new experimental data means that a more detailed
representation has become a necessity.
One of the key simplifying assumptions made by Tranquillo and Murray (1992) was
that alterations to the ECM do not modify the mechanical properties of the tissue.
However, experimental results reveal that this is not the case (Shultz et al., 2005). In
the present study, we aim to improve on this model by assuming, like authors such
as Ramtani et al. (2002), that tissue elasticity is dependent upon the collagen density.
4.1 Introduction 87
As mentioned in Section 2.4.1, Olsen and co-workers extended the work of Tranquillo-
Murray in a series of papers (Olsen et al., 1995, 1996, 1997, 1998, 1999). Their first
advance considered two distinct cellular populations: fibroblasts and myofibrob-
lasts. Inter-conversion between the two phenotypes is assumed, and this is taken to
be dependent on the presence of a growth factor (PDGF). Previously, Tranquillo and
Murray (1992), in an extension of (4.1)-(4.6), assumed a static distribution for the
chemical species. To make the description more realistic, Olsen et al. (1995) incorpo-
rated a time-dependent representation. Additionally, Olsen and colleagues included
collagen synthesis and degradation. Olsen et al. (1995) was able to predict plastic
deformation (permanent wound contraction), but only in the absence of collagen
kinetics. However, it is now known that matrix turnover is initially rapid, implying
that collagen kinetics should not be neglected. Hence, further modelling is required
to generate plastic deformation.
The description developed by Tranquillo and Murray (1992) used a purely viscoelas-
tic formulation for the mechanics. Consequently, the system returns to its original
state unless a nonhomogeneous chemical mediator is assumed. With this in mind,
Cook (1995) extended Tranquillo and Murray’s work by developing a more realistic
representation of tissue mechanics that accounts for the structure of a changing,
anisotropic ECM. In so doing, Cook was the first to address tissue growth and re-
modelling and their associated effects upon tissue mechanics. These effects are also
considered in Murphy et al. (2011a), who also incorporated direct stress coupling
between the cells and their mechanical environment.
When cultured under mechanical strain and/or on a stiff substrate, fibroblasts de-
velop actin stress fibres (Grinnell, 2000; Tomasek et al., 2002; Grinnell, 2003; Des-
moulie`re et al., 2005). In this state, the cells are termed proto-myofibroblasts, and
they exert more cell traction on the ECM than fibroblasts and exhibit upregulated
collagen synthesis. Under the action of TGFβ, proto-myofibroblasts differentiate
into myofibroblasts, which are distinguished by the presence of α-smooth muscle
actin (α-SMA) (Hinz, 2007; Wells and Discher, 2008; Wipff and Hinz, 2008, 2009; Hinz,
2010). To our knowledge, Javierre et al. (2009) and Murphy et al. (2011a) are the only
88 Chapter 4. A Fibrocontractive Model of Wound Healing
papers to present mathematical models for dermal wound healing that incorpo-
rate the stress-dependency of fibroblast to myofibroblast differentiation. However,
neither representation considers the proto-myofibroblast stage, instead adopting a
combined proto-myofibroblast and myofibroblast population.
The model developed by Javierre et al. (2009) is an extension of the Olsen et al. (1995)
model in which PDGF is assumed to be the chemical involved in activating fibrob-
lasts. While PDGF can induce the formation of proto-myofibroblasts, it does not
induce transformation to myofibroblasts or expression of α-SMA (Tomasek et al.,
2002). Moreover, Javierre et al. (2009) assume that cell traction stress activates fi-
broblasts, but Hall (2009) found that, for consistency between the mathematical
representation and experimental results, the stress component involved in fibrob-
last activation is the elastic stress and not the cell traction stress. In our model, we
assume that fibroblast modulation is dependent upon the elastic stress.
Incorporating these observations into a model means that it is impossible to de-
couple the mechanics from the biology because there is two-way feedback between
cellular behaviour and mechanical stress. In the Olsen et al. (1995) and Tranquillo
and Murray (1992) descriptions, passive ECM-mediated advection was the only in-
teraction between the cell and ECM behaviour and the wound mechanics. However,
since the velocity was generally small, advection could be neglected without signif-
icantly altering the model predictions (Hall, 2009). Consequently, the cellular and
ECM components could essentially evolve independent of the mechanics. We argue
that this coupling is important in light of recent experimental results and so attempt
to resolve this issue by incorporating the stress-dependence in the activation of fi-
broblasts and myofibroblast proliferation.
The wound healing model proposed by Dale et al. (1997) does not incorporate tissue
mechanics, but it contains the most detailed description of the chemical kinetics of
the bioactive species in a dermal wound. Here, we adopt a reduced version of the
Dale et al. (1997) model, in spite of the fact that this represents a simplification of
the in-vivo kinetics. Additionally, we modify the model to incorporate recent exper-
imental results.
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When comparing model predictions against experimental data, researchers devel-
oping mechanochemical representations of dermal repair typically consider the
wound contraction dynamics recorded by McGrath and Simon (1983). However, the
wound contraction data obtained by McGrath and Simon (1983) are for rat dermal
repair, and mechanochemical modellers are generally seeking to justify a model for
human dermal wound healing. Rat and human dermal wounds heal primarily by
different mechanisms. While rat wounds heal mainly by contraction, human dermal
wounds (while still experiencing contraction) heal primarily as a result of infilling.
Thus, we qualitatively compare our predictions against the observations of McGrath
and Simon (1983), but seek to ascertain the relevance of our model by comparing our
predictions against the wound contraction data obtained by Catty (1965) for human
dermal repair.
The role of TGFβ is now considered to be critical to dermal repair but there are, as
yet, no mechanochemical models that consider TGFβ as the primary growth factor
in dermal repair. Additionally, none include the regulatory effects of collagenase on
the collagen density. Here, we incorporate TGFβ and collagenase into a simplified
representation of chemical kinetics and then couple this with a description of tissue
mechanics and cellular dynamics. With regard to cellular interactions, our model
includes a novel representation of the fibroblast to myofibroblast activation.
We develop our proposed model in Section 2 below and present the model results
in Section 3. Our model predicts early retraction followed by contraction and late
retraction. The results are compared with two sets of experimental data on wound
closure, that of Catty (1965) for human wounds, and that of McGrath and Simon
(1983) for rat dermal repair. We seek only to obtain qualitative agreement with the
McGrath and Simon data. Our analysis shows that the model predicts all phases of
wound repair (retraction, contraction, permanent contraction and late retraction)
for both situations.
90 Chapter 4. A Fibrocontractive Model of Wound Healing
4.2 Mathematical Model
We consider seven dependent variables in our model: fibroblast density (n), myofi-
broblast density (m), transforming growth factor-β concentration (β), collagen den-
sity (ρ), collagenase density (z), ECM displacement (u) and velocity (v). We assume
that the wound is long and thin, and that it is much longer than it is deep. As such, a
one-dimensional representation is appropriate.
As was the case in Chapter 3, the wound deforms under the action of cell traction
forces, yielding a corresponding movement in the wound boundary location indi-
cating contraction or retraction of the lesion. This movement in turn shifts the cells
and extracellular material across the region, and we refer to this as passive advec-
tion or ECM-mediated advection. Each species in the model is assumed to undergo
passive advection.
We assume that a small strain representation is valid and thus the velocity can be
approximated by the Eulerian time derivative of displacement:
v =
∂u
∂t
. (4.7)
4.2.1 Force Balance Equation
Following Tranquillo and Murray (1992), we neglect inertial forces and so the mo-
mentum conservation equation reduces to a mechanical force balance between the
forces related to the physico-chemical ECM properties (consisting of tethering to the
underlying fascia, elastic and viscous forces) and the cell-generated traction forces.
We assume that the tethering force is proportional to the local collagen concentra-
tion and tissue displacement. Together, this gives the following force balance equa-
tion:
sρu =
∂
∂x
(
σ + µ
∂v
∂x
+ ψ
)
, (4.8)
where s is the tethering coefficient, µ is the tissue viscosity, and σ and ψ represent
the elastic and cell traction forces, respectively.
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Since we are considering a linear viscoelastic framework, the elastic force is propor-
tional to the deformation gradient (Skalak et al., 1996). However, we further assume
that variations in collagen density will affect the elastic modulus (Ramtani et al.,
2002; Ramtani, 2004). Specifically, we will assume that the elastic modulus is directly
proportional to the collagen density, with a constant of proportionality, E. Thus, σ
takes the form
σ = Eρ
∂u
∂x
. (4.9)
There are a number of possible expressions for cell traction. Following Tranquillo
and Murray (1992), we assume that cell traction forces depend upon the product of
the cellular and collagen densities. We also assume that fibroblasts and myofibrob-
lasts contribute differently to cell traction but we do not include any ‘social loafing’
terms. This gives
ψ = λρ(n+ ξm), (4.10)
where λ is a constant and ξ is the myofibroblast tractional stress relative to fibrob-
last tractional stress. We note that Olsen et al. (1995) assume that myofibroblasts
increase the cell traction generated by the fibroblasts, but that myofibroblasts do
not work independently to enhance cell traction. However, Tomasek et al. (2002) in-
dicates that myofibroblasts work independently of fibroblasts to effect contraction.
Also we note that other expressions for cell traction could be adopted in which ψ is
no longer directly proportional to n, m or ρ (see Tranquillo and Murray, 1992, and
Olsen et al., 1995). It is preferable to use the simplest form available for cell traction
consistent with experimental observations, and so we adopt the above expression.
4.2.2 Fibroblasts
We assume that the fibroblasts exhibit random motility (modelled by diffusion)
and experience ECM-mediated advection. TGFβ stimulates fibroblast proliferation
which, in the absence of other factors, is assumed to be logistic. Fibroblast to myofi-
broblast transformation requires tension (represented by positive elastic stress) and
the presence of active TGFβ. Hence, we obtain
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∂n
∂t
+
∂
∂x
(nv) = Dn
∂2n
∂x2
+ (1 + anββ)n (r − θnnn)− ασ+βn, (4.11)
whereDn is the fibroblast random motility coefficient, α is the fibroblast differentia-
tion rate, σ+ represents the positive elastic stress, anβ represents the upregulation of
fibroblast proliferation in the presence of TGFβ, r is the intrinsic fibroblast prolifer-
ation rate and θnn represents the reduction in proliferation due to crowding.
Since there is insufficient experimental evidence to suggest otherwise, we assume
that myofibroblasts do not transform back to fibroblasts, but instead undergo apop-
tosis (Moulin et al., 2004; Hinz, 2007; Farahani and Kloth, 2008). However, we note
that Olsen et al. (1995) include the reversion of myofibroblasts to fibroblasts. More-
over, we do not include a proto-myofibroblast population, and instead consider a
combined proto-myofibroblast and myofibroblast population, which we simply re-
fer to as myofibroblasts.
4.2.3 Myofibroblasts
Without evidence that myofibroblasts are actively motile, we assume that their trans-
port is due only to ECM-mediated advection. As long as the granulation tissue is
under stress, myofibroblasts will proliferate (Grinnell, 1994; Hinz, 2007). Hence, we
follow Hall (2009) and assume that myofibroblasts only proliferate under stress and
that this growth is bounded. Finally, myofibroblasts undergo natural cell death. To-
gether, these assumptions give
∂m
∂t
+
∂
∂x
(mv) = m
(
amσσ
+ (1 + amββ)− θm − θmmm
)
+ ασ+βn, (4.12)
where amβ represents the upregulation in myofibroblast proliferation under the ac-
tion of TGFβ, amσ is the intrinsic myofibroblast proliferation rate under tension, θm
is the natural cell death rate and θmm represents the decrease in proliferation due to
crowding.
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4.2.4 TGFβ
TGFβ diffuses and is passively advected by the ECM. This growth factor is produced
by both fibroblasts and myofibroblasts (Hinz, 2007; Wipff et al., 2007), with produc-
tion inhibited by the presence of TGFβ (Dale et al., 1996). We recognise that TGFβ is
synthesized by cells in a latent form, which is then activated by one of two mecha-
nisms. These are the activation by myofibroblasts from large latent complex stores
attached to the ECM (Wipff et al., 2007; Wells and Discher, 2008) and the cleavage of
circulating latent TGFβ by proteases (Dale et al., 1996). For simplicity, we consider a
combined latent and active TGFβ species. TGFβ also undergoes natural decay. In-
corporating all of these effects into a model, we obtain:
∂β
∂t
+
∂
∂x
(βv) = Dβ
∂2β
∂x2
+
aββ(n+ pim)
1 + bββ
+ aβmmρ+ aβzzβ − δββ, (4.13)
where Dβ is the TGFβ diffusivity, aβ characterizes the production rate of TGFβ by
fibroblasts, pi is the ratio of myofibroblast to fibroblast production of TGFβ, aβm is
the activation rate of TGFβ from matrix stores, aβz is the activation rate of latent
TGFβ by collagenases and δβ is the decay rate of TGFβ. We adopt a saturation form
for the production of TGFβ, with bβ related to the half-maximal rate of production.
4.2.5 Collagen
Collagen undergoes ECM-mediated advection and is synthesized by both cell types,
with production upregulated by the presence of TGFβ. Additionally, collagen is de-
graded by the action of collagenases. Thus, we obtain
∂ρ
∂t
+
∂
∂x
(ρv) = k(n+ ηm)(1 + aρββ)− δρρz, (4.14)
where k characterizes the production rate of collagen by fibroblasts, η is the ratio of
myofibroblast to fibroblast collagen production, aρβ is a measure of the increase in
synthesis due to the presence of TGFβ and δρ is the degradation rate. Note that we
refer to collagen and ECM interchangeably throughout the rest of this paper, since
dermal ECM consists mainly of collagen.
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4.2.6 Collagenase
While several species of collagenase (a type of matrix metalloproteinase or MMP) are
involved in the wound healing process, we consider here a general representation of
these enzymes. Since collagenase binds to the local ECM, we assume that diffusion is
negligible and thus collagenase transport is only by ECM-mediated advection (Dale
et al., 1997). Both fibroblasts and myofibroblasts secrete collagenase in the presence
of collagen, with production of collagenase inhibited by the presence of active TGFβ
(Wipff and Hinz, 2009). Furthermore, collagenase undergoes natural decay. Putting
this together, we have
∂z
∂t
+
∂
∂x
(zv) =
azρ(n+ ζm)
1 + bzβ
− δzz, (4.15)
where az characterizes the production rate of collagenase by cells in the presence
of collagen, ζ is the rate of myofibroblast collagenase synthesis relative to fibroblast
collagenase synthesis, bz measures the inhibition of collagenase synthesis due to the
presence of TGFβ, and δz is the collagenase decay rate.
We note that collagenase is secreted by cells in a latent form that is activated through
proteolytic cleavage. Dale et al. (1997) incorporate this feature into their model.
However, for simplicity, we have chosen to combine the latent and active forms of
collagenase as a single species. We also note that collagenases are a subset of the
matrix metalloproteinases (MMPs) and that the collagenase in this model could be
identified with MMP-1. Both Chakraborti et al. (2003) and Jenkins (2008) provide
extensive reviews of MMPs in ECM.
4.2.7 Initial/Boundary Conditions and Non-Dimensionalization
The initial conditions of our model refer to the state of the wound at the onset of the
proliferative phase. At this stage, we take the wound to occupy −L < x < L, so that
L represents the wound boundary. We assume:
1. Symmetry about x = 0, and so we can restrict ourselves to considering the
domain where x is positive;
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2. x > L represents unwounded tissue;
3. The characteristic time scale of the model, T , is one day;
4. There are no fibroblasts within the wound space and they are at unwounded
levels outside;
5. The initial myofibroblast density is zero everywhere;
6. Due to growth factor release in the inflammatory stage, TGFβ is present inside
the wound space, but not outside;
7. There is a small amount of collagen in the wound space initially, while un-
wounded levels prevail outside; and
8. Collagenase is only produced in the presence of collagen, and thus that there is
no collagenase in the wound initially and that it is at unwounded levels outside.
To avoid discontinuities which can give rise to numerical instabilities when solving
the PDE system we approximate these piecewise conditions using tanh functions
(see Appendix B.2 for details).
Immediately following injury, there is an almost instantaneous retraction of the
wound boundary (see for example Billingham and Medawar, 1955, Catty, 1965). In-
deed, the unwounded dermis surrounding the wound has an elastic tension that
tends to draw the wound edges apart (Watts, 1960; Kennedy and Cliff, 1979). There-
fore, the initial displacement is not zero throughout the domain, but is rather found
by demanding the force balance expression (4.8) hold. Since this initial retraction is
driven by elastic tension, we neglect viscosity when determining the initial displace-
ment.
The symmetry around x = 0 implies zero flux conditions for all species other than
displacement and velocity, which must necessarily be zero at the wound centre. For
numerical purposes all species are assumed to take on their unwounded values at
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the right-hand boundary (far away from the wound site),
n(xRH , t) = nU , m(xRH , t) = 0, β(xRH , t) = βU ,
ρ(xRH , t) = ρU , z(xRH , t) = zU , u(xRH , t) = 0,
where xRH is the position of the right hand boundary and xRH  L, and nU , βU , ρU
and zU represent the unwounded densities of fibroblasts, TGFβ, collagen and colla-
genases, respectively.
The system was non-dimensionalized (see Appendix B.1), discretised using finite
difference approximations in space and solved numerically using MATLAB’s inbuilt
routine, ode45. Grid independent results are obtained providing the grid size ex-
ceeds 301 nodes. As such, we consider a grid size of 401. A computational domain of
10 semi-wound lengths is employed; this ensures that the right hand boundary is far
enough from the wound site so as not to affect the solution within the wound. Advec-
tive terms are determined by solving the tri-diagonal system obtained by discretising
the force balance expression, (4.8), with displacement found by subsequently using
(4.7).
4.2.8 Parameter Values
Almost all parameter values have been estimated from experimental results or taken
from previous models of dermal repair. Table 4.1 contains the dimensional values of
the parameters together with the source of the data; if a given parameter has been
estimated in this chapter, this is indicated by TW. The sensitivity analysis shows our
model to be quite robust to significant variations in a number of parameter values.
For a full discussion on parameter estimation see Appendix B.3.
4.3 Results and Discussion
Figures 4.1(a), 4.1(b) and 4.2 show the results obtained from the numerical solution
of the system of governing equations and we now discuss these in detail.
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Parameter Range Reference
Dn, Fibroblast random motility Dn ≈ O(10−3)cm2/day Sillman et al. (2003)
r, Fibroblast proliferation 0.832 < r < 0.924/day Ghosh et al. (2007)
anβ , Enhancement of fibroblast 2/β0 Strutz et al. (2001)proliferation by TGFβ
θnn, 1/Fibroblast carry capacity 10−6cells Vande Berg et al. (1989)
α, Fibroblast activation
r ≈ 0.0108/day.(ng/mL) Desmoulie`re et al. (1993)
to myofibroblasts
amσ, Myofibroblast proliferation amσ = 0.25r TW
amβ , Enhancement of myofibroblast amβ = anβ Olsen et al. (1995)proliferation by TGFβ
θm, Myofibroblast apoptosis θm ≈ 0.9/day Olsen et al. (1995)
θmm, 1/Myofibroblast carrying capacity θmm = 2θnn Masur et al. (1996)
Dβ , TGFβ diffusivity 0.0254cm2/day TW
aβ , TGFβ synthesis by fibroblasts 0.125× 10−6ng/cell.day TW
pi, TGFβ synthesis by myofibroblasts
2 TW
relative to fibroblasts
bβ , Inhibition of TGFβ synthesis 0.0013mL/ng Dale (1995)
aβm, TGFβ activation by myofibroblasts 4.35× 10−9mL.day/cell TW
aβz, TGFβ activation by 0.00144ng/cell TW
proteolytic cleavage
δβ , TGFβ decay b ≈ 0.354/day Yang et al. (1999)
k, Collagen production 1.75pg/cell.day Bahar et al. (2004)
η, Relative collagen production
2
Moulin et al. (1998),
by myofibroblasts Olsen et al. (1995)
aρβ , Enhancing of collagen production 2/β0 Eickelberg et al. (1999)by TGFβ
δρ, Collagen degradation 0.3k Aumailley et al. (1982)
az, Collagenase production 4.73× 10−9mL2/ng2.day−1 TW
ζ, Relative collagenase production
2 TW
by myofibroblasts
bz, Inhibition of collagenase production 3/β0 Overall et al. (1991)by TGFβ
δz, Collagenase decay 0.3616/day Overall et al. (1991)
s, Tethering coefficient 1 Olsen et al. (1995)
µ, Viscosity O(10) Olsen et al. (1995)
Y , Elastic modulus 10 < Y < 300N
Silver et al. (2001),
Genzer and Groenewold (2006)
τ , Fibroblast cell traction 1 < τ < 3µN/cell
Wrobel et al. (2002),
Fray et al. (1998)
ξ, Ratio of myofibroblast to
ζ ≈ 2 Wrobel et al. (2002)
fibroblast cell traction
β0, Initial TGFβ concentration 275ng/mL Yang et al. (1999)
Table 4.1: Table of parameters, which unless otherwise specified, are used for all
simulations. TW refers to parameters that were calculated during this work.
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Figure 4.1(a): Model predictions for the fibroblast and myofibroblast densities, and the
TGFβ concentration. Black solid curves represent the initial condition of each species. Solid,
dashed then dotted curves follow alternately, with an incremental time step of 6 days out to
30 days. The computational domain is ten semi-wound lengths, so that 0 < x < 10. In order
to show behaviour in the wound more clearly, only the domain 0 < x < 4 is shown. Arrows
indicate the direction of increasing time. Parameter values are given by Dn = 0.001, α = 3,
anβ = 2, r = 0.832, amβ = 2, amσ = 0.21, θm = 0.9, θmm = 0.41, Dβ = 0.025, aβ = 0.1, η = 2,
bb = 0.3, aβz = 0.25, aβm = 0.21, δβ = 0.35, κ = 0.1, pi = 2, aρβ = 2, ω = 0.2, ζ = 2, bz = 5,
s = 1, µ = 20, E = 10, λ = 2.2, ξ = 2.
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Figure 4.1(b): Model predictions for the collagen density, collagenase concentration and
collagen displacement. Black solid curves represent the initial condition of each species.
Solid, dashed then dotted curves follow alternately, with an incremental time step of 6 days.
Arrows indicate the direction of increasing time. Parameter values are the same as Figure
4.1(a). We note that the computational domain is ten semi-wound lengths, such that 0 <
x < 10, and that the displacement, u, does tend to zero at the right hand boundary.
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4.3.1 Fibroblasts
Initially, there are no fibroblasts inside the wound space and they are at unwounded
levels outside. While fibroblasts are recruited from the surrounding dermis, prolif-
eration is the primary mode by which the fibroblast population within the wound
space is restored. There is significant conversion of fibroblasts to myofibroblasts
over the first fortnight of repair, which accounts for the unusual shape of the fi-
broblast distribution. Indeed, the mechanical stimulation of fibroblast activation
impedes the restoration of the fibroblast density within the wound space through
modulation to myofibroblasts. Nonetheless, by day 30 the fibroblast density across
the domain has essentially been restored to undamaged tissue values.
4.3.2 Myofibroblasts
Initially, there are no myofibroblasts in the system. Fibroblasts are activated to be-
come myofibroblasts under the action of elastic stress and TGFβ, and, for this pa-
rameter set, this conversion is found to be the primary source of myofibroblasts.
Differentiation of fibroblasts generates a population of myofibroblasts within the
wound domain, which proliferate and generate stress. Thus, myofibroblasts con-
tribute to both wound contraction and further fibroblast activation. Fibroblasts con-
tinue to transform to myofibroblasts, with the greatest density of myofibroblasts oc-
curring where the elastic stress is highest. There is a small level of myofibroblast
activation predicted outside the wound due to small elastic stresses and the pres-
ence of a small concentration of TGFβ there. At long time, both the elastic stress and
TGFβ tend to zero, and so the myofibroblast density tends to zero also (results not
shown).
4.3.3 Transforming Growth Factor β
TGFβ appears early in the wound healing process as a result of the inflammatory
cascade. Since there is no active TGFβ in unwounded dermis, the TGFβ concentra-
tion is initially zero outside the wound space (see Figure 4.1(a)). The concentration
of TGFβ within the wound is gradually depleted through natural decay. However,
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both fibroblasts and myofibroblasts produce TGFβ and it can be activated through
cleavage by collagenase and from latent stores in the matrix by myofibroblasts. As a
result, the decay of TGFβ is quickly stemmed, which explains why it is still present at
day 30, and why there is an increase in TGFβ around the wound boundary for early
times. At later times, the TGFβ concentration tends to zero throughout. We note
that our expression for myofibroblast activation of TGFβ from local matrix stores as-
sumes that fibroblasts and myofibroblasts bind more TGFβ to the ECM than can be
activated when the myofibroblasts contract the collagen fibres. Hence it is assumed
that there is always a supply of TGFβ attached to the matrix available for activation,
which may or may not be accurate.
4.3.4 Collagen
Initially we assume that there is a low density of collagen within the wound while
the density is at unwounded levels outside. Synthesis of collagen by both fibroblasts
and myofibroblasts is the primary source of collagen. The wound is largely healed
as a result of infilling, consistent with experiments on human dermal repair (Catty,
1965). Collagen production by cells is upregulated by the presence of TGFβ. This
fact, combined with the near-unwounded levels of fibroblasts and the high density
of myofibroblasts, gives rise to excess collagen within the wound space; as we see,
the collagen profile is very similar to the collagenase profile. While not shown in
Figure 4.1(b), remodelling by the fibroblasts at later times ensures that the collagen
density ultimately tends to unwounded levels throughout the domain.
4.3.5 Collagenase
It is assumed that there is no collagenase within the wound initially, but that the col-
lagenase is at unwounded levels outside. The collagenase concentration inside the
lesion decreases at early times, which can be attributed to the large early retraction.
As the cells synthesize collagenase, the production is inhibited by the presence of
TGFβ, and collagenase secretion is lowest at the wound centre where the TGFβ con-
centration is highest. Collagenase levels eventually tend to unwounded levels. Since
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collagenase is non-zero at steady state, this implies that there is a balance reached
between collagenase production and degradation at steady state. Furthermore, this
suggests that there is continuous turnover of ECM in unwounded tissue, which is
consistent with clinical observations (Roberts et al., 1990).
4.3.6 Wound Boundary
The current position of the wound boundary can be obtained by finding the point x,
where the dimensionless displacement satisfies
xwb = 1 + u(xwb, t). (4.16)
Thus, xwb represents the material point that was located at x = 1 when t = 0. The
movement of the wound boundary is represented by the black curves in Figure 4.2.
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Figure 4.2: The wound boundary prediction from our model is the black curve. Two series of
data for human wound closure were obtained from Catty (1965). Series A and B correspond
to the red and blue points respectively. The daily collection of wound boundary data ceased
at day 16 post wounding. One further measurement was made at 6 months. Parameter values
are the same as Figure 4.1(a).
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Figure 4.3: The wound boundary prediction from our model is the black curve, and has been
scaled respective to the initial wound size. Data showing the contractile phases of wound
closure were obtained from McGrath and Simon (1983) for circular (•), small square (+) and
large square (×) wounds respectively. The data from McGrath and Simon (1983) was scaled
to be comparable with human dermal repair. Parameter values are the same as Figure 4.1(a).
Figures 4.2(a) and 4.2(b) show the comparison between our predicted curve and the
data obtained by Catty (1965) for human wounds. Our model predicts the large ini-
tial retraction, and slow contraction of the wound, agreeing well with the data. How-
ever, our model does not predict an initial scaled wound boundary position of unity.
This is because our model begins after the almost-instantaneous retraction that oc-
curs following injury. As such, our predictions begin, at most, several minutes fol-
lowing injury while Catty’s (1965) data starts pre-excision of the tissue. Therefore,
the mild discrepancy in start time could also contibute to the difference between
the initial wound boundary positions. Finally, whilst our model does predict a small
late retraction, we did not observe the large late retraction seen by Catty. Apart from
these few data points however, good agreement is seen between the data of Catty
(1965) and our prediction curves. This is especially true when examining the early
expansion and contraction measurements.
Table 4.2 gives the values for expansion (or retraction), contraction and late retrac-
tion observed by both Catty and colleagues and our simulation curve. We note that
our model did not predict the maximum retraction to occur at day 16, but rather at
day 18. Hence, we give two “healed” estimates: the predicted day 16 result and the
value obtained at the maximum contraction (day 18). However, the day 16 and 18
predictions differ very little and both indicate that the majority of contraction oc-
curs during the first three weeks of wound repair. These predictions are very similar
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to those obtained by Catty (1965), aside from the post 6-months column. This again
confirms that for the proliferative stage of wound repair that we are modelling, good
agreement is seen between the model predictions and the data.
Series Actual Area Pre- Post- Healed Six
(sq. cm.) Excision Excision Months
A 1.01 1.000 1.316 1.041 1.123
B 1.07 1.000 1.343 0.960 1.139
Model - 1.000 1.279
Day 16 Max
0.998
0.942 0.947
Table 4.2: Data reproduced from Catty (1965) together with the corresponding pre-
dictions from our model. The healed model value at day 16 corresponds to the
point when Catty terminated the daily measurements, while ‘max’ represents the
predicted maximum contraction from the model at day 18. Series A contained 11
patients, while Series B had 9 patients. Pre-excision refers to the area to be re-
moved from the patient, actual area indicates the area of tissue actually excised,
post-excision is the area of the wound after the retraction or expansion of the wound
following removal of the tissue, healed refers to the day 16 values while six months
values refer to the amount of retraction observed six months following wounding, as
measured by Catty and predicted by the model.
We note from Table 4.2 that the expansion and healed values are comparable. With
regard to the amount of late retraction predicted by our model, we were not able to
obtain the large retraction observed by Catty (1965). However, the purpose of our
model was to simulate the proliferative phase of wound repair, and so it is really
only appropriate for the first 30 days of wound repair; during this time, the model
compares well with the experimental data.
In Figure 4.3 we consider the same simulation curve, but in this case we compare
our prediction of wound closure qualitatively against the McGrath and Simon (1983)
data for rat dermal repair. Rat wounds exhibit far greater contraction than do human
dermal injuries. Consequently, we scale the data from McGrath and Simon (1983)
using
yscaled =
5
7
+
2
7
ydata, (4.17)
so that comparable contraction is observed in both the data and the model predic-
tions. This scaling is sensible as human wounds heal with almost a third the con-
traction observed in rat dermal repair.
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We see from the figure that the initial retraction, contraction, permanent contrac-
tion and late retraction observed in the data of McGrath and Simon (1983) are all
predicted by our model. Hence, not only does our model correctly predict the clo-
sure of human dermal wounds, it reproduces all the phenomena found in murine
dermal wound closure. Therefore, we believe this model represents a reasonable de-
scription of the closure of dermal wounds.
Our model predicts the large retraction and subsequent contraction seen during
the first month of human dermal repair, a phenomenon not considered in previous
mechanochemical representations of wound healing. The large retraction is due to
the absence of fibroblasts and collagen within the wound space, and the contraction
occurs following infilling as the fibroblasts and myofibroblasts contract the newly
formed collagen matrix.
Previous researchers have not addressed the manner in which TGFβ and tissue me-
chanics inform the activation of fibroblasts to myofibroblasts. Our model predicts
that it is the elimination of TGFβ from the system, together with the reduction in lo-
cal tension that reduces the presence of myofibroblasts towards the end of the pro-
liferative phase.
Our model investigates the complex interactions between cells, TGFβ and collage-
nase in the regulation of collagen expression. During the period when the TGFβ
concentration is high, we found that collagen expression is heightened within the
wound space. This can be attributed to both the presence of myofibroblasts and to
the increased production of collagen by both fibroblasts and myofibroblasts in the
presence of TGFβ. The myofibroblast density and TGFβ concentration tend to zero,
but remodelling of the collagen network by fibroblasts and collagenase continues,
so that the collagen density approaches healed levels across the wound space.
We now discuss possible extensions of this model. One possibility would be to anal-
yse how repair is affected by wound debridement, in which the granulation tissue
and other constituents are removed. Alternatively, it would be possible to examine
the effect of addition or removal of TGFβ. Indeed, Ferguson and O’Kane (2004) found
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that addition of different isoforms of TGFβ can improve or exacerbate repair. There-
fore, one may wish to distinguish between the TGFβ isoforms instead of considering
a general TGFβ distribution.
As our model includes TGFβ, collagenase and collagen, it can be used to investigate
wound healing pathologies, such as keloid development, where the interactions be-
tween these three species are significant. In Chapter 6, we examine the formation of
keloids using an extension of this model.
Finally, another key process involved during the proliferative phase is angiogenesis.
Indeed, McGrath and Emery (1985) found that impaired wound contraction appears
related to a delay in the onset of angiogenesis. Therefore, a logical extension of this
model would be to couple this system together with a representation of angiogenesis
to examine the combined effect of inflammation, fibroplasia and angiogenesis in
wound closure.
CHAPTER 5
Clinical Predictions for Hypertrophic Scars
The work presented in this chapter is currently under review at PLoS ONE (Murphy
et al., 2011c). As such, this chapter represents a self-contained work, with some ma-
terial discussed in Chapter 2 overviewed again in this chapter.
Author Contribution: KEM, SWM and DLSM developed the mathematical model
and KEM implemented the numerical algorithms. KEM performed the numerical
experiments and analyzed the data. KEM, SWM and DLSM wrote the manuscript.
Dermal wound healing is a complicated process where the final product, scar tis-
sue, is inferior to unwounded dermis. Hypertrophic scars and keloids are associated
with poor regulation of cell apoptosis and an exuberant inflammatory response. In
Chapter 3, we developed a mathematical model for dermal repair that incorporates
the chemical, cellular and mechanical aspects of dermal wound healing. Using this
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model, we examine pathological scarring in dermal repair including a small apop-
totic rate for myofibroblasts and a long inflammatory response, in an attempt to de-
termine a possible optimal intervention strategy to promote normal repair, or termi-
nate the fibrotic scarring response. Our model predicts that in both cases, it is best
to apply the intervention strategy early in the wound healing response. Further, the
earlier an intervention is made, the less aggressive the intervention required. Finally,
if intervention is conducted at a late time during healing, a significant intervention is
required; however, there is a threshold concentration of the drug or therapy applied,
above which minimal further improvement to wound repair is obtained.
5.1 Introduction
Dermal wound healing is a complex process in which the resulting structure, scar
tissue, is inferior to unwounded dermis on a biological and mechanical basis. In
5 − 15% of all wounds, disorders in the repair process occur, giving rise to patho-
logical outcomes including hypertrophic scars, contractures and keloids (Enoch and
Leaper, 2007). This represents a significant problem, particularly for surgeons and
other clinicians where up to 94% of surgical wounds and up to 91% of burn injuries
may heal with scar hypertrophy (Bloemen et al., 2009).
Hypertrophic scars are characterised by the over-expression of collagen, downregu-
lated collagenase, heightened presence of fibroblasts, persistence of the myofibrob-
last phenotype, reduced apoptosis and upregulation of pro-fibrotic mediators such
as transforming growth factor-β (TGFβ) (Aarabi et al., 2007; Kose and Waseem, 2008).
Fibroblasts are activated to myofibroblasts under the action of TGFβ and mechanical
tension, with myofibroblasts performing much greater contraction than fibroblasts
(Wrobel et al., 2002). Dysregulation of myofibroblasts and chronic myofibroblast
activity generates contractures and leads to loss of organ function. Such tissue con-
tractures are clearly visible in skin hypertrophic scars that develop following burns,
scleroderma and Dupuytren’s disease (Varga and Abraham, 2007; Castella et al., 2010;
Hinz, 2010). Additionally, myofibroblast-generated contractures are intrinsically as-
sociated with organ fibrosis in the liver, heart, lung and kidney (Castella et al., 2010;
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Hinz, 2010).
The poorly regulated collagen and collagenase synthesis intrinsic to hypertrophic
scars are probably associated with over-stimulated fibroblasts and myofibroblasts,
and not causative factors. Consequently, treatments that do not target these cells
should not be expected to be as effective as therapies which aim to address the stim-
ulation and persistence of fibroblasts and myofibroblasts. The regulatory mecha-
nism of the fibroblast density is likely impaired by two key issues: the downregula-
tion of apoptosis and the stimulatory effects of TGFβ, both of which are considered
in the present study.
When considering closure of mice dermal wounds, Aarabi et al. (2007) found that
application of mechanical tension to a healing wound generated hypertrophic scar-
ring, increasing cellularity and giving rise to a four-fold decrease in cell apoptosis.
They then clarified the importance of cell apoptosis in hypertrophic scarring by ex-
amining p53-null mice, with consequent down-regulated cell apoptosis. In these ex-
periments, significantly greater scar hypertrophy and cellular density were observed.
To further elucidate the link between hypertrophic scars and small apoptotic rates,
Aarabi et al. considered pro-apoptotic BclII-null mice, and found significantly re-
duced scar hypertrophy and cellular density. Indeed, Linge et al. (2005) found that
while over 40% of fibroblasts undergo apoptosis in contractile collagen, there was no
detection of apoptosis in hypertrophic scar fibroblasts. Moreover, Kose and Waseem
(2008) state that, while myofibroblasts of a normotrophic wound origin are usually
more sensitive than fibroblasts to apoptotic cues, the reverse is true in wounds heal-
ing with scar hypertrophy. Hence, it is clear that down-regulated apoptosis is a key
feature of hypertrophic scars.
Poorly regulated TGFβ is associated with tissue fibrosis (Jagadeesan and Bayat, 2007;
Pohlers et al., 2009). TGFβ is perhaps the key growth factor in dermal repair, and is
ubiquitous in the healing response. It is implicated in the stimulation of angiogen-
esis, the formation of granulation tissue, the regulation of collagen synthesis and
the development of fibroplasia (Roberts et al., 1992; Murata et al., 1997; Rhett et al.,
2008). It is known that the TGFβ isoforms TGFβ1 and TGFβ2 are strongly pro-fibrotic,
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with exogenous addition to healing wounds giving rise to fibrotic scars (Ferguson
and O’Kane, 2004). However, the addition of TGFβ3 ameliorates the severity of the
final scar (Franz et al., 2007). Thus, a treatment strategy that aims to block TGFβ1
and TGFβ2 or increase TGFβ3 should prove effective in the treatment of pathologi-
cal scars. Indeed, clinical trials by Occleston et al. (2008) and Ferguson et al. (2009)
are showing promising results for the use of TGFβ3. They have found that early ad-
dition of TGFβ3 to cutaneous wounds reduces early ECM deposition, improves the
dermal architecture and decreases subsequent scarring. Additionally, recent exper-
imental results suggest that silicone sheeting may lessen the appearance of hyper-
trophic scars by decreasing fibroblast contraction while simultaneously downregu-
lating TGFβ2 (Franz et al., 2007).
The persistence of the myofibroblast phenotype is mediated by both reduced sensi-
tivity to apoptotic cues and up-regulated levels of TGFβ1 and TGFβ2. Greater avail-
ability of these isoforms of TGFβ implies that more fibroblasts are activated to be-
come myofibroblasts, and less apoptosis implies that myofibroblasts themselves
have a longer time to apoptotic death than their normal wound counterparts. To-
gether, this suggests that the key behind hypertrophic scars is the maintenance of
the myofibroblast phenotype. Indeed, Wynn (2008) states that myofibroblasts are
the “key cellular mediator of fibrosis”.
Interestingly, targeting of myofibroblasts has been suggested as an anti-fibrogenic
therapy for liver fibrosis (Douglass et al., 2008; Kim et al., 2005), pulmonary fibro-
sis (Mizuno et al., 2005), and as a potential anti-cancer therapy (Pines, 2008). Drugs
such as basic fibroblast growth factor (bFGF), halofuginone and interferon, used in
the treatment of pathological scarring in the dermis may decrease the presence of
myofibroblasts by increasing the myofibroblast apoptotic rate or blocking activation
of fibroblasts to myofibroblasts (Pines, 2008; Bloemen et al., 2009; Viera et al., 2010).
However, this reduction in myofibroblast density appears to be incidental, with re-
searchers usually targeting collagen production or degradation. Thus, to the authors’
knowledge, no current therapies for pathological scarring in the dermis specifically
target the presence of myofibroblasts. Hence, a treatment involving one or a combi-
nation of factors that increase myofibroblasts apoptosis should reduce the excessive
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contraction and aid resolution of scar hypertrophy. We examine this idea in Section
5.3.1.
In our mathematical model we consider the actions of myofibroblasts and TGFβ1 on
the wound repair process. In Section 5.2 we briefly outline the predictive mathemat-
ical model of dermal wound repair described previously in Chapter 3. In Section 5.3
we use the mathematical model to investigate treatment modalities for pathologi-
cal scarring. We suggest in Section 5.3.1 that targeting of myofibroblast apoptosis is
a key mechanism whereby dermal pathological scarring may be alleviated. We also
consider the actions of TGFβ1 in Section 5.3.2, and predict that reducing the concen-
tration of TGFβ1 reduces contracture.
5.2 Model Summary
In Chapter 3 we described a morphoelastic representation of dermal repair in a
mathematical model that incorporated chemical, cellular and mechanical compo-
nents (see Section 3.3.1 for a full description). Here we summarise the interaction
between the cells, TGFβ, extracellular matrix (ECM) and wound mechanics in the
model. Fibroblasts are recruited from the surrounding dermis into the wound space
where they proliferate and are activated to become myofibroblasts under the action
of TGFβ and elastic stress (Tomasek et al., 2002). Together, fibroblasts and myofi-
broblasts perform collagen production and degradation. They give rise to local tis-
sue strain through contraction of collagen fibres and remodelling of the local colla-
gen network. We assume that it is the balance of elastic and cell traction forces inside
and outside the wound that determine the movement of the wound boundary.
The mathematical model involves six coupled ordinary differential equations with
twenty-six dimensionless parameters. The equations are solved numerically using
standard routines of the mathematical programming language MATLAB. Where pos-
sible, parameters are estimated using experimental data for adult human dermal re-
pair. For a full description, see Murphy et al. (2011a).
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5.3 Clinically Relevant Model Predictions
We now use this model to consider wound intervention strategies to alleviate the
development of a type of pathological scarring known as a contracture, which is as-
sociated with excessive wound contraction. In order to gauge the efficacy of treat-
ments, a regime corresponding to normal wound contraction needs to be quanti-
fied. Moulin et al. (2004) obtained myofibroblasts from human dermal wounds after
12 days of repair. Pre-confluence cell cultures between passage 3 and 6 were used,
and apoptosis induced over a 24−72-hour period. Moulin et al. (2004) states that ap-
proximately 8 − 20% of human dermal myofibroblasts underwent apoptosis during
this time. We consider this range for myofibroblast apoptosis to be a characteristic
feature of wound repair, and so use this range in our model to predict the expected
amount of contraction when 8%/day or 20%/day of myofibroblasts undergo apop-
tosis. This corresponds to changing the rate parameter, a, in our model from 0.096
to 0.24 (see the Appendix for details). We assume the same rate of myofibroblast
apoptosis throughout the healing processes.
A myofibroblast apoptotic rate of 8%/day predicts wound contraction of approxi-
mately 30%. Farahani and Kloth (2008) state that under normal circumstances hu-
man dermal wounds heal with at most 30% contraction. Hence, the maximum pre-
dicted contraction corresponds with that observed experimentally, and so we are
confident that this range for contraction reflects normal repair. This region of nor-
mal repair is represented in each of the figures by a grey shaded area. We assume
that a successful intervention strategy will be one that ensures the final amount of
contraction is within this normal range.
5.3.1 Disorder: Small Rate of Myofibroblast Apoptosis
A small apoptotic rate for myofibroblasts is associated with poor dermal repair
(Aarabi et al., 2007). Since myofibroblasts perform the majority of wound contrac-
tion, persistence of this phenotype can lead to excessive contraction of the wound.
We investigate increasing the apoptotic rate of myofibroblasts and the resulting im-
pact on wound contraction.
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Figure 5.1: Disorder: Small myofibroblast apoptotic rate. Intervention: Increase apoptotic
rate after 8 days (early intervention) or after 13 days (late intervention). The shaded region
indicates the normal repair. Moulin et al. (2004) gives a range for the apoptotic rate of my-
ofibroblasts of 8 − 20%/day. Simulations are run with minimum and maximum apoptotic
rates, allowing a normal range for wound contraction to be calculated. We chose to con-
sider a normal rate of 10%/day (i.e. a = 0.12). Aarabi et al. (2007) found a four-fold decrease
in apoptosis in hypertrophic scars. Hence, prior to intervention and in the untreated case,
we assume an apoptotic rate for myofibroblasts of 2.5%/day (i.e. a = 0.03). When the in-
tervention strategy is implemented, it increases the apoptotic rate to 10%/day. Increasing
the apoptotic rate to normal levels is able to rescue normal repair when effected early and
significantly reduce the resulting predicted wound contraction such that contraction is also
within the normal limits of no more than 30% (Farahani and Kloth, 2008).
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Figure 5.1 gives the predictions for the movement of the wound boundary, with half
the width of the wound represented by L(t), and L(0) = L0. The shaded region in
Figure 5.1 indicates the region of normal wound contraction predicted by our model.
Curves below this region predict wounds that heal with excessive contraction, indi-
cating the formation of a contracture.
Two treatment times are considered: an early treatment effected at day 8 or a late
therapeutic intervention beginning on day 13. Comparing the predictions shows
that strategies instituted at day 8 reduce the excessive wound contraction more effec-
tively than the same treatment applied from day 13. This indicates that the therapy
is more effective when implemented early. Increasing the apoptotic rate to normal
levels is able to rescue normal repair when effected early and significantly reduce
the resulting predicted wound contraction such that contraction is also within the
normal limits of no more than 30% (Farahani and Kloth, 2008).
While the model predicts that increasing the apoptotic rate to 10% per day is able to
restore a normal repair response when the therapy is applied early, this is not the case
when the treatment is applied after two weeks of repair. When applied late, a more
aggressive treatment is required to restore normal repair. These results indicate that
to restore normal repair, apoptosis must be returned to at least normal levels, with
early intervention strategies requiring less aggressive responses.
There are a number of methods to arrest myofibroblast development or induce my-
ofibroblast apoptosis. Akasaka and colleagues have found that application of bFGF
promotes apoptosis, reducing the presence of myofibroblasts and thereby leading
to a reduction in wound contraction (Akasaka et al., 2007; Ono et al., 2007; Akasaka
et al., 2010). Indeed, Tiede et al. (2009) suggests bFGF as a potential therapeutic
agent for the treatment of hypertrophic scars and keloids. Mizuno et al. (2005) found
addition of hepatocyte growth factor induced matrix metalloproteinase (MMP) de-
pendent apoptosis in mouse lung fibrosis, reducing the advance of fibrotic tissue.
Similar results have been obtained in dermal tissue (Viera et al., 2010). It has also
been suggested that interferon, a potential drug for treatment of hypertrophic scars,
induces myofibroblast apoptosis (Bloemen et al., 2009). Finally, Douglass et al.
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(2008) found that using antibody targeting to increase liver myofibroblast apopto-
sis is the most effective anti-fibrogenic therapy, promoting resolution of liver fibro-
sis. Thus, given these experimental results and the predictions of our mathemati-
cal model, we suggest that specifically targeting myofibroblast apoptosis in dermal
pathologies should meet with similar success.
5.3.2 Disorder: Small TGFβ Decay Rate
The second disorder that we investigate occurs when the TGFβ decay rate is small.
The size of the decay rate is indicative of the length of the inflammatory response. It
has long been argued that inflammatory mediators such as TGFβ can cause patho-
logical scarring, with acute or poorly regulated TGFβ associated with fibrosis (Fer-
guson and O’Kane, 2004; Beanes et al., 2003). A small decay rate of TGFβ indicates a
long inflammatory response, or poorly regulated activation of TGFβ.
Intervention: Neutralize TGFβ
We first investigate neutralizing TGFβ as a treatment strategy. By this, we mean any
method by which the TGFβ pathway may be blocked, such as inhibiting activation
or production of TGFβ, blocking TGFβ receptor activation, blocking intracellular sig-
nalling or coactivator recruitment (for a full discussion see Varga and Pasche (2009)).
The intervention is implemented at day 8 or at day 13. To determine if normal re-
pair is rescued, we consider the range of myofibroblast apoptotic rates described by
Moulin et al. (2004) of 8 − 20%/day to be an intrinsic property in wound repair, and
we use the normal decay rate of TGFβ estimated from data obtained by Yang et al.
(1999). This gives the shaded region in Figure 5.2. Curves representing the wound
boundary predicted to lie in this region are considered to indicate normal repair.
Figure 5.2 shows that in this case there is little difference between a treatment strat-
egy effected at day 8 and one implemented at day 13. Nonetheless, neutralizing or
blocking the action of TGFβ essentially eliminates TGFβ from the wound space fol-
lowing application of the treatment for 12 days. Consequently, by significantly reduc-
ing the concentrations of TGFβ, there is a corresponding decrease in the activation
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Figure 5.2: Disorder: Disorder: Small TGFβ decay rate. The TGFβ decay rate is charac-
terised by the parameter, b (see the Appendix for details). Here we show the intervention of
increasing the decay rate of TGFβ at day 8 (blue curves) or day 13 (red curves). Following
intervention, the TGFβ decay rate is increased to its “normal” value. The black curves rep-
resents the predicted response if no intervention strategy is implemented, while the red and
blue curves show the predictions for healing following intervention. We again use the ex-
perimental data of Moulin et al. (2004) to ascertain the normal range of wound contraction
(shaded grey).
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of fibroblasts to myofibroblasts (since differentiation is TGFβ-dependent). Indeed,
it can be seen from Figure 5.2 that under this treatment regime, we obtain “normal”
repair. Hence, we predict that neutralizing TGFβ will significantly reduce wound
contraction through decreasing the presence of myofibroblasts and rescue normal
repair. This is consistent with the experimental findings of Lu et al. (2005) in rabbits
who found a reduction in scar hypertrophy when TGFβ antibodies are injected into
the lesion one week following wounding.
There are a number of proposed treatments that aim to block the TGFβ pathway,
thereby acting as therapeutic strategies for various disorders. These interventions
include blocking TGFβ production or activity, blocking TGFβ receptor activation,
blocking intracellular signal transduction or by blocking coactivator recruitment (Varga
and Pasche, 2009). Indeed, to the authors’ knowledge, of the drugs currently avail-
able that act with anti-TGFβ activity, only Tranilast R© is being applied to hypertrophic
scars and keloids with the view to reducing the appearance of these scars (Varga and
Pasche, 2009). Tranilast R© inhibits the synthesis of collagen in keloid fibroblasts by
suppressing the secretion of TGFβ from fibroblasts (Viera et al., 2010).
Varying the ratio of the different TGFβ isoforms in the wound may also be a vi-
able treatment strategy. The isoforms TGFβ1 and TGFβ2 are known to be strongly
pro-fibrotic, exacerbating the appearance of hypertrophic scars and keloids. How-
ever, topical addition of TGFβ3 has been found to mediate the action of TGFβ1 and
TGFβ2 in acute wounds. Indeed, promising results are currently being obtained by
the Renovo group for the prevention of scars, and the attainment of regenerative
repair (Ferguson and O’Kane, 2004; Occleston et al., 2008). One particular drug,
avotermin R©, which is essentially a delivery system for TGFβ3 is showing promis-
ing results in the treatment of acute wounds in the human dermis (Occleston et al.,
2008). This concept may yet also prove a potential curative strategy for hypertrophic
scars and keloids where heightened TGFβ1 is an issue. Indeed, therapies which aim
to reduce TGFβ1 are currently being investigated as potential treatments for fibrotic
scars (Liu et al., 2004; Viera et al., 2010).
Finally, since inflammation persists until an epithelial cover is restored (Greenhalgh,
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1998), ensuring that there is rapid reepithelialisation may mediate the effects of an
exuberant inflammatory response or indeed, down-regulate the inflammatory re-
sponse itself. This may explain why the practice of transferring keratinocytes (the
cells responsible for reepithelialisation), and thereby covering the burn injury is crit-
ical to the healing of burn injuries (Zhu et al., 2005; Atiyeh and Costagliola, 2007).
Intervention: Increase Myofibroblast Apoptotic Rate
The decrease in contraction when TGFβ is neutralized is associated with the result-
ing reduction in myofibroblast density. Therefore, it is proposed that increasing the
death rate of myofibroblasts could also be an effective method in the case where
TGFβ persists.
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Figure 5.3: Disorder: Small TGFβ decay rate. Intervention: Increase the apoptotic rate of
myofibroblasts on day 8.
Figure 5.3 shows the predictions obtained when the rate of myofibroblast cell death
is increased. While there is a reduction in the predicted extent of contraction, this re-
duction is not sufficient to restore normal repair. Indeed, the wound still heals with
approximately 60% contraction, twice the maximum for normal repair. Therefore,
we predict that simply increasing myofibroblast apoptosis is not an effective treat-
ment strategy when TGFβ is poorly regulated. As mentioned above, TGFβ acts on
the fibroblast population, increasing the activation of fibroblasts to myofibroblasts.
Increasing the myofibroblast apoptotic rate simply enhances the death rate of cells
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once they have become myofibroblasts, but does not address the issue of contin-
ued and heightened activation of fibroblasts to myofibroblasts. However, simply de-
creasing the sensitivity of fibroblasts to activation by TGFβ is predicted to also prove
ineffective as the key issue of continued and heightened presence of TGFβ would
again be left unaddressed. This illustrates that the underlying cause for fibrotic scar
development must be addressed in order to rescue normal wound healing. While
decreasing activation of fibroblasts to myofibroblasts and increasing apoptosis of
myofibroblasts will improve the resulting scar, TGFβ must be targeted if normal re-
pair is to be regained.
These ideas are consistent with observations by Zhang and Phan (1999) and Phan
(2002) in lung tissue, and Chipev and Simon (2002) in dermal tissue, that TGFβ1 can
actually afford protection against apoptosis (Hinz, 2007). Thus, targeting of TGFβ or
myofibroblast apoptosis alone may not be enough, but rather a combination therapy
that neutralizes TGFβ and induces myofibroblast apoptosis may be required.
Interestingly, we note that in each instance, effective treatment strategies ensure that
contraction terminates within three weeks post injury. Figures 5.1 and 5.3 show cases
where contraction is not terminated within this time, and excessive contraction oc-
curs. According to our model, once contraction stops, the healing response has es-
sentially terminated. Thus, the model predicts that early rescuing of normal repair
in order to ensure healing within three weeks post wounding is critical to preventing
hypertrophic scar development. This result is supported by clinical studies of burn
injuries by Cubison et al. (2006) who found that if wounds heal after the three week
point there is a significantly higher risk of hypertrophic scar development.
5.4 Discussion
Our model predicts that targeting of TGFβ and decreasing the myofibroblast density
are effective methods to reduce or eliminate pathological scarring. Therefore, we
suggest that development of treatment modalities that target these aspects of repair
will be the most effective in achieving normal repair of wounds. Importantly, how-
ever, we also determined that early intervention is key, in that normal repair must be
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completed within the first three weeks post wounding. While late interventions re-
duce the overall contraction predicted, the therapy is nowhere near as effective as if
it had been implemented early. As noted above, this is consistent with clinical stud-
ies by Cubison et al. (2006) who found that there is a link between the healing time
of burn injuries and the development of hypertrophic scars. In fact, Cubison et al.
(2006) confirmed that the three week point is an important predictor of hypertrophic
scar development, and that burns which take greater than three weeks to heal are at
a significantly higher risk of developing hypertrophic scars.
Since persistence of TGFβ, chronic inflammation and down-regulated apoptosis
are associated with hypertrophic scar development (Greenhalgh, 1998; Tuan and
Nichter, 1998; Akaishi et al., 2008), and our model predicts that pathological scar-
ring occurs under these circumstances, it is possible that wounds which heal prior
to the three week marker possess a normal or short inflammatory response and
normal regulation of apoptosis, while wounds that require longer to heal have a
prolonged inflammatory response and upregulated apoptosis. Indeed, Greenhalgh
(1998) states that healing of burns is prolonged as a result of chronic inflamma-
tion. Additionally, in this instance, myofibroblasts overcompensate, leading to se-
vere scarring abnormalities (Greenhalgh, 1998). These assertions are confirmed
by the predictions of our model. Therefore, the further implications of this model
should be reliable in that, early treatment modalities which aim to reduce inflam-
mation or induce myofibroblast apoptosis should significantly improve the resulting
scar and reduce the appearance of hypertrophic scars and contractures.
Finally, since myofibroblast activation is enhanced by local skin tension, decreasing
the tension across the wound may reduce the myofibroblast population and there-
fore the risk of hypertrophic scar development. Deep buried subcutaneous sutures
diminish the tension around skin sutures, and many authorities advocate the use of
deep dermal sutures where possible (Zuber, 2002). The horizontal mattress stitch
also reduces skin tension if the distance between the wound edges is sufficient so as
to spread the tension over a greater region with each stitch (Lloyd et al., 2007). An ad-
ditional side effect of this technique may be to physically separate the local sources
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of tension and TGFβ. Since fibroblasts require both tension and TGFβ to differenti-
ate into myofibroblasts, stitching techniques such as this may, by their very nature,
prevent or significantly reduce myofibroblast development. However, care must be
taken as deep suture placement of contaminated wounds, even if thoroughly irri-
gated, results in increasing infection (Lloyd et al., 2007).
In conclusion, we predict that reducing the myofibroblast density and TGFβ con-
centration within healing acute wounds will significantly improve the quality of the
resulting scar, especially if an intervention strategy is implemented early. We have
also presented potential techniques for achieving these aims, together with possible
explanations for why these methods would be effective.

CHAPTER 6
Keloids: A Bio-Mathematician’s Perspective
Keloids are benign dermal tumours arising following injury to the dermis. The scars
invade the neighbouring unwounded tissue and do not regress with time. We de-
velop a mathematical model for keloid growth incorporating cellular, chemical and
mechanical stimuli. We find that the presence of TGFβ vitiates dermal repair, stim-
ulating the formation and spread of highly collagenous tissue indicative of keloid
development. Neutralizing TGFβ was found to predict keloid regression.
6.1 Introduction
As mentioned in Section 2.1.2, keloids represent a type of scar that presents as a
benign dermal tumour formed following a prolonged repair response in genetically-
susceptible individuals (Russell et al., 1989). These scars frequently arise from trivial
injuries such as ear piercings or insect bites (Jagadeesan and Bayat, 2007). They do
not remain within the original wound boundary (Butler et al., 2008). Instead, keloids
invade the surrounding dermis, and do not regress with time (Wolfram et al., 2009).
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Keloids themselves are characterized by a raised appearance, large dense regions
of collagen, elevated collagen expression and the absence of myofibroblasts (Aarabi
et al., 2007; Jagadeesan and Bayat, 2007; Kose and Waseem, 2008; Wolfram et al.,
2009). Experimental observations of collagenase activity are contradictory. Enoch
and Leaper (2007) state that collagenase activity is significantly higher than in nor-
mal wounds, but Wolfram et al. (2009) comment that there is reduced synthesis of
matrix metalloproteinases (MMPs, which include the collagenases). Indeed, Wol-
fram et al. (2009) hypothesises that reduced expression of MMPs is the reason why
keloids do not regress.
While the body of research regarding keloids is extensive, the aetiology of keloids
remains elusive (Enoch and Leaper, 2007). Nonetheless, strongly pro-fibrotic growth
factors such as transforming growth factor-β1 (TGFβ1) and platelet-derived growth
factor (PDGF) have heightened expression in keloid-derived fibroblasts and so have
been proposed as initiators of keloid formation (Butler et al., 2008). Overproduction
and poor regulation of TGFβ is of particular significance as TGFβ is ubiquitous in
the wound repair response (Gordon and Blobe, 2008), and so dysregulation of the
amount of this growth factor can have critical consequences for repair (see Beanes
et al., 2003, or Douglas, 2010, for a review of the role of TGF-β in wound repair).
Several bio-mathematicians have tackled the issue of keloid development. Olsen
and co-workers developed a chemically-driven representation involving PDGF and
persistent inflammation (Olsen et al., 1996, 1997). However, in their description, my-
ofibroblasts are always predicted to be present within the invading scar and in both
their full and caricature model, the fibroblast density is substantially greater than its
healed density (Olsen et al., 1996, 1997). While hypertrophic scars are characterised
by the presence of myofibroblasts and a heightened fibroblast density, keloids are
not (Tuan and Nichter, 1998; Aarabi et al., 2007; Kose and Waseem, 2008; Wolfram
et al., 2009). Thus, even though this model predicts invasion of the healthy dermis,
the resulting scar is not indicative of a keloid, but rather, a hypertrophic-like scar that
invades the surrounding healthy tissue. However, scar hypertrophy is not associated
with tissue invasion (Juckett and Hartman-Adams, 2009).
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Cobbold and Sherratt (2000) also developed a mathematical representation of keloid
and hypertrophic scar development focusing on the importance of nitric oxide.
Known to stimulate collagen secretion by fibroblasts, Cobbold and colleagues pre-
dict that inhibiting nitric oxide will impede keloid recurrence following surgical ex-
cision of keloid tissue. Additionally, Cobbold and Sherratt (2000) state that TGFβ
is not important for keloid development. However, recent experimental research
has highlighted the importance of TGFβ in generating keloids (Peltonen et al., 1991;
Hanasono et al., 2003; Xia et al., 2004; Fujiwara et al., 2005; Jagadeesan and Bayat,
2007).
Neither of these representations examined the effect of mechanics in keloid devel-
opment. Experiments by Chipev and Simon (2002) suggest that tension across the
wound bed is fundamental to determining the severity and type of the resulting
keloid. In Chapter 4, we developed a mechanochemical model for dermal repair
incorporating fibroblasts and myofibroblasts (the main cell types in dermal repair),
TGFβ, collagenase, collagen and tissue mechanics which we briefly overview in Sec-
tion 6.2 (for a full description see Section 4.2). In Section 6.3 we adapt this model
in order to stimulate the generation of a keloid. We then investigate this modified
representation in Section 6.4 to ascertain the conditions for keloid invasion, before
determining possible treatment strategies to induce keloid regression, which we dis-
cuss in Section 6.6.
6.2 Mechanochemical Model Framework
Here, we consider the fibrocontractive model developed in Chapter 4 for the investi-
gation of the growth, cessation and regression of keloids.
The system from Chapter 4 is discretized using finite differences and solved numer-
ically using MATLAB’s inbuilt ordinary differential equation routine, ode45. Advec-
tive terms are estimated by solving the tri-diagonal system obtained by discretising
the force balance expression, (6.10), with displacement found by considering (6.12).
The solutions appear to be independent of grid size when the node count exceeds
roughly 201. Hence, we use a grid size of 401.
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6.2.1 Modelling Keloid Growth
The initial wound size is assumed to be 1cm, and the wound is initially devoid of
fibroblasts, myofibroblasts, collagen and collagenase, but contains TGFβ within the
lesion produced during the inflammatory stage. All species are assumed to be at un-
wounded densities in the tissue surrounding the injury. We allow the wound to heal
and observe the predicted development of a keloid, results for which are in Figures
6.1(a) and 6.1(b).
Since the initial wound is small, the fibroblast density rapidly returns to unwounded
levels within the wound space. As the keloid invades the surrounding dermis, there is
a decrease in the fibroblast density at the invading front corresponding to activation
of fibroblasts to myofibroblasts. As the front passes, the fibroblast density returns to
normal levels. The myofibroblast density is initially zero throughout the domain. At
the invading front of the keloid, the presence of both elastic stress and TGFβ stim-
ulates the activation of fibroblasts to myofibroblasts. However, as the front passes,
the elastic stress returns to zero, as does the myofibroblast density. There is a mov-
ing peak in the density of myofibroblasts at the invading front of the keloid. TGFβ
is produced primarily by the fibroblasts and myofibroblasts. In this model, TGFβ
diffusion into the surrounding dermis is initiating the spread of keloidal tissue. This
increase in TGFβ concentration stimulates fibroblasts and myofibroblasts to syn-
thesize more collagen, yielding a heightened collagen density within the keloid. As
TGFβ inhibits the production of collagenase, the heightened concentration of TGFβ
induces a decrease in collagenase density within the keloid. This contributes to the
excess collagen density as there is reduced degradation of the local collagen network.
Cell traction forces at the wound boundary induce contraction at the invading keloid
front. As the front passes, the cell densities return to their healed levels and the tissue
displacement tends to zero.
It is known that myofibroblasts are activated from fibroblasts in the presence of both
TGFβ and tension (Tomasek et al., 2002). The travelling front of TGFβ together with
the regions of mechanical stimulation indicates that myofibroblasts are present at
the invading front of keloids. Since the displacement is negligible within the keloid,
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Figure 6.1(a): Model predictions for keloid development. Black solid curves represent the
initial conditions. Solid, dashed then dotted blue curves follow alternately, with an incre-
mental time step of 30 days out to 180 days. Grey arrows indicate the direction of time.
The system is computed using equations B.1-B.9. Dimensionless parameter values are:
Dn = 0.001, α = 3, anβ = 2, r = 0.832, amβ = 2, amσ = 0.21, θm = 0.9, θmm = 0.41,
Dβ = 0.025, aβ = 0.1, η = 2, bb = 0.3, aβz = 0.025, aβm = 0.21, δβ = 0.35, κ = 0.1, pi = 2,
aρβ = 2, ω = 0.2, ζ = 2, bz = 5, s = 1, µ = 20, E = 10, λ = 2.2, ξ = 2.
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Figure 6.1(b): Model predictions for keloid development. Black solid curves represent the
initial conditions. Note the initial retraction of the wound boundary. This is a consequence
of large cell traction forces outside and small cell traction forces inside the wound, resulting
in wound expansion. Solid, dashed then dotted blue curves follow alternately, with an in-
cremental time step of 30 days out to 180 days. Grey arrows indicate the direction of time.
Dimensionless parameter values are as defined in Figure 6.1(a).
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this indicates that behind the front there is no mechanical stimulation, and so my-
ofibroblasts are absent in the central area of a keloid. Hence, a travelling front of
myofibroblasts activated by TGFβ and tension at the leading edge of a keloid, with
none present in the remainder of the keloid would be consistent with the experimen-
tal findings that there are no myofibroblasts within keloid tissue (Kose and Waseem,
2008). However, we note that myofibroblasts are not necessary for keloid growth to
occur. Keloids in simulations where the myofibroblast density was uniformly zero at
all times were predicted to grow more slowly then when myofibroblasts are present.
Thus, while myofibroblasts may exacerbate keloid development, these cells are not
necessary for triggering keloids.
This phenomenon of myofibroblasts exacerbating an underlying condition and aid-
ing growth of abnormal tissue is also observed in tumour metastasis. As discussed
by Desmoulie`re et al. (2004), Beacham and Cukierman (2005), De Wever et al. (2008)
and Scha¨fer and Werner (2008) the presence of large numbers of fibroblasts and my-
ofibroblasts in the stroma is a hallmark of advanced cancer. Indeed, Desmoulie`re
et al. (2004) suggests that myofibroblasts may control mechanisms such as tumour
invasion and angiogenesis and suggest myofibroblasts as potentially an important
target for antitumour therapies. This idea of myofibroblasts aiding the spread of ab-
normal tissue is mirrored here, and supports the hypothesis that keloids represent
a benign dermal tumour. Additionally, myofibroblasts are not necessary for the for-
mation of a cancer, but these cells work to aid an already present tumour invade
the surrounding tissue. We predict that myofibroblasts in the periphery of invading
keloid tissue act in a similar manner.
From Figures 6.1(a) and 6.1(b), it can be seen that the keloid has grown approx-
imately 27cm in 6 months and so at a rate of 4.5cm/month or approximately
0.15cm/day. While this rate of keloid expansion may represent normal keloid growth,
keloids, while aggressive, do not invade tissue ad infinitum, as is the case here. Thus,
we now consider a caricature representation to examine the nature of keloid invasion
predicted by this model as well as mechanisms by which cessation or regression of
keloid growth may occur.
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6.3 Caricature Model for Fibroproliferative Wound Healing
Disorders
As mentioned in Section 6.1, myofibroblasts do not appear to be present in keloidal
tissue, and so we assume that the myofibroblast density is identically zero. We as-
sume that fibroblasts are at some uniform density, n0, throughout the domain, such
that n(x, t) = n0 for all x and for all t. We assume that collagenase dynamics are fast,
so that we can make a pseudo-steady state approximation for its local concentration.
We also neglect inhibition of collagenase synthesis by TGFβ. Thus, the collagenase
concentration, z, satisfies the equation
z(x, t) =
az
δz
n0ρ(x, t), (6.1)
where az characterizes the rate of synthesis of collagenase, δz is the intrinsic decay
rate of collagenase and ρ is the collagen density.
We also assume that collagen kinetics are rapid, so that we can make a pseudo-steady
state approximation for the collagen density to give
0 = kn0(1 + aρββ)− δρρz. (6.2)
Substitution of (6.1) into (6.2) and rearranging for the collagen density yields
ρ(x, t) =
√
kδz
δρaz
(1 + aρββ(x, t)), (6.3)
where k is the intrinsic production rate of collagen, δρ characterizes the decay of col-
lagen, aρβ indicates the increase in collagen production by fibroblasts when these
cells are in the presence of TGFβ, and β represents the TGFβ concentration. This
was found to be a good approximation for the collagen density of the full model, ac-
curately predicting the collagen density at all times. From equation (6.3) we see that
the higher the concentration of TGFβ, the higher the collagen density. Increasing
the degradation of collagen, δρ or decreasing the decay of collagenase, δz, so that the
concentration of collagenase is higher, will decrease the collagen density.
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No alterations are made to the governing equation for the TGFβ concentration and
the displacement. Hence, the reduced system we have established to investigate
keloids is
∂β
∂t
+
∂
∂x
(βv) = Dβ
∂2β
∂x2
+
aβn0β
1 + bββ
+ aβzQρβ − δββ, (6.4)
sρu =
∂
∂x
(
Eρ
∂u
∂x
+ µ
∂v
∂x
+ +λρn0
)
, (6.5)
ρ(x, t) = P
√
1 + aρββ(x, t), (6.6)
∂u
∂t
≈ v, (6.7)
Q =
az
δz
n0 and P =
√
kδz
δρaz
, (6.8)
where Dβ is the TGFβ diffusivity, aβ characterises TGFβ production, bβ determines
the inhibition of TGFβ synthesis when TGFβ is present in the system, aβz is the in-
trinsic activation rate of TGFβ from proteolytic cleavage by collagenase, δβ is the in-
trinsic decay rate of TGFβ, s is the tethering coefficient, E is the elastic coefficient,
λ is the parameter characterizing the cell traction force and µ represents the tissue
“viscosity”.
We make the following assumptions about the initial and boundary conditions:
1. Our simulations begin immediately following the closure of the wound;
2. The tissue displacement is zero initially;
3. There is an increased concentration of TGFβ above unwounded levels in the
region corresponding to the closed wound;
4. Due to the pseudo-steady state assumption regarding the collagen density, we
assume the initial collagen density is consistent with the initial condition for
TGFβ, such that there is an increased density of collagen in the region corre-
sponding to the closed wound.
5. Keloids typically arise from small lesions, so we consider an initial half-wound
width of 1mm;
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6. The wound and keloid are symmetric about the centre at x = 0, where dis-
placement is zero and TGFβ takes its non-zero steady state value of β = 0.81225
as determined from (6.9). Solutions for equation (6.9) were ascertained using
Maple (see Appendix C.1), which were then evaluated for the chosen param-
eter set. Phase plane analysis using MATLAB’s routine pplane8 enabled de-
termination of which non-zero steady state would give rise to travelling wave
behaviour;
7. In unwounded dermis and at the boundary far from the scar site, the TGFβ
concentration and displacement are both zero.
We non-dimensionalize the system using
t = T tˆ, x = Lxˆ, ρ = P ρˆ, β = β0βˆ, u = Luˆ and v =
L
T
vˆ,
where T is taken as one day, L is a typical length scale used for skin of 1cm, and β0 is
the initial concentration of TGFβ within the lesion. Hence, dropping hats and bars
for convenience, we obtain the following non-dimensional equations
∂β
∂t
+
∂
∂x
(βv) = Dβ
∂2β
∂x2
+
aββ
1 + bββ
+ aβzρβ − δββ, (6.9)
sρu =
∂
∂x
(
Eρ
∂u
∂x
+ µ
∂v
∂x
+ λρ
)
, (6.10)
ρ(x, t) =
√
1 + aρββ(x, t), (6.11)
∂u
∂t
≈ v. (6.12)
Non-dimensional parameters are given by
D¯β =
DβT
L2
, a¯β = aβn0T, b¯β = bββ0, a¯βz = aβzQn0T, δ¯β = δβT,
a¯ρβ = aρββ0, s¯ = sL
2, E¯ = E, µ¯ =
µ
PT
, λ¯ = λn0.
The same numerical algorithm that was used for the full system is employed to solve
the caricature system.
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Figure 6.2: Predictions from the reduced model of keloid development. Black solid curves
represent the initial conditions. Solid, dashed then dotted blue curves follow alternately,
with an incremental time step of 30 days out to 180 days. Grey arrows indicate the direction
of time. Dimensionless parameter values are: Dβ = 0.025, aβ = 0.4, bβ = 0.36, aβz = 0.025,
δβ = 0.35, aρβ = 2, s = 1, µ = 20, E = 10, λ = 2.2.
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As previously mentioned, one key characteristic of keloid development is the for-
mation and spread of highly collagenous tissue. Therefore, in this study we assume
that a keloid is associated with a “wave” of increased collagen density that “invades”
healthy tissue.
Figure 6.2 shows the result obtained by integrating the reduced system of equations.
As can be seen, keloid invasion is again observed. The TGFβ is heightened within
the scar and diffuses into the surrounding tissue. Consequently, heightened colla-
gen production occurs yielding an increased collagen density within the region cor-
responding to the keloid. Again, we observe a moving trough of displacement asso-
ciated with the keloid interface. This is due to the imbalance in cell traction forces
around the boundary of keloid and normal tissue.
Our model predicts that increasing the synthesis rate of TGFβ as well as decreas-
ing the proteolytic cleavage (characterized by the parameter aβz) allows keloids to
develop. The model predicts travelling wave-like behaviour as the keloid invades
normal tissue as is shown in Figure 6.2 and we will discuss this further in Section 6.4.
Development of the keloid is driven by the diffusion of TGFβ into the surrounding
dermis. As the TGFβ diffuses into normal dermis, production of collagen is increased
resulting in a higher density of collagen behind the TGFβ front. This is not surpris-
ing, since the relationship (6.11) leads us to expect the collagen and TGFβ profiles to
be qualitatively similar.
Figure 6.2 also indicates that there is a moving front of mechanical stimulation coin-
ciding with the leading edge of the keloid. The wave of negative displacement sug-
gests that as the keloid invades normal tissue, contraction occurs. This is caused by
cell traction (the λρ term in equation (6.10)) generated by the difference in collagen
density between normal and keloidal tissue. As the invading front passes, the col-
lagen density around that point becomes uniform, and the displacement tends to
zero.
Our predictions indicate that keloid growth can occur in the absence of myofibrob-
lasts and is associated with the spread of TGFβ. We conclude that while targeting
myofibroblasts may curtail or prevent keloid invasion of the surrounding dermis, an
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intervention strategy which seeks to neutralize TGFβ will likely prove the most effec-
tive method of treatment.
6.4 Travelling Wave Analysis of the Caricature System
Figure 6.2 suggests the presence of travelling wave solutions. We now analyse the
system to determine if these are travelling waves. Firstly, we note that the velocity
is small throughout the simulation, and therefore advection contributes little to the
spread of TGFβ. Hence, we neglect advection in the equation governing the TGFβ
concentration and obtain
∂β
∂t
= Dβ
∂2β
∂x2
+ β
(
aβ
1 + bββ
+ aβz
√
1 + aρββ − δβ
)
. (6.13)
We now make the transformation into travelling wave coordinates z = x− ct, where
c is a constant representing the speed of the wave. This gives the system
dB
dz
=
1
Dβ
(
β
[
δβ − aβ
1 + bββ
− aβz
√
1 + aρββ
]
− cB
)
, (6.14)
dβ
dz
= B. (6.15)
This system has steady states given by,
(β,B) = (0, 0) , and (6.16)
(β,B) =
(
βˆ, 0
)
, (6.17)
where βˆ is the solution of the equation
δβ − aβ
1 + bββˆ
= aβz
√
1 + aρββˆ. (6.18)
We discuss the solutions of (6.18) in Appendix C.1.
For travelling waves to exist, we must ensure that there is at least one positive real
solution to (6.18). We make the assumption that bβ is small (which is true for the
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chosen parameter set), so that (6.18) reduces to
δβ − aβ = aβz
√
1 + aρββˆ, (6.19)
which has the solution of
βˆ =
1
aρβ
(
(δβ − aρ)2
a2βz
− 1
)
. (6.20)
We require a non-zero solution. Hence, we demand the condition that
(δβ − aβ)2 > a2βz (6.21)
or |δβ − aβ| > aβz. (6.22)
Thus, we expect a non-zero solution to exist for (6.18) when (6.22) holds.
To determine the linear stability of these steady states, we consider conditions on
the trace and determinant of the associated Jacobian matrix. For the steady states to
be linearly stable we require
tr(J) = − c
Dβ
< 0, (6.23)
and
det(J) =
1
Dβ
aβz(3aρββˆ + 2)
2
√
1 + aρββˆ
− δβ + aβ
(1 + bββˆ)2
 > 0, (6.24)
where c, Dβ , δβ , aβz, aρβ , aβ and bβ are all positive parameters. The inequality (6.23)
holds for all values of c andDβ . Hence, to determine the stability of each steady state,
we need to consider the condition (6.24).
6.4.1 Linear Stability of the Trivial Steady State
We consider the linear stability of the trivial steady state (0, 0), and so substitute βˆ =
0 into (6.24). This yields the following condition for this steady state to be linearly
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stable:
1
Dβ
(aβ − δβ + aβz) > 0 (6.25)
or aβ + aβz > δβ (6.26)
Hence, normal repair or regression of the keloid will occur when the decay of TGFβ
is greater than its production, when the TGFβ concentration is small. In this case,
we note from the PDE that the TGFβ production is approximately (aβ + aβz)β. Con-
versely, for keloid growth, we require that the production of TGFβ exceed the rate
at which it can be eliminated from the tissue. We have established this result for
small TGFβ concentration and numerical simulations suggest that this is a global
phenomenon. Hence, this suggests that a treatment strategy that aims to neutralize
TGFβ throughout the keloid should trigger regression.
For the existence of travelling waves, we require an unstable steady state. Solutions
to (6.18) using the chosen parameter set were determined, with two possible non-
zero steady states found (see Appendix C.1) of
βˆ1 = 0.81225 and βˆ2 = 90.9756.
Substitution into (6.24) determines that βˆ1 is unstable and βˆ2 is stable. Thus, we
expect travelling waves to exist between βˆ = 0 and βˆ1 = 0.81225. Given the form of
the travelling wave transformation, as x → −∞ or t → ∞, the travelling wave will
tend from βˆ = 0 to βˆ1 = 0.81225. Hence, we will experience keloid growth.
6.4.2 The Minimum Wavespeed
We consider a linearization near the front of the travelling wave to determine a con-
dition for the existence of travelling waves. This reduces (6.14) and (6.15) to
dB
dz
=
1
Dβ
(β (δβ − aβ − aβz)− cB) , (6.27)
dβ
dz
= B, (6.28)
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which we note is equivalent to the Fisher-Kolmogorov system (Murray, 2003a).
The eigenvalues of the Jacobian of this linearized system are as follows
λ =
2
Dβ
(
−c±
√
c2 − 4Dβ (aβ + aβz − δβ)
)
. (6.29)
Therefore, the minimum wavespeed is
c ≥ 2
√
Dβ (aβ + aβz − δβ). (6.30)
Since negative TGFβ concentrations are not physically realistic, we cannot permit
oscillatory solutions. Therefore, we require
aβ + aβz > δβ, (6.31)
which we note is the same condition to ensure the trivial steady state is stable. When
combined with the conditions obtained by considering (6.18), we require that the
parameters satisfy the following conditions in order for the system to admit travel-
ling wave solutions:
Condition 1: aβz < |δβ − aβ| (6.32)
Condition 2: aβ + aβz > δβ. (6.33)
To verify that travelling waves exist for this parameter set, we evaluate the system
described by (6.14) and (6.15) using the MATLAB routine pplane8. Figure 6.3 shows
the results for this system. Similar to the Fisher-Kolmogorov system, the non-zero
steady state for TGFβ is a saddle point, while the trivial steady state is a nodal sink.
From Figure 6.3, it appears that there is a heteroclinic orbit linking the two steady
states.
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Figure 6.3: Phase plane solution determined using MATLAB’s routine pplane8 for
the chosen parameter set. Grey arrows illustrate the vector field, red points show the
locations of the steady states, blue curves indicate solutions and the pink and yellow
curves indicate the nullclines. From the figure it can be seen that a heteroclinic orbit
is likely to exist. From MATLAB the steady states are estimated as (β,B) = (0, 0) and
(β,B) = (0.81125, 0). Dimensionless parameter values are: Dβ = 0.025, aβ = 0.4,
bβ = 0.36, aβz = 0.025, δβ = 0.35, aρβ = 2.
6.5 Cessation of Keloid Growth
In Section 6.2.1, we pointed out that keloids do not continue to invade tissue ad in-
finitum, instead eventually ceasing growth. We now consider how cessation of keloid
growth may be achieved.
In Section 6.4, conditions were determined for the existence of travelling waves, and
therefore, keloid growth. These conditions essentially stated that the net production
of TGFβ must exceed TGFβ decay. Thus, it is proposed that the keloid grows until it
reaches a region where the net TGFβ production is lower than TGFβ decay. Travelling
wave solutions will not exist within this region, and as such negligible concentrations
of TGFβ will prevail, ensuring that fibroblasts do not produce excess collagen, and
as such the keloid boundary will no longer advance. Figure 6.4 illustrates this idea.
Prior to the point x = 20, aβ+aβz > δβ . However, for x > 20, this is no longer the case.
Consequently, the keloid grows until it reaches this “barrier” after approximately 300
days. After which, it ceases invading the surrounding tissue and after 500 days, the
keloid boundary has not advanced beyond this point.
The implication is that there appears to be some signal that terminates keloid
growth. Alternatively, perhaps the keloid grows until it reaches a region where the
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Figure 6.4: Model predictions for cessation of keloid growth. Black solid curves represent
the initial condition of each species. Solid, dashed then dotted blue curves follow alternately,
with an incremental time step of 50 days out to 300 days. At this point, a treatment was
effected that decreased the synthesis rate of TGFβ from aβ = 0.4 to aβ = 0.1 at x = 20.
Final time calculated at t = 500 to show cessation of keloid growth. Grey arrows indicate
the direction of time. Dimensionless parameter values are given by Dβ = 0.025, aβ = 0.4,
bβ = 0.36, aβz = 0.025, δβ = 0.35, aρβ = 2, s = 1, µ = 20, E = 10, λ = 2.2.
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majority of fibroblasts are less sensitive to TGFβ stimulus, and growth is effectively
halted. A similar phenomenon is observed in gluteal muscle contracture (GMC)
where there is excessive production of collagens and TGFβ within the contracture,
but only weak expression in the adjacent muscle (Zhao et al., 2010). Patients with
GMC are also at risk of developing hypertrophic scars and keloids (Zhao et al., 2010).
However, if increased TGFβ synthesis is a symptom of a region of tissue exhibiting
pathological scarring, this begs the question, what is the mechanism that elicits and
maintains heightened expression in this region? In this model, keloid development
is driven by heightened production of TGFβ, suggesting that fibroblast sensitivity to
cues to synthesize TGFβ is the key behind keloid growth.
6.6 Strategies to Stimulate Keloid Regression
Since TGFβ appears to be a potent stimulator of keloid development, numerical sim-
ulations were conducted in which a keloid is allowed to grow until a time where an
intervention is implemented that decreases the concentration of TGFβ. Such a treat-
ment modality was found to cause regression of the keloid (see Figure 6.5) as indi-
cated by the cessation of the moving front, decreased presence of TGFβ, the colla-
gen density tending to normal levels and the displacement tending to zero through-
out the domain. Therefore, we recommend targeting TGFβ, in particular TGFβ1 and
TGFβ2, which are known to be potent pro-fibrotic chemokines.
Currently, a number of potential treatment options exist for reducing the TGFβ con-
centration. These include blocking TGFβ production or activity, blocking TGFβ re-
ceptor activation, blocking coactivator recruitment or by blocking intracellular sig-
nal transduction (Varga and Pasche, 2009). One currently available drug with anti-
TGFβ activity, Tranilast R© suppresses the secretion of TGFβ by fibroblasts thereby
inhibiting the synthesis of collagen in keloid tissue (Viera et al., 2010). In our model,
this corresponds to decreasing TGFβ production by fibroblasts, aβ , which we pre-
dicted to reduce the appearance of keloids through a reduction in TGFβ concentra-
tion and collagen density.
Interestingly, these results agree with predictions by Olsen et al. (1997) who found
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that cessation of PDGF production by fibroblasts also ameliorated scar quality, in-
ducing keloid regression. In light of this and our predictions, we suggest clinicians
actively seek to neutralize both TGFβ and PDGF in order to improve keloid appear-
ance and possibly prevent keloid development.
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Figure 6.5: Model predictions for keloid regression. Black solid curves represent the initial
condition of each species. Solid, dashed then dotted curves follow alternately, with an in-
cremental time step of 60 days out to 180 days. At this point, a treatment was effected that
decreased the synthesis rate of TGFβ from aβ = 0.4 to aβ = 0.3. Simulation curves following
treatment are red. Time increments are then every thirty days and show regression of the
keloid. Grey arrows indicate the direction of time. Parameter values are given byDβ = 0.025,
aβ = 0.4, bβ = 0.36, aβz = 0.025, δβ = 0.35, aρβ = 2, s = 1, µ = 20, E = 10, λ = 2.2.

CHAPTER 7
Conclusions
Biology is fast becoming one of the most attractive fields of applications for math-
ematics. Indeed, using the lens of mathematics, researchers have been able to in-
vestigate a vast array of biological phenomena including pattern formation, popu-
lation dynamics, tumour growth, musculoskeletal repair, infectious diseases and it
has been applied to everything from the molecular to the macroscale.
In this thesis we considered the application of dermal wound repair and the associ-
ated forms of pathological scarring that may result: hypertrophic scars, contractures
and keloids. In particular we examined the interaction between chemical mediators,
cells and the resulting interplay with tissue mechanics.
Chapter 3 saw the development of a morphoelastic representation of dermal repair
that was capable of modelling the large deformations intrinsic to dermal wound
healing. We considered a new representation of the activating mechanism for fibrob-
last to myofibroblast differentiation, considering elastic stress dependence instead
of tractional stress dependence or purely chemical dependence as previously pro-
posed by Javierre et al. (2009) and Olsen et al. (1995), respectively. Significant care
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was taken with parameter estimation in order to maintain confidence that the nu-
merical predictions were accurate. Indeed, this model was able to predict not only
the closure of human dermal wounds, but it received cross-species validation in that
it was capable of simulating the exceptional deformations observed in rat wound re-
pair. We also used this model to investigate possible mechanisms for pathological
scar development, and found that factors which governed the myofibroblast phe-
notype were critical. These features included heightened myofibroblast activation,
decreased myofibroblast apoptosis and the prolonged presence of TGFβ (since TGFβ
mediates the activation of fibroblasts to myofibroblasts). These ideas were explored
more fully in Chapter 5 where potential treatment modalities for hypertrophic scars
and contractures were examined.
While significant care was taken when estimating parameter values, approximations
for some parameters remained elusive. The parameters governing effective strain
cannot be measured. However, an upper bound on these values exists in accordance
with the model assumption that effective strain is small. However, the ratio of kζ to
kρ can significantly influence the type of closure observed and the extent of contrac-
tion. Currently, these parameters are estimated subject to numerical simulations
and are approximated after all other parameters so that the best estimate may be
achieved.
Issues also arose when attempting to determine an appropriate value for the param-
eters governing the extent of fibroblast and myofibroblast traction. This particular
parameter is especially key, with cell traction forces governing the extent of both re-
traction and contraction. Unfortunately, experiments which aim to determine the
forces generated by both fibroblasts and myofibroblasts disagree. Consequently, an
estimate was chosen that was consistent with both numerical predictions and exper-
imental measurements. However, since these parameters could significantly effect
the simulation outcome, as well as inform the appropriateness, applicability and
predictions of the model, there is a large and definate need to ascertain the actual
magnitidue of the force generated by these cells.
147
While this representation involved a far more realistic description of the local tis-
sue mechanics, the fact remains that it is a one-dimensional model, and so spatial
considerations are impossible to consider within this framework. Consequently, ef-
fects such as wound geometry, wound depth, anisotropy and collagen fibre align-
ment, factors known to affect wound contraction and the quality of repair cannot
be examined in this spatially-independent system. Thus, there is a need to extend
this representation by developing a two-dimensional morphoelastic model. Addi-
tionally, there are modelling issues to be overcome when representing this model in
a partial differential equation formulation; most notably with how the form of the
force balance equation should be treated. Indeed, it was chosen to focus on using
the current one-dimensional model to investigate treatments for pathological skin
conditions and thus, a spatial representation of the morphoelastic model of dermal
repair remains as future work.
The morphoelastic description discussed in Chapter 3 possessed a very simple rep-
resentation of the inflammatory kinetics. In reality, the chemical dynamics are
far more complicated than a simple exponential decay curve for just one cytokine
species, and this representation is not sufficient to model the true complex inter-
actions between the cells, growth factors, and the extracellular matrix. Currently,
any effects due to the production of TGFβ cannot be examined, nor can the regula-
tory role of TGFβ on collagen synthesis and degradation. Therefore, an appropriate
extension would be to couple the morphoelastic model to a more general represen-
tation of the chemical and inflammatory kinetics.
The need to incorporate a realistic representation of chemical kinetics within a me-
chanical description of dermal repair led to the development of the fibrocontractive
model described in Chapter 4. The complex interactions between TGFβ, collagen
and collagenase were all introduced. Additionally, we considered the new represen-
tation of fibroblast to myofibroblast activation and incorporated the mechanical de-
pendence of fibroblast and myofibroblast proliferation. Significant parameter esti-
mation was again performed to ensure reliable results. Indeed, the fibrocontractive
model ably simulated the human wound contraction data obtained by Catty (1965),
and was found to simulate all qualitative features of wound repair, when compared
148 Chapter 7. Conclusions
with scaled experimental data for rat dermal repair described by McGrath and Si-
mon (1983). Thus, we are confident that this description also represents a reason-
able simulation of dermal wound repair. Nonetheless, this model is not without its
limitations.
While almost all of the parameters were either stated in or calculated from experi-
mental data reported in the literature, there was found to be a paucity in the exper-
imental literature of researchers reporting basic figures such as the synthesis rates
of TGFβ or collagenase by fibroblasts per day or the ratio of myofibroblast to fibrob-
last activities such as collagen production, proliferation, excretion of growth factors
and cell traction forces. Mathematical models can provide valuable insight into bio-
logical phenomena, but their appropriateness and the reliability of their predictions
lies almost entirely on the information provided by experimentalists. The value and
magnitude of parameters dictates the system dynamics, and if these cannot be found
from the literature, it decreases the likelihood that the model will ably predict exper-
imental observations. There is a great need for significantly more dialogue between
experimentalists and mathematicians, as not only will this improve the predictions
gleaned from mathematical models, but these predictions can inform experimen-
tal investigations and suggest possible mechanisms for the behaviour observed by
experimentalists.
As regards limitations of the model itself, the ratio of TGFβ1 to TGFβ3 is known to
alter scar quality. High TGFβ3 concentrations relative to TGFβ1 yield a healing re-
sponse more representative of regeneration than repair, while heightened levels of
TGFβ1 increase the likelihood of a fibrotic or pathological response. Additionally, the
fibrocontractive system described in Chapter 4 presented a governing equation for
the TGFβ concentration that represented an amalgamation of the latent and active
forms of TGFβ. In reality, TGFβ is secreted from fibroblasts and myofibroblasts in an
inactive form, which must be activated before it can regulate repair. It is also known
that the ratio of collagen type I to III alters the constitution of the extracellular ma-
trix, effecting the tensile strength of the wound. Moreover, this ratio can be used as a
measure for scar quality. Therefore, extensions should be considered which address
these issues.
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Although the fibrocontractive model was capable of simulating the large deforma-
tions associated with human dermal repair, it used a linear viscoelastic framework.
Consequently, the strains predicted by this model are possibly at the limit of the
linear elasticity assumption. As such, a combination of the fibrocontractive model
with a partial differential equation version of the morphoelastic model described in
Chapter 3 would represent a desirable target for future work. Finally, other processes
known to be important in wound healing were not included when developing a sim-
plified representation of the chemical, cellular and mechanical interactions. Thus,
incorporating more complex interactions or other processes, such as reepithelialisa-
tion and angiogenesis (factors also known to influence the quality of wound closure
and scarring), is also left as future work. However, as with the morphoelastic model
where clinical implications were chosen as the focus of research, so too with the fi-
brocontractive model. In Chapter 6, the fibrocontractive model was investigated to
elucidate mechanisms of keloid growth, cessation and regression.
In Chapter 5, we investigated the assertion that prolonged inflammation and down-
regulated myofibroblast apoptosis were critical to hypertrophic scar and contracture
development. The model predictions confirmed that this idea was accurate and that
persistence of TGFβ and myofibroblasts within the wound site caused pathological
scars to develop. As this was found to be the case, we considered treatment regimes
whereby either TGFβ or myofibroblasts were eliminated from the system. If the in-
tervention were applied early, preferably earlier than three weeks post injury, then
significant improvement was predicted. Several suggestions were made for possible
methods whereby either the myofibroblast density or TGFβ concentration within the
wound could be reduced, and therefore act as possible intervention strategies in the
treatment of acute wounds. Together, these results indicate that targeting of TGFβ
and myofibroblasts early in the wound healing response is critical to improving the
healing response or rescuing normal repair.
Finally, Chapter 6 considered the growth, cessation and regression of keloids. It was
found that the full fibrocontractive model described in Chapter 4 was capable of pre-
dicting keloid growth. This growth was mediated by the presence of myofibroblasts
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at the invading front of the keloid, with targeting of myofibroblasts found to signifi-
cantly reduce the invasion speed of keloids. It is also known that myofibroblasts aid
the invasion of tumours into the surrounding tissue. Therefore, due to the similari-
ties between keloid and tumour invasion predicted by this model, it is suggested that
keloids are indeed some form of benign dermal tumour.
A caricature representation of the fibrocontractive model was considered in Chap-
ter 6. Travelling wave analysis of the caricature model found that the key conditions
for keloid growth were for the net production of TGFβ to exceed the decay of TGFβ,
such that the total concentration of TGFβ within the wound remained elevated, and
for the activation of TGFβ due to proteolytic cleavage to be small. As a consequence
of diffusion, the TGFβ invaded the surrounding unwounded dermis causing fibrob-
lasts to increase TGFβ and collagen production, thereby advancing the spread of the
keloid. If the keloid boundary was such that increased TGFβ production is not in-
duced in the surrounding skin, then growth ceased. Together, these ideas suggested
that if the TGFβ production within the keloid were reduced then keloid regression
should occur. This was predicted to be the case. Indeed, travelling waves were not
supported when the net TGFβ production was less than TGFβ decay.
There are many possible extensions of this work, and perhaps one of the most nec-
essarily is the incorporation of angiogenesis into one of the above models. McGrath
and Emery (1985) found that inhibition of angiogenesis results in a delay in the onset
of contraction, thereby impeding wound closure. Indeed, impaired vascularisation
is one feature of chronic wounds (Singer and Clark, 1999). Interestingly, angiogenesis
appears to facilitate keloid development with endothelial cells expressing TGFβ1 and
thereby activating adjacent fibroblasts to produce elevated levels of TGFβ1 and colla-
gen (Peltonen et al., 1991). Furthermore, active angiogenesis and hypoxia appear to
play a key role in maintaining keloids, and consequently, may prevent keloid regres-
sion (Tuan and Nichter, 1998). Moreover, blocking angiogenesis has been proposed
as a therapeutic target for preventing keloid development (Louw, 2007). Hence, in-
hibition of angiogenesis appears to be associated with delays in wound closure or
indeed, prevention of healing as in the case of chronic wounds, while continued
active angiogenesis appears to facilitate over-healing in the form of keloids. Thus,
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angiogenesis appears to be a critical factor in both normal and pathological wound
repair.
Several approaches could be followed when considering the inclusion of angiogen-
esis. The first would be to modify the model of Pettet et al. (1996) or Schugart et al.
(2008) to include inflammation and tissue mechanics. Secondly, one may consider a
simple extension of the fibrocontractive model in Chapter 4 by incorporating the de-
scription of endothelial cells established by Olsen et al. (1997) or Gaffney et al. (2002).
Another approach would be to modify the model of angiogenesis developed by Olsen
et al. (1997), Pettet et al. (1996), Gaffney et al. (2002) or Schugart et al. (2008) from a
partial differential equation description into a one-dimensional version, and com-
bine this representation of angiogenesis with the morphoelastic model described in
Chapter 3. This would yield a model of dermal wound repair incorporating prolifer-
ation, inflammation, angiogenesis and tissue mechanics, allowing the interactions
between each of these aspects of wound repair to be investigated. Moreover, re-
searchers could explore how these components of wound healing cooperate to gen-
erate pathological scarring and chronic wounds.
In this thesis, we have necessarily stood at the interface of biology, mechanics
and mathematics, and have seen the examination of both normal and pathological
wound repair. We have considered possible preventative therapies for hypertrophic
scars and contractures, and methods by which keloid invasion may be terminated
and regression instituted. While in practice, the lofty ideals of “accelerated rates of
ulcer and normal wound repair, scars of greater strength, prevention of keloids and
fibrosis and substitution of tissue regeneration for scar formation” have not yet been
achieved (Clark, 1996), we observe that future coordinated work between the fields
of biology, mechanics, engineering and mathematics will advance the remedies for
poor wound repair and consequently, improve the human condition. Indeed, with
this combined approach we will see today’s scientific breakthroughs become tomor-
row’s therapeutic successes.

APPENDIX A
Appendix for the Morphoelastic Model in Chapter 3
A.1 Parameter Estimates and Non-Dimensionalization
Accurate parameter estimation is always an essential component of the modelling
process. In view of this, it is important to state any simplifying assumptions before
discussing parameter values. In our case:
• The proportionality constants for myofibroblast to fibroblast collagen produc-
tion and degradation are assumed to be equal, and we set η = δ.
• The proportionality constant for myofibroblast to fibroblast matrix turnover is
assumed to be the same as that of myofibroblast collagen production, since
these processes are essentially the same. Hence we set piρ = η.
Before considering the remaining parameters, we estimate values for the scalings
used to non-dimensionalize the variables (see below).
α: A typical length scale for acute dermal wounds is 1cm.
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g: It was chosen to scale time relative to fibroblast proliferation. Alberts et al. (1989),
Morgan and Pledger (1992) and Ghosh et al. (2007) state that the average doubling
time for fibroblasts is approximately 18 − 20 hours. This gives a range for the pro-
liferation rate of 0.832 < g < 0.924, which is consistent with curve fitting estimates
for cell growth from Khorramizadeh et al. (1999). We choose the lower limit, and so
g = 0.832/day.
Nˆ : The carrying capacity of fibroblasts is known to be approximately 106/mL
(Vande Berg et al., 1989). Hence, we take Nˆ = 106cells/mL.
k1/k2: It is known that 30% of newly synthesized collagen is degraded (Aumailley
et al., 1982). Hence, k2 = 0.3k1, such that k1/k2 = 3.33. The value for k1 was chosen
following order of magnitude approximations using numerical simulations, and was
found to be approximately 0.1− 1µg/cell.day.
β0: Yang et al. (1999) found the initial concentration of TGFβ in the wound to be
0.275ng/cm3. Hence, we take β0 = 0.275ng/cm3.
We can now apply the following non-dimensionalization:
L¯ =
L
α
, t¯ = gt, n¯ =
n
Nˆ
, m¯ =
m
Nˆ
, s¯ =
k2s
k1
, S¯ =
k2S
k1
,
e¯ = e, E¯ = E, βˆ =
β
β0
The values for the remaining dimensional parameters are as follows.
R: Experiments by Sillman et al. (2003) on collagen I found that fibroblasts de-
rived from normal human dermal wounds migrate at an average velocity of 0.23 −
0.36µm/min. This gives a range of 0.033 < R < 0.052cm/day. We choose the lower
limit of R = 0.033cm/day.
r: Desmoulie`re et al. (1993) found that culturing fibroblasts in the presence of TGFβ
increased the percentage of cells expressing α-SMA from 7.5% to 45.3%, representing
an activation of 37.8% of fibroblasts. This is consistent with other estimates (Masur
et al., 1996; Moulin et al., 1996). The Desmoulie`re experiment took place over a one
week period, yielding an approximation of r ≈ 0.054/day.
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Y : Estimates of Y range from 10 − 300N/cm2 (Silver et al., 2001; Genzer and Groe-
newold, 2006). We consider an area of approximately 1cm2, which gives a range of
Y of 10 < Y < 300N. We use the estimate by Ahlfors and Billiar (2007) of 71.3N/cm2,
such that Y = 71.3N.
a: Moulin et al. (2004) estimate that 8 − 20% of myofibroblasts undergo apoptosis.
Hence, we choose a = 0.2/day.
b: The TGFβ decay rate was estimated from the exponential phase of the data from
Yang et al. (1999), giving a rate of b ≈ 0.354/day.
η, δ: On a percentage basis, myofibroblasts produce roughly twice the collagen that is
synthesized by fibroblasts (Olsen et al., 1995; Moulin et al., 1998; Kim and Friedman,
2009). Hence, we choose η = δ = 2.
kζ , kρ: During the non-dimensionalization, it was seen that kζ and kρ are both pro-
portional to fibroblast synthesis. Further, since strain must be small, this implies
kζ  kρ. Based on this, we choose kζ = kρ/100.
piζ : This value is unknown. However, since myofibroblasts are much stronger than
fibroblasts, we suggest that piζ is approximately O(10) (i.e. of order 10).
τ : Values for τ differ by several orders of magnitude. By comparing some reported
experimental values and values used in other models of dermal repair, it seems real-
istic to take τ = 2µN/cell. This is consistent with Fray et al. (1998) and Wrobel et al.
(2002).
ζ: Myofibroblasts are known to perform the majority of wound contraction, and so a
value of ζ = 5 was chosen (Olsen et al., 1995; Javierre et al., 2009).
Finally, the following non-dimensionalization is used.
R˜ =
R
αg
, r˜ =
rK1n
gK2n
, Y˜ = Y, a˜ =
a
g
, b˜ =
b
g
κ =
K2nNˆ
g
, η˜ = η = δ = piρ, k˜ρ =
kρκ
k1
, k˜ζ =
kζk1κ
k22
, p˜i = piζ
τ˜ = τNˆ , ζ˜ = ζ.

APPENDIX B
Appendices for the Fibrocontractive Model in
Chapter 4
B.1 Non-Dimensional Equations
Applying the following non-dimensionalization,
Nˆ =
r
θnn
, Bˆ = β0, Zˆ
2 =
azkNˆ
2
δρδζ
, Rˆ =
kNˆ
δρZˆ
, Vˆ =
L
T
D¯n =
DnT
L2
, α¯ = αBT, a¯nβ = anβBˆ, a¯n = rT, a¯mσ = amσT,
a¯mβ = amβBˆ, θ¯m = θmT, θ¯mm = θmmNˆT, a¯β = aβNˆT, b¯β = bβBˆ,
D¯β =
DβT
L2
, η¯ = η, a¯βm =
aβmNˆRˆT
Bˆ
, a¯βz = aβzZˆT, δ¯β = δβT,
K¯ =
kNˆT
Rˆ
, a¯ρβ = aρβBˆ, ω¯ = δζT, b¯ζ = bζBˆ, s¯ = sL
2,
E¯ = E, µ¯ =
µ
RˆT
, λ¯ = λNˆ, ξ¯ = ξ, p¯i = pi,
ζ¯ = ζ,
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and dropping bars, we obtain the following non-dimensional equations,
∂n
∂t
+
∂
∂x
(nv) = Dn
∂2n
∂x2
+ r (1 + anββ)n (1− n)− ασ+βn, (B.1)
∂m
∂t
+
∂
∂x
(mv) = m
(
amσσ
+ (1 + amββ)− θm − θmmm
)
+ ασ+βn, (B.2)
∂β
∂t
+
∂
∂x
(βv) = Dβ
∂2β
∂x2
+
aββ(n+ pim)
1 + bββ
+ aβmmρ+ aβzzβ − δββ (B.3)
∂ρ
∂t
+
∂
∂x
(ρv) = κ ((n+ ηm)(1 + aρββ)− ρz) , (B.4)
∂z
∂t
+
∂
∂x
(zv) = ω
(
ρ(n+ ζm)
1 + bzβ
− z
)
, (B.5)
sρu =
∂
∂x
(
σ + µ
∂v
∂x
+ ψ
)
, (B.6)
σ = Eρ
∂u
∂x
, (B.7)
ψ = λρ(n+ ξm), (B.8)
v =
∂u
∂t
. (B.9)
B.2 Initial Conditions
The following represent the scaled initial conditions employed in this model
n(x, 0) =
1
2
{
1 + tan
(
x− L
n
)}
, (B.10)
m(x, 0) = 0, (B.11)
β(x, 0) =
1
2
{
1− tan
(
x− L
β
)}
, (B.12)
ρ(x, 0) =
1
2
{
(1 + ρin) + (1− ρin)tan
(
x− L
ρ
)}
, (B.13)
z(x, 0) =
1
2
{
1 + tan
(
x− L
z
)}
, (B.14)
where n = 0.1, β = ρ = z = 0.4, controlling the steepness across the boundary,
ρin = 0.1, the initial scaled collagen density within the wound space and L = 1, the
scaled initial position of the wound boundary.
B.3 Parameter Estimation
First, we estimate values for the scalings used to non-dimensionalize the variables:
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L: A typical length scale for acute dermal wounds is 1cm.
T : A typical length scale for time is days. Hence, T = 1 day.
r: In Murphy et al. (2011a) we estimate fibroblast proliferation to be r = 0.832/day.
θ−1nn : The carrying capacity of fibroblasts is known to be approximately 106/mL
(Vande Berg et al., 1989). Hence, we take θ−1nn = 106cells/mL.
k/δρ: It is known that 30% of newly synthesized collagen is degraded (Aumailley et al.,
1982). Hence, δρ = 0.3k, such that k/δρ = 3.33. Bahar et al. (2004) estimates a colla-
gen production rate of 1.75pg/cell.day.
β0: Yang et al. (1999) found the initial concentration of TGFβ in the wound to be
275ng/mL. Hence, we take β0 = 275ng/mL.
We can now apply the following non-dimensionalization.
x¯ =
x
L
, t¯ =
t
T
, n¯ =
n
Nˆ
, m¯ =
m
Nˆ
,
ρ¯ =
ρ
Rˆ
, z¯ =
z
Zˆ
, βˆ =
β
β0
u¯ =
u
L
, v¯ =
Tv
L
,
The values for the remaining dimensional parameters are as follows.
Dn: Experiments by Sillman et al. (2003) found that fibroblasts derived from normal
human dermal wounds migrate at an average velocity of 0.23 − 0.36µm/min. This
gives a range for the minimum wavespeed of 0.00033 < Dn < 0.001cm2/day. We
choose the upper limit of Dn = 0.001cm2/day.
anβ : Strutz et al. (2001) found TGFβ to increase fibroblast proliferation by 2−3 times.
Hence, we assume that anβ = 2/β0.
α: Desmoulie`re et al. (1993) found that culturing fibroblasts in the presence of TGFβ
increased the percentage of cells expressing α-SMA from 7.5% to 45.3%, representing
an activation of 37.8% of fibroblasts, and is consistent with other estimates (Masur
et al., 1996; Moulin et al., 1996). This experiment occurred over a one week period,
with a TGFβ dose of 5 − 10ng/mL. This gives a range for the activation of 0.0054 <
α < 0.0108/day.(ng/mL). We choose the upper limit of α = 0.0108/day.(ng/mL).
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amσ: We assume that myofibroblasts proliferate slowly under stress, with a rate pro-
portional to the fibroblast proliferation rate, such that amσ = 0.25r.
amβ : We assume that myofibroblasts experience the same increase in proliferation
due to TGFβ as fibroblasts. Hence, amβ = anβ .
θm: The doubling time of fibroblasts is approximately 18 hours (Olsen et al., 1995).
We assume that the doubling time of myofibroblast is the same as that for fibroblasts.
Hence, this gives a natural cell death rate for the myofibroblasts of θm ≈ 0.90.
θmm: As myofibroblasts are roughly twice the size of fibroblasts (Masur et al., 1996),
we assume that myofibroblasts have half the carrying capacity of fibroblasts, i.e.,
θmm = 2θnn = (0.5× 106)−1.
Dβ : Using known estimates of the molecular weight of epidermal growth factor
(EGF) and TGFβ (Cell Signaling Technology, 2010) and the diffusivity of epidermal
growth factor (Thorne et al., 2004), we were able to determine the diffusivity of TGFβ
using the Stokes-Eintsein formula, such that Dβ ≈ 0.0254cm2/day.
aβ : Experiments by Wang et al. (2000) give the range for TGFβ production by fibrob-
lasts as 0.125 < aβ < 0.525× 10−6ng/(cell.day). We choose the lower limit, such that
aβ = 0.125× 10−6ng/(cell.day).
η: On a percentage basis, myofibroblasts produce roughly twice the collagen that
is synthesized by fibroblasts (Kim and Friedman, 2009; Moulin et al., 1998; Olsen
et al., 1995). Hence, we choose η = 2. We assume a similar trend for myofibroblast
synthesis of TGFβ and collagenase. Hence, pi = ζ = η = 2.
bβ : Using estimates from Dale (1995), inhibition of TGFβ synthesis is assumed to be
bβ = 0.0013mL/ng.
aβz: Using order of magnitude approximation, we estimate the activation of TGFβ by
collagenase as 0.00144ng/cell.
aβm: We assume that the amount of TGFβ activated from matrix stores is of the same
order of magnitude as the amount of TGFβ activated by collagenase. Hence, we es-
timate the activation of TGFβ by myofibroblasts to be 4.35× 10−9mL.day/cell.
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δβ : The TGFβ decay rate was estimated from the exponential phase of the data from
Yang et al. (1999), giving a rate of δβ ≈ 0.354/day.
aρβ : Eickelberg et al. (1999) found a 2 − 3-fold increase in collagen expression by
human lung fibroblasts in the presence of TGFβ. We assume that TGFβ induces a
similar increase collagen production by dermal fibroblasts. Hence, we estimate that
aρβ = 2/β0.
az: We assume that the non-dimensional collagen growth parameter, κ, should be of
O(10−1). This gives an estimate of az = 4.73× 10−9 (ng/mL)−2.day.
bz: Overall et al. (1991) found a reduction of 66− 75% of collagenase synthesis in the
presence of TGFβ. This gives an estimate of bz = 3/β0.
δz: Overall et al. (1991) estimate the half-life of MMP-2 as 46 hours. We assume that
collagenase (MMP-1) has the same half-life, giving a decay rate of 0.3616/day.
s: Following Tranquillo and Murray (1992), Olsen et al. (1995) and Javierre et al.
(2009), we consider a tethering coefficient of s = 1.
µ: We follow Olsen et al. (1995) and Javierre et al. (2009), and choose µ such that its
non-dimensional value is 20.
E: Estimates of E range from 1 − 300N/cm2 (Silver et al., 2001; Genzer and Groe-
newold, 2006). We consider an area of approximately 1cm2, which gives a range ofE
of 10 < E < 300N. We use the lower limit, such that E = 10N.
τ : In Murphy et al. (2011a), we estimated a range for τ of 1 < τ < 3µN/cell. Hence,
we consider a value of τ = 2.65µN/cell, consistent with Fray et al. (1998) and Wrobel
et al. (2002).
ζ: Wrobel et al. (2002) found that myofibroblasts can apply up to twice the cell trac-
tion force generated by myofibroblasts. Hence, we choose ξ = 2.

APPENDIX C
Appendix for the Keloid Caricature Model in
Chapter 6
C.1 Non-Zero Steady State Solutions for the Fibrocontractive
Caricature Model
The non-zero steady states were calculated with the aid of Maple. As these solutions
are complex, we set
Z = 4(aρβ − bβ)3a4βz + bβ(8δ2β(aρβ − bβ)2 + 9aβaρβ(3aρβaβ
− 4δβ(aρβ − bβ)))a2βz − 4δ3βb2β(aρβaβ − δβ(aρβ − bβ)),
Y = 36a2βz(2δβ(aρβ − bβ)− 3aβaρβ) + 8δ3βbβ,
X =
(
Y + 12aβz
√
3Z
bβ
)
b2β.
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One non-zero steady state is given by
βˆ1 =
1
aρβ

[
X1/3
6aβzbβ
− 2(3a
2
βz(aρβ − bβ)− δ2βbβ)
3aβzX1/3
+
δβ
3aβz
]2
− 1
 .
The other two non-zero steady states are given by
βˆ2,3 =
1
aρβ
{[
(3a2βz(aρβ − bβ)− δ2βbβ)
3aβzX1/3
− X
1/3
12aβzbβ
+
δβ
3aβz
±
√
3i
2
(
X1/3
6aβzbβ
+
2(3a2βz(aρβ − bβ)− δ2βbβ)
aβzX1/3
)]2
− 1
 .
We note that whether or not βˆ1, βˆ2 and βˆ3 are complex depends on the chosen pa-
rameter set. For the parameter set considered in this paper, these steady states can
be estimated as
βˆ1 = 90.9756, βˆ2 = 0.81225, βˆ3 = 0.15663.
We note that βˆ3 does not appear in the phase plane determined by MATLAB in Figure
6.3. To verify, we plot the curves
Y1 = δβ − aβ
1 + bββ
− aβz
√
1 + aρββ (C.1)
Y2 = a
2
βz(1 + aρββˆ)(1 + bββˆ)
2 − (δβ(1 + bββˆ)− aβ)2. (C.2)
where Y1 is the equation we wish to solve and Y2 is the equation given by rearranging
(6.18), representing a squaring of Y1 so as to determine solutions for Y1. Figure C.1
shows these curves for the chosen parameter set.
From Figure C.1, it can be seen that while (C.2) has a solution at β = 0.15663, that
(C.1) does not. Therefore, the solution of β = 0.15663 is a spurious root that arises
during the solution of (C.1). Therefore, the three possible steady state solutions for
β are
βˆ1 = 0, βˆ2 = 0.81225, βˆ3 = 90.9756.
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Figure C.1: Predicted solution curves for β. The black curves represents where Y = 0.
Curves crossing this line indicate a solution of the equation. The red curve corresponds to
Y1, while the blue curve represents Y2. Dimensionless parameter values are: Dβ = 0.025,
aβ = 0.4, bβ = 0.36, aβz = 0.025, δβ = 0.35, aρβ = 2.
Travelling waves have been found to exist between βˆ1 and βˆ2.

List of Symbols
Variable and Parameter Names for the Morphoelastic Model
The following are the variables with their names as used in the morphoelastic model
described in Chapter 3:
• n: Fibroblast density inside the wound
• m: Myofibroblast density inside the wound
• s: Collagen density inside the wound
• e: Effective strain inside the wound
• S: Collagen density outside the wound
• E: Effective strain outside the wound
• L: Distance of wound boundary from wound centre
Table S.1 lists the parameters prior to non-dimensionalization together with their
names and units.
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Parameter Name Units
R Ingress of fibroblasts cm/day
g Fibroblast proliferation 1/day
r Fibroblast activation to myofibroblasts 1/N.(µg)2.day
a Myofibroblast apoptosis 1/day
b TGFβ decay 1/day
k1 Collagen production µg/cell.day
k2 Collagen degradation 1/cell.day
η Relative collagen production by myofibroblasts U
δ Relative collagen degradation by myofibroblasts U
kζ Contractile strain produced by fibroblasts 1/cells.µg.day
kρ Matrix turnover by fibroblasts µg/cells.day
piζ Myofibroblast to fibroblast contractile strain generation U
piρ Myofibroblast to fibroblast remodelling U
Y Elastic modulus N
τ Fibroblast cell traction N/cell
ζ Myofibroblast to fibroblast cell traction U
Table S.1: Table of parameters names and units. U refers to a parameter with unit
dimension.
Variable and Parameter Names for the Fibrocontractive Model
The following are the variables with their names as used in the fibrocontractive
model discussed in Chapter 4:
• n: Fibroblast density
• m: Myofibroblast density
• β: TGFβ concentration
• ρ: Collagen density
• z: Collagenase concentration
• u: Tissue displacement
• σ: Elastic Stress
• ψ Cell traction stress
• v: Tissue velocity
Table S.2 lists the parameters prior to non-dimensionalization together with their
names and units.
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Parameter Name Units
Dn Fibroblast random motility cm2/day
r Fibroblast proliferation 1/day
anβ Enhancement of fibroblast proliferation by TGFβ mL/ng
θnn 1/Fibroblast carry capacity 1/cells
α Fibroblast activation to myofibroblasts 1/day.(ng/mL)
amσ Myofibroblast proliferation 1/day
amβ Enhancement of myofibroblast proliferation by TGFβ mL/ng
θm Myofibroblast apoptosis 1/day
θmm 1/Myofibroblast carrying capacity 1/cells
Dβ TGFβ diffusivity cm2/day
aβ TGFβ synthesis by fibroblasts ng/cell.day
pi Relative TGFβ synthesis by myofibroblasts U
bβ Inhibition of TGFβ synthesis mL/ng
aβm TGFβ activation by myofibroblasts mL.day/cell
aβz TGFβ activation by proteolytic cleavage ng/cell
δβ TGFβ decay 1/day
k Collagen production pg/cell.day
η Relative collagen production by myofibroblasts U
aρβ Enhancing of collagen production by TGFβ mL/ng
δρ Collagen degradation pg/cell.day
az Collagenase production mL2/ng2.day−1
ζ Relative collagenase production by myofibroblasts U
bz Inhibition of collagenase production by TGFβ mL/ng
δz Collagenase decay 1/day
s Tethering coefficient N/cm2
µ Viscosity N.cm.pg/day
Y Elastic modulus N
τ Fibroblast cell traction µN/cell
ξ Ratio of myofibroblast to fibroblast cell traction U
β0 Initial TGFβ concentration ng/mL
Table S.2: Table of parameters names and units. U refers to a parameter with unit
dimension.
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